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EXERCISE-INDUCED EPISODIC LARYNGEAL BREATHING DISORDERS: 
CLINICAL FEATURES AND MECHANISMS 
Adrianna C. Shembel, PhD 
University of Pittsburgh, 2017 
Introduction: Exercise-induced episodic laryngeal breathing disorders (E-ELBD) are frequently 
misdiagnosed, leading to protracted periods of mismanagement (Bernstein, 2014; Traister, Fajt, & 
Petrov, 2016). These shortcomings are due to gaps in differential diagnosis of ELBD. A poor 
understanding of underlying mechanisms driving clinical expression further complicates ELBD 
management. Therefore, objectives of the proposed dissertation study were to (1) identify clinical 
benchmarks indicative of E-ELBD and (2) investigate two potential mechanisms driving E-ELBD: 
autonomic imbalance and stress reactivity (temperament).  
Methods: 13 adolescent athletes with E-ELBD and 14 athletic volunteers participated in an 
exercise challenge and simultaneous flexible laryngoscopy. Participants were asked to rate their 
symptoms at rest and exercise from a list of symptoms associated with ELBD using a visual analog 
scale. Participants were then asked to complete the Early Adolescent Temperament Questionnaire 
(EATQ-R) Fear Subscale to measure perceived stress reactivity. Cardiovascular measures were 
taken throughout the protocol to evaluate autonomic responses. Glottal configuration and 
supraglottic responses at rest and exercise were analyzed post hoc using recorded endoscopic 
videos.  
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Results: Statistical differences between group and condition were seen with dyspnea severity and 
glottal configuration (p < .05). Other clinical features prevalent in the E-ELBD cohort—arytenoid 
prolapse, throat tightness, and stridor—were variably present amongst individuals with and 
without E-ELBD. Smaller sympathetic responses to vigorous exercise and faster parasympathetic 
reactivation post-exertion were observed in the E-ELBD group compared to controls. However, 
differences were not statistically significant (p > 0.05). Finally, responses on the Fear Subscale of 
the EATQ-R showed stress reactivity to be similar between the two groups, with significant 
differences between the athletes and the general adolescent population (p < .001). 
Conclusion: Results showed inspiratory glottal configuration (> 8° adduction) and dyspnea (> 
30/100 on VAS) with provocation to be good diagnostic indicators of E-ELBD. Blunted expiratory 
abduction responses in the E-ELBD group (< 32° abduction) suggests respiratory compensation. 
Sympathovagal balance may play a role in E-ELBD and should be further investigated. Caution 
should be exercised when extrapolating the role of temperament in E-ELBD pathogenesis. 
Outcomes can improve clinical management and sensitivity of inclusionary criteria for future 
studies.  
vi 
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1.0 INTRODUCTION 
 
Breathing is central to survival. We breathe for ventilation (gas exchange) as well as for voicing, 
speech, and smell (CliftonSmith & Rowley, 2011; van Dixhoorn, 1994). Dysfunctional breathing 
patterns can affect any of these tasks. Episodic laryngeal breathing disorders (ELBD) are one 
example of dysfunctional breathing. The term ELBD defines a spectrum of functional respiratory 
disorders thought to originate in the larynx (Christopher et al., 1983; Hoyte, 2013; Shembel, 
Sandage, & Verdolini Abbott, 2017). The predominant symptom is considered to be dyspnea 
resulting from dynamic laryngeal airway obstruction. In ELBD, these dyspneic symptoms are 
episodic, with sudden onset believed to be triggered by sensory, mechanical, or psychological 
stimuli (Christopher & Morris, 2010). Symptoms can be alarming and frightening, with 
considerable adverse effects on quality of life, work or school productivity, and social interactions 
(Mathers-Schmidt, 2001). Terms used to describe this spectrum of conditions include paradoxical 
vocal fold motion disorder (PVFMD), vocal cord dysfunction (VCD), inter-arytenoid region 
prolapse (IARP), irritable larynx syndrome (ILS), and more than 90 additional terms to denote 
pathology based on aberrant laryngeal-respiratory kinematics (Shembel et al., 2017) (see Appendix 
A: Episodic Laryngeal Breathing Disorders Nomenclature for list of terms). ELBD are most likely 
not a single disease process, but a composite of syndromes with as much overlap as there is 
differentiation in their features and mechanisms. Although dyspnea and atypical laryngeal 
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movement are considered axiomatic to the condition, the degree to which signs and symptoms 
present, how they manifest, and the triggers that induce these events can differ across individuals. 
1.1 STATEMENT OF PROBLEM 
ELBD encompass a heterogeneous spectrum of clinical features. Manifestations involve different 
symptom complaints, laryngoscopic findings, and trigger stimuli that induce episodes. In fact, over 
200 observations of ELBD have been described across various bodies of literature within the last 
140 years (Maat et al., 2011). However, efforts to organize and systematize these features have 
been sparse. This lack of unification has led to unclear diagnostic criteria, which has further 
resulted in diagnostic approaches based on exclusion (e.g., cardiopulmonary workup), 
misdiagnoses (e.g., asthma), and mismanagement (e.g., tracheotomy and intubation) (Ibrahim, 
Gheriani, Almohamed, & Raza, 2007). To further complicate matters, symptoms of ELBD both 
mimic and can co-occur with other conditions such as asthma, anxiety disorders, muscle tension 
dysphonia, and allergies (Ayres & Mansur, 2011; Benninger, Parsons, & Mastronarde, 2011; 
Campainha et al., 2012; Caraon & O’toole, 1991; Chiang et al., 2008; Christopher et al., 1983; 
Holmes et al., 2009; Jain et al., 2006; Kenn & Hess, 2008; Kivity et al., 1986; Low et al., 2011; 
MacConnell, Danielsen, & Symington, 2014; Martin et al., 1987; McFadden & Zawadski, 1996; 
Mokoka et al., 2013; Newman & Dubester, 1994; Niggemann et al., 1998; Parsons et al., 2010; 
Sokol, 1993; Tonini et al., 2009; Vertigan et al., 2008; Yelken et al., 2009). Therefore, 
differentiating symptoms specific to ELBD from other conditions can be challenging. In addition 
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to the lack of standardized methods to identify ELBD, there is also poor understanding of 
underlying mechanisms driving its manifestations.  
1.2 SIGNIFICANCE OF WORK 
In sum, gaps in the understanding of ELBD include (1) lack of systematic criteria to identify and 
categorize ELBD pathology, (2) dearth of physiological and pathophysiological comparisons 
between those affected and those without the condition, and (3) poor understanding of underlying 
pathophysiological mechanisms. These gaps have hampered our ability to accurately diagnose and 
treat individuals with ELBD.  The focus in this work is on athletic adolescents with exercise-
induced ELBD (herein referred to as E-ELBD, except for manuscript Chapters 4 & 5, which will 
use exercise-induced paradoxical vocal fold motion disorder [E-PVFM] due to familiarity issues). 
E-ELBD is thought to occur in 3-10% of athletes, typically in those who are young and competitive 
in their athleticism (Abu-Hasan, Tannous, & Weinberger, 2005; Backer, 2010; Brugman, 2003; 
Christensen et al., 2011; Christensen et al., 2010; De Guzman V et al., 2014; Heimdal, Roksund, 
Halvorsen, Skadberg, & Olofsson, 2006; Johansson et al., 2015; Landwehr, Wood II, Blager, & 
Milgrom, 1996; Maat et al., 2007; Nielsen et al., 2013; Nielsen, Hull, & Backer, 2013; Olin et al., 
2014; Rundell & Spiering, 2003). However, it is unclear whether there is truly a higher prevalence 
of E-ELBD in competitive, young athletes, compared to the general adolescent population, or if 
this cohort is more likely to seek medical care due to the burdens E-ELBD imposes on their quality 
of life (Wiese-Bjornstal, 2010). Recent literature suggests, however, that athletes may be at a 
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greater risk of developing breathing problems (11-50%),1 compared to the general population (10-
12%). The thought is this higher prevalence may be related to increased exposure to cold, dry 
environments, or to pollen and pollutants during training periods. These influences can have 
synergistic effects with high physical loads and environmental exposure (Medelli, Lounana, 
Messan, Menuet, & Petitjean, 2006), although this theory is currently speculative. 
Because symptoms mimic exercise-induced asthma, athletes with E-ELBD are often 
misdiagnosed as such and are administered high doses of inhaled corticosteroids or prednisone as 
a first line approach (Abu-Hasan et al., 2005; Bernstein, 2014; De Guzman V et al., 2014; 
Landwehr et al., 1996; Powell et al., 2000). Repercussions of this irrelevant pharmacological 
intervention can involve serious long-lasting iatrogenic consequences including osteoporosis, 
obesity, stunted growth, Cushing’s disease, and hypertension (Christopher et al., 1983; Heinle, 
Linton, & Chidekel, 2003; Nahmias, Tansey, & Karetzky, 1994; Newman, Mason, & Schmaling, 
1995; Noyes & Kemp, 2007; Sokol, 1993). Protracted mismanagement also has psychological 
consequences including impairments to self-concept, feelings of isolation, and withdrawal from 
sports and the sports community altogether (De Guzman et al., 2014; Røksund et al., 2009; 
Weinberg & Gould, 2011). 
                                                 
1 Asthma being the most common breathing condition.  
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1.3 DESCRIPTION OF CHAPTER STRUCTURE 
The goal of this dissertation was to address gaps in knowledge of how we understand and recognize 
E-ELBD clinical presentation and pathogenesis as a means to better manage the condition. This 
work is part of a programmatic line of study to systematically identify biomarkers for ELBD 
subgroups, and to better understand pathophysiological mechanisms driving clinical expression 
across the ELBD spectrum. Chapter 2 is an overview of current knowledge in the domain of ELBD 
across the condition complex, with emphasis on E-ELBD features and mechanisms. Taxonomic 
and etiological frameworks driving the study’s design will also be addressed in this chapter. 
Chapter 3 is an overview of the study’s aims and study design. In brief summary, the primary aim 
(SA1) targeted cardinal features thought to be axiomatic for E-ELBD: paradoxical vocal fold 
adduction with inspiration and inspiratory dyspnea. For this aim, magnitude of glottal obstruction 
(SA1A) and perceived dyspnea severity (SA1B) were quantified at rest and during an attack-
inducing exercise challenge in athletic adolescents diagnosed with E-ELBD, compared to findings 
for athletic control subjects. The goal of the secondary aim (SA2) was to identify auxiliary 
laryngeal patterns (i.e., supraglottic activity—arytenoid prolapse, epiglottic collapse, and 
ventricular compression) (SA2A) and symptoms (SA2B) from a comprehensive list of symptoms 
attributed to E-ELBD and investigate these findings within the same conditions as SA1. The 
exploratory aim (SA3) addressed two potential mechanisms involved in E-ELBD pathogenesis: 
altered autonomic (sympathovagal) balance (SA3A) (Ayres & Gabbott, 2002; Undem, 
McAlexander, & Hunter, 1999) and temperament (stress reactivity, a correlate to anxiety) (SA3B) 
(Al-Alwan & Kaminsky, 2012; Ferris, Eisele, & Tunkel, 1998; Husein et al., 2008; Kaufman, 
Mohebati, & Sotolongo, 2004; Lund, Garmel, Kaplan, & Tom, 1993; Nayar, Zanak, & Ahmed, 
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2003; Niggemann, 2010; R. Patterson, Schatz, & Horton, 1974; Powell et al., 2000; M. S. Smith, 
1983; H. S. Snyder & Weiss, 1989). Chapters 4 and 5 are submission-ready chapters, divided into 
perceptual and physiological features of E-ELBD. Chapter 6 summarizes and synthesizes the 
dissertation study’s findings and provides a description of potential future directions for this 
programmatic line of work. 
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2.0 BACKGROUND & THEORETICAL FRAMEWORKS 
Correctly identifying individuals with E-ELBD is a challenge. No standard definition of E- ELBD 
exists and inclusion/exclusion criteria lack for observable clinical features (Christopher & Morris, 
2010; Lima, 2012; and Campainha et al., 2012). Therefore, methods to correctly diagnose E- 
ELBD and thus prevent frequent mismanagement—the goal of this proposed study—are vital. 
Section 2.1 provides an overview and appraisal of traditional diagnostic approaches in ELBD as 
well as a summary regarding the importance of multidisciplinary study of ELBD to help improve 
diagnostic paradigms. Section 2.2 is a summary of the development of a comprehensive taxonomy 
framework for clinical features of ELBD, using previously proposed conceptual frameworks. 
Applications of the comprehensive taxonomy framework to the dissertation study’s design will 
also be addressed in this section. A summary of potential underlying mechanisms driving clinical 
expressions of ELBD will be addressed in Section 2.3.  
2.1 CURRENT ELBD DIAGNOSTIC STANDARDS  
Standard diagnostic procedures for ELBD involve taking a clinical history to identify symptoms 
suggestive of ELBD; procedures may also involve a physical examination to rule out anatomical 
defects that could be causing symptoms as well as to identify abnormal laryngeal-respiratory 
patterns. Ancillary procedures such as pulmonary function testing (PFT) and measures of blood 
oxygenation levels may also be performed at the time of evaluation, depending on the medical 
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setting. Additional cardiopulmonary, exercise, psychological, allergy, or gastroesophageal testing 
may be warranted, depending on the ELBD presentation. Unfortunately, because no robust 
methods to diagnose ELBD exist, diagnostic protocols are largely based on patient report, 
symptom history, subjective clinical findings, and exclusion after other dyspneic-inducing 
conditions have been ruled out. Furthermore, symptom reporting can be a double-edged sword 
since symptoms are typically non-specific, have poor predictive value, and can mask the 
underlying problem as much as they can provide insights into causes. 
2.1.1 Case history 
Case history in the diagnosis of ELBD provides valuable information. Interview questions may 
pertain to signs and symptoms described by the patient, as well as predisposing or precipitating 
factors. Symptoms described by the patient can shed light on whether other disorders co-occur 
with or resemble ELBD (Martin et al., 1987). Clinicians may follow up with questions related to 
occurrence of dyspnea within the respiratory cycle, sensation of constriction in the throat or chest, 
presence of noisy breathing, onset, resolution, and duration of symptoms, and anything the patient 
has noticed that improves the symptoms or makes symptoms worse. Questions may relate to other 
physiological conditions including gastroesophageal or laryngopharygeal reflux disorders, voice 
problems, or presence of a chronic cough (Hoyte, 2013). Symptom-based questionnaires, such as 
the Dyspnea Index (DI) may be used to quantify perceived severity of dyspneic-related symptoms 
as they relate to quality of life (Gartner-Schmidt, Shembel, Zullo, & Rosen, 2014). Other 
questionnaires, such as the Cough Severity Index (CSI), Voice Handicap Index – 10 (VHI-10), 
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and the Reflux Severity Index (RSI) can all aid in the differential diagnosis of ELBD (Jacobson et 
al., 1997; Shembel, Rosen, Zullo, & Gartner-Schmidt, 2013).  
2.1.2 Physical examination 
The goal of the physical examination is to rule out upper airway obstruction of structural origin, 
laryngeal edema, and to appreciate acute signs of episodic ELBD (e.g., stridor, tachypnea, 
accessory muscle tightness, or clinical signs of heightened anxiety, panic or distress). Direct 
visualization of the larynx with flexible rhino-laryngoscopy (often referred to as flexible 
laryngoscopy) guided through the nose (transnasally) and pharyngeal cavity, with the tip of the 
camera lens near the laryngeal inlet (the opening that connects the pharynx and the larynx), is the 
current gold standard for diagnosing ELBD (Bahrainwala & Simon, 2001; Balkissoon & Kenn, 
2012; Chiang et al., 2008; Christopher & Morris, 2010; Hoyte, 2013; Ibrahim et al., 2007). Once 
the laryngoscope is placed in the optimal position for visualizing laryngeal dynamics, the larynx 
is carefully observed in conjunction with inspiratory/expiratory cyclical respiratory patterns during 
a period of quiet metabolic breathing. The patient may also be asked to perform tasks such as 
sniffing, speaking, or sustaining vowels to rule out vocal fold paresis or paralysis as the cause of 
laryngeal obstruction and associated dyspnea.  
During asymptomatic periods, when no respiratory distress is noted, the arytenoids and 
ventricular folds should be abducted, and the epiglottis should point upwards in such a way that 
the true vocal folds can be readily visualized on laryngoscopy (Blager, 2000). The true vocal folds 
should move slightly away from midline (abduct) during inspiration and should move slightly 
towards midline (adduct) on expiration (Brancatisano, Collett, & Engel, 1983; Klahn & Perlman, 
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1999; Yasushi Murakami & Kirchner, 1972). However, during symptomatic events, any number 
of laryngeal structures may move abnormally or paradoxically. The arytenoids can prolapse 
forwards and downwards, moving towards the open glottis, creating obstruction in the upper 
airways. The ventricular folds can compress medially or anteriorly-posteriorly. The true vocal 
folds can adduct on inspiration or expiration, reducing the area of the glottal lumen. Abnormal 
“twitching,” “shaking,” or “spasms” of the larynx have all been suggested to be characteristic of 
ELBD during both asymptomatic and symptomatic periods (Blager, 2000; Sandhu & Kuchai, 
2013; Treole, Trudeau, & Forrest, 1999).  
The majority of these purported abnormal laryngeal presentations require some sort of 
provocation challenge. The type of challenge is based on the triggers that induce the transient 
episodes in ELBD. For example, individuals with irritant-associated ELBD may be presented with 
perfume, ammonia, capsaicin, or methacholine. Stress may be induced in those with psychogenic-
associated ELBD using a timed mental arithmetic test. Recent literature has also proposed the use 
of continuous laryngoscopy exercise (CLE) testing in individuals with exertion-associated ELBD 
using a treadmill, exercise trainer, or in the swimming pool2 (Heimdal et al., 2006; Maat et al., 
2009; Olivier, Argentão, Lima, da Silva, & dos Santos, 2013; Selner, Staudenmayer, Koepke, 
Harvey, & Christopher, 1987; Tervonen et al., 2009; Walsted et al., 2017). Ideally, trigger 
provocation should be conducted with simultaneous direct visualization of the larynx to be able to 
observe how the larynx responds to the instigating stimuli. 
                                                 
2 Continuous laryngoscopy examinations with swimming have recently been described by Walsted et al., 2017 using 
an inner and outer swim cap, a laryngoscope, waterproof tape to secure the laryngoscope to the nose, and a battery 
powered hand-held monitor/recorder. See Walsted, E.S., Swanton, L.L., van Someren, K. et al. (2017). Laryngoscopy 
during swimming: A novel diagnostic technique to characterize swimming-induced laryngeal obstruction. The 
Laryngoscope. doi: 10.1002/larynx.26532, for details. 
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Various studies suggest laryngoscopy is a highly sensitive diagnostic method when 
individuals with ELBD are symptomatic (Sullivan, Heywood, & Beukelman, 2001). In a study by 
Newman and colleagues, abnormal laryngeal movement was accurately identified during acute 
dyspneic episodes in 100% of participants with known ELBD (Newman et al., 1995). However, 
although laryngoscopy is considered the current gold standard for diagnosing ELBD, according to 
a literature review by Christopher and Morris (2010), only 38% of patients are diagnosed with 
ELBD using direct endoscopic laryngeal visualization methods (Christopher & Morris, 2010).  
Reasons for diagnosing ELBD without laryngoscopy are numerous. First, laryngoscopic 
equipment may not be available due to logistical or budget constraints. Second, because of the 
transient nature of ELBD, an episode may not always occur during the clinical examination or 
within the clinical setting. Third, medical professionals may not want to purposefully induce an 
episode out of concern the individual may not be able to pull out of the ELBD “attack.” Fourth, 
laryngoscopy can be considered invasive. Even if an episode is induced during the clinical 
assessment, these events are understandably frightening, and the patient may not tolerate 
laryngoscopy during the event, resulting in a distressing situation for everyone involved 
(Bernstein, 2014; Hicks, Brugman, & Katial, 2008; Rhodes, 2008).  
As a result of any number of these challenges, clinicians may resort to diagnosing patients 
with ELBD based on exclusion of symptoms, patient interview, or case history out of necessity. 
“Trial treatment” sessions, an inefficient and burdensome method from both the perspective of the 
patient, family/caregivers, and medical staff/resources, may also be used at times to confirm the 
diagnosis made by the referring physician (Bernstein, 2014; Gallena et al., 2013). Diagnostic 
therapy can be especially burdensome when symptoms do not improve with traditional therapy for 
ELBD and the symptoms mimicking ELBD are deemed representative of another condition 
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entirely. The realization that therapy is not helping typically occurs after 3-4 sessions once the 
“buy-in” and investment to partake in therapy with a speech-language pathologist has been made. 
Repercussions include frustration on the part of the patient or family and adverse effects on the 
credibility of the treating clinician and the field of speech-language pathology, in general. 
When laryngoscopy is performed, incorporation of provocation challenge with 
laryngoscopy into standard clinical practice is the exception. Proponents of foregoing provocation 
challenge in conjunction with laryngoscopy believe there are distinct laryngeal presentations 
during asymptomatic periods that indicate ELBD. These presentations include laryngeal edema, 
erythema, and heightened oscillatory responses of the arytenoids to flexible endoscope in the 
laryngeal vestibule, causing a “twitchy”-like pattern of the corniculate cartilages and true vocal 
folds (Andrianopoulos, Gallivan, & Gallivan, 2000; Morrison & Rammage, 2010b; Rosen & 
Murry, 2000; Treole et al., 1999; A. E Vertigan, Gibson, Theodoros, & Winkworth, 2007). The 
thought is that because these characteristics, present at all times, are believed to indicate ELBD, 
the condition can be diagnosed without provocation. However, a dearth of comparisons of 
laryngeal presentations and responses amongst patients with ELBD, healthy normals, and other 
clinical populations lack. Therefore, whether these patterns are specific to the ELBD population 
and whether they are diagnostic indicators of ELBD is unknown. 
The second rationale is that not everyone with suspected ELBD can be induced with 
provocation in the clinical setting. Since case history and symptom reporting are so heavily 
weighted in clinical decision making, a diagnosis of ELBD is provided and the patient treated 
accordingly, regardless of whether an event is provoked. The question then arises as to why 
provoke if the method does not necessarily change the plan of care. However, the absence of an 
ELBD attack may indicate some other condition mimicking ELBD symptoms and should be 
13 
 
considered when an ELBD attack cannot be elicited. Furthermore, when an event is provoked, the 
traditional method involves insertion of the laryngoscope after the instigating stimuli have been 
presented. Unfortunately, previously studies have shown that laryngeal responses to provocation 
can return to baseline very quickly after the instigating stimuli are withdrawn (Bernstein, 2014). 
That robust laryngeal responses to provocation are typically not detected with laryngeal 
examination after stimulus withdrawal is not surprising. 
When laryngoscopy equipment is not available, other ancillary diagnostic procedures may 
be incorporated into the diagnostic assessment. The most common ancillary diagnostic procedure 
is pulmonary function testing (PFT) with flow-volume loops. During asymptomatic intervals, 
flow-volume loops appear normal in individuals with ELBD (and other variable extrathoracic 
obstruction), where the inspiratory loop takes on a U-shaped pattern (Figure 2-1A). During an 
episodic event, the inspiratory loop will be flat, truncated, and saw-toothed instead of U-shaped, 
while the expiratory loop continues to exhibit a normal shape (although at times the loop can 
appear to be diminished) (Figure 2-1B) (Balkissoon & Kenn, 2012; Mikita & Mikita, 2006; Tilles, 
2003; Vlahakis, Patel, Maragos, & Beck, 2002). Inhaled methacholine challenge testing is 
typically used in individuals with lower airway pathology, but is also sometimes used in 
conjunction with PFT in individuals with ELBD. The protocol involves presentation of inhaled 
methacholine in increasing concentrations, with PFT performed prior to and after each incremental 
methacholine increase (Altman et al., 2002; Balkissoon, 2002; MacConnell & Danielsen, 2013; 
Murry et al., 2011; Newman & Dubester, 1994).  
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Figure 2-1. A.) Flow volume loops in normal healthy controls and B.) Flattened inspiratory 
loop with normal expiratory loop, consistent with ELBD. Flow (Liters/sec) is on the Y-Axis 
and volume (Liters) is on the X-Axis. 
 
However, the diagnostic sensitivity and specificity of PFT and methacholine challenge in 
ELBD is uncertain.  A review by Morris and colleagues (2006) showed only 28% of patients with 
ELBD exhibited inspiratory truncation on flow-volume loops when symptomatic. These same PFT 
patterns were also found in a cohort of individuals with ELBD during nasal provocation challenge 
(positive PFT results were found with 29% of symptomatic participants) (Olivier et al., 2013). 
However, in a study by Watson and colleagues (2009), flow-volume loops predicted severity of 
symptoms of ELBD, but results of PFTs were not predictive of simultaneous laryngoscopic 
findings. This is probably because laryngoscopic findings and perceived intensity of dyspneic 
symptoms (and as a result, PFTs) do not always directly correlate. 
In a study to determine the sensitivity of methacholine challenge testing in patients with 
presumed ELBD, 34 participants (10 with ELBD, 12 with exercised-induced asthma, and 12 
healthy controls) with normal flow-volume loops at baseline were recruited from a large army 
A.)  
Abnormal pattern 
in ELBD. 
Truncated, saw-
toothed on 
inspiration 
B.)  
Inspiration 
Expiration 
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medical center. Truncated inspiratory loops were found in four out of the ten (4/10) participants 
with presumed ELBD after exposure to methacholine, although two out of the four participants 
with positive inspiratory results showed inspiratory adduction of the vocal folds at baseline, despite 
the negative flow-volume loops found at that same time. One participant with exercise-induced 
asthma also had truncated flow-volume loops on inspiration, instead of the usual truncated and 
concave appearance on expiration indicative of asthma, after exposure to methacholine (Perkins 
& Morris, 2002). This result is suggestive of either a false positive result or undiagnosed 
extrathoracic airway pathology.  
Results of these studies suggest flow-volume loops and methacholine challenge may not 
always be sensitive or specific to ELBD, but could be used to help differentiate ELBD from asthma 
based on differences in appearances of flow-volume loops between the two pathologies (see Figure 
2-2 for details to distinguish between ELBD and asthma) (Guss & Mirza, 2006).  
 
Figure 2-2. Flow volume loops during different respiratory pathologies. Flow (Liters/sec) is 
on the Y-Axis and volume (Liters) is on the X-Axis. The first flow volume loop is an example of 
normal breathing pattern. The second is an example of a flow volume loop during an ELBD 
episode. The third flow volume loop is an example of breathing patterns during an acute asthma 
attack. Letter (a) pointing to the middle flow volume loop shows truncation that can occur on 
inspiration with ELBD. The letter (b) pointing to the third loop demonstrates a “scooped” 
appearance on expiration that can occur with obstructive lung disease (e.g., asthma). 
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Methacholine challenge may also be more sensitive with certain types of ELBD (e.g., irritant-
associated ELBD). If PFT and methacholine challenge testing is to be used, it should be performed 
in conjunction with laryngoscopy, but should not be used to influence the decision to perform 
laryngoscopy, and should not be performed in place of laryngoscopy, especially when structural 
laryngeal pathology has not been ruled out. This is especially true because flow volume loops may 
appear similar during the inspiratory phases in both fixed extrathoracic (laryngeal) obstruction 
(e.g., laryngeal stenosis; laryngeal neoplasms) (Figure 2-3(a)) and variable extrathoracic (laryngeal 
obstruction (e.g., ELBD) (Figure 2-3(b)), resulting in potential for misdiagnosis with serious 
consequences (e.g., failure to identify laryngeal cancer). 
 
 
 
Figure 2-3. Flow volume loops for different types of airway pathologies. (a) Fixed extrathoracic 
obstruction (e.g., goiter, laryngeal stenosis, tracheal stenosis); (b) variable extrathoracic airway 
obstruction (e.g., tracheomalacia, vocal fold paralysis, ELBD). Inspiratory, but not expiratory, 
volumes are flat because of negative inspiratory pressures “sucking in” laryngeal or tracheal tissue. 
Conversely, expiratory flow is thought to blow the tissue “out of the way” during expiration. Or 
in the case of ELBD, paradoxical laryngeal movement patterns happen on inspiration but not 
expiration, due to unknown mechanisms involved in laryngeal patterns. Flow (Liters/sec) is on the 
Y-Axis and volume (Liters) is on the X-Axis. 
  
 
(a) (b) 
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2.1.3 Common concomitant disorders in differential diagnosis 
A large part of the diagnostic differential process is to rule out other concomitant pathologies that 
could be either co-occurring with ELBD or mimicking ELBD symptoms. The conditions that most 
often co-occur with ELBD are chronic cough, non-organic dysphonic voice disorders (e.g., muscle 
tension dysphonia), gastro-esophageal and laryngo-pharyngeal reflux disorders, and pulmonary 
conditions. Inflammatory disorders, sino-nasal disorders, psychogenic disorders, and symptoms of 
dysphagia have also been suggested to commonly co-occur with ELBD, but their prevalence in, 
and relationship to, ELBD is largely unknown. These conditions are summarized in the following 
sections. 
2.1.3.1 Chronic cough 
Coughing is a normal physiological reflex, initiated by receptors within the larynx, to protect the 
sublaryngeal airways from foreign particulates. The reflex can be activated with any number of 
exogenous or endogenous stimuli, including, but not limited to, upper respiratory infections, 
smoking, lung pathology, reflux disorders, postnasal drip, and use of ACE inhibitors (Bolser & 
Davenport, 2002; Bolser et al., 2006; Boushey, Richardson, & Widdicombe, 1972; Cobeta, 
Pacheco, & Mora, 2013; Fontana & Lavorini, 2006; Irwin, Curley, & French, 1990; Rolla et al., 
1998; Vertigan, Bone, & Gibson, 2013; Widdicombe, 1998).  
When coughing becomes non-productive, refractory, and persists for more than 3 weeks 
without known underlying cause (e.g., upper respiratory infection), it is referred to as chronic 
cough (Chung, 2011; Milgrom et al., 1990). Although there may be no known physiological reason 
or benefit for the cough, chronic cough may be precipitated by a known event such as an upper 
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respiratory infection (URI), or may be present in individuals with asthma or chronic irritant 
exposure. Episodic symptoms of chronic cough usually start with a tickle or sensation in the larynx 
or pharynx, which quickly turn into coughing fits that can result in incontinence, lightheadedness, 
or syncopic events; these presentations can severely affect quality of life to the point of social 
isolation and agoraphobia (Dicpinigaitis, Lim, & Farmakidis, 2014; Hu et al., 2014; Minassian, 
Drutz, & Al-Badr, 2003; Puetz & Vakil, 1995). Symptoms may worsen with external (e.g., noxious 
fumes, temperature/weather change, exercise), internal (e.g., post-nasal drip, GERD/LPR), or 
psychological (e.g., stress, anxiety) triggers. The gold standard for the management of chronic 
cough is a combination of pharmacological intervention (e.g., reflux medication) and behavioral 
management (i.e., cough suppression therapy) (Gaziano & Serrano, 2012; Milgrom et al., 1990; 
Murry & Sapienza, 2010; Ryan, Vertigan, & Gibson, 2009). 
2.1.3.2 Muscle tension dysphonia 
Muscle tension dysphonia (MTD) is a voice disorder proposed to be characterized by normal 
laryngeal anatomy with so-called abnormal physiological coordination between respiratory and 
phonatory gestures (Gillespie et al., 2013; Hixon & Putnam, 1983; Rubin, Macdonald, & Blake, 
2011). Signs and symptoms of MTD involve either the sound or the feel of voice production. 
Deviation in sound may include dysphonia, harsh vocal quality, or pitch breaks; deviation in the 
feel of the voice may include pain with phonation (odynophonia), vocal fatigue or effort, globus 
sensation, or shortness of breath (Koufman & Block, 1982; Sapienza, Al-Natour, Schmalz, & 
Ritter, 2000). 
The exact “abnormal” laryngeal muscle patterns or underlying pathophysiological 
mechanisms that result in muscle tension have yet to be elucidated, although preliminary studies 
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suggest individuals with MTD have some combination of lower than normal lung volumes during 
phonation, increased extrinsic and supraglottic laryngeal muscle activity, greater laryngeal 
resistance and subglottal pressure, and increase in expiratory muscle activation (Gillespie et al., 
2014; Gillespie et al., 2013; Hillman, 2004; Hillman et al., 1989; Mehta & Hillman, 2008). 
2.1.3.3 Pulmonary disorders 
A variety of obstructive and restrictive pulmonary conditions can co-occur with ELBD.3 Reduction 
in airflow in obstructive disorders (e.g., asthma, COPD) occurs with increased secretions, 
inflammation, mucosal thickening, smooth muscle contraction (bronchoconstriction or 
bronchohyperresponsiveness), or edema due to chronic inflammation of the airways. Obstruction 
can also result from destruction of lung tissue (parenchyma). Obstructive diseases are 
characterized by a reduction in expiratory airflow (FEV1 and FEV1/FVC), which occurs when the 
diameter of the airways decreases or there is a loss of elasticity in the lungs. FEV1 is the volume 
of air expired within the first second after full inspiration. In healthy normal individuals, FEV1 is 
between 80-120% of average value, dependent on sex, age, and height. In individuals with 
obstructive disease, FEV1 will be decreased because of increased airway resistance to expiratory 
airflow (West, 2012).  
FVC is forced vital capacity, or the volume of air that can be fully blown out after full 
inspiration. In individuals with lung obstruction, FVC may be reduced due to the premature closure 
of the lower airway during expiration. FEV1/FVC is the ratio between FEV1 and FVC. Usually 
FEV1 will be more reduced than FVC in obstructive disease. Tidal Volume (TV) is the amount of 
                                                 
3 Of note, ELBD is considered a type of (variably) obstructive respiratory condition.  
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air inspired and expired during quiet breathing. In obstructed lungs, TV may be normal or 
increased if air is trapped in the lungs; if there is incomplete emptying of the lungs, over time the 
residual volume (RV) and overall volume of the lungs will increase (TLC). Bronchodilators to 
increase airway diameter or steroids to reduce inflammation within the airways are the standard of 
care for individuals with obstructive disease (West, 2012) (see Figure 2-4 for summary of 
physiological changes in obstructive disorders. 
 
The most common type of obstructive disorder that co-occurs with ELBD is asthma, with 
30-40% of individuals with ELBD thought to have both asthma and ELBD (Christopher & Morris, 
2010; Hicks et al., 2008; Hoyte, 2013). Asthma is a chronic inflammatory lower airway disease, 
characterized by noisy breathing on expiration (wheezing), tightness in the chest, shortness of 
breath, and cough. Asthma exacerbations, as with ELBD, begin with stimuli/triggers (e.g., 
allergens, smoking, pollution, viruses, and occupational exposure), resulting in acute episodes of 
Figure 2-4. Volume and capacity changes in obstructive lung disease. Flow volume loop 
represents these changes in obstructive lung disease. Flow (Liters/sec) is on the Y-Axis and volume 
(Liters) is on the X-Axis. Acronyms: Peak expiratory flow (PEF); mid-expiratory flow (MEF); mid-
inspiratory flow (MIF); forced vital capacity (FVC); total lung capacity (TLC); residual volume 
(RV). 
21 
 
paroxysmal airway hyperresponsiveness and obstruction, commonly referred to as “asthma 
attacks” (Ates & Vaezi, 2014; Krouse et al., 2007).  
To make matters more challenging, ELBD may also be misdiagnosed as asthma in 33-90% 
of cases due to the common overlap in symptom presentation between the two disorders (Koufman 
& Block, 2008; MacConnell & Danielsen, 20103.; Mikita & Mikita, 2006; Morris et al., 2006; 
Nascimento et al., 2013; Tilles & Inglis, 2009). Adverse effects resulting from misdiagnosis are 
not trivial. Data from a systematic review by Hoyte (2013) showed 90% of misdiagnosed patients 
with ELBD were erroneously given bronchodilators (52%) and systemic steroids (44%), the 
standard of care regimen for patients with asthma (Hoyte, 2013). Newman and Dubester (1994) 
found a high prevalence of individuals with ELBD (81%) on exceedingly high corticosteroid 
dosages for prolonged periods. Chronic and unnecessary corticosteroid use can result in iatrogenic 
Cushing’s Syndrome (secondary to hypothalamic-pituitary axis suppression), obesity, 
osteoporosis, diabetes, and hypertension (Heinle, Linton, & Chidekel, 2003; Hicks et al., 2008; 
Mikita & Mikita, 2006; Newman et al., 1995). 
Various methods to distinguish symptoms of asthma from symptoms of ELBD have been 
proposed to help reduce the occurrence of misdiagnosis. Unfortunately, the majority of the 
literature on the asthma/ELBD relationship, except one recent prospective, observational study by 
Bernstein (2014), is based on expert opinion. A summary of reported clinical features and their 
differences between ELBD and asthma from the vantage point of expert opinion (Christopher & 
Morris, 2010; Gallena et al., 2013; Hoyte, 2013; Nascimento et al., 2013; Ritz, Steptoe et al., 2006; 
Sarafino & Goldfedder, 1995; Tilles & Inglis, 2009) and from the perspective of patient-reporting 
(Bernstein, 2014) is shown in Table 2-1. Inconsistencies are most prominent between expert 
opinion versus patient-report with regard to timing of noisy breathing within the respiratory cycle, 
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recurrent symptom rates with additional trigger presentation, and duration of recovery time without 
treatment. 
Specifically, conventional wisdom based on expert opinion considers noisy breathing to 
happen on inspiration (stridor) in individuals with ELBD and on expiration (wheeze) in individuals 
with asthma. However, according to patient self-report, both stridor and wheezing can occur 
equally during episodes of ELBD and acute asthma episodes, suggesting timing of noisy breathing 
as a criterion in the differential should be considered with caution. Additionally, symptoms in 
ELBD are thought to return after repeated exposure of trigger stimuli, usually with increased 
severity during the second exposure. However, patient-reported symptoms suggest this occurs in 
less than half of individuals with ELBD. Last, symptoms in ELBD are believed to resolve as 
quickly as they occurred, but the study by Bernstein (2014) showed more than half of individuals 
with ELBD were still symptomatic more than an hour after the episode was triggered. According 
to the results of the study by Bernstein (2014), the following clinical features may help distinguish 
asthma from ELBD: the disorder may point towards asthma if the individual responds positively 
to bronchodilators, and if there is presence of chest tightness and (possibly) wheezing. Symptoms 
may point towards ELBD if the individual has no response to bronchodilators, and if throat 
tightness is present (Bernstein, 2014). 
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Table 2-1. Upper Versus Lower Respiratory Tract Pathology: Steps Towards Differential 
Diagnosis.4 
 
                                                 
4 Expert opinion columns based on work by Christopher & Morris, 2010; Gallena et al., 2013; Hoyte, 2013; 
Nascimento et al., 2013; Ritz, Steptoe et al., 2006; Sarafino & Goldfedder, 1995; Tilles & Inglis, 2009. Patient reported 
columns are based on a prospective study by Bernstein (2014). 
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2.1.3.4 Rhinosinusitis and reflux disorders 
Systemic irritation conditions are commonly associated with ELBD, especially in the irritant-
associated ELBD variant. Gastroesophageal Reflux Disorder (GERD)5 and laryngopharyngeal 
reflux disorder (LPR) have been reported to co-occur in up 95% of individuals with ELBD 
(Loughlin & Koufman, 1996; Powell et al., 2000). GERD results from relaxation of the lower 
esophageal sphincter, while LPR involves relaxation of the upper esophageal sphincter. Primary 
symptoms of GERD are heartburn and indigestion; primary symptoms of LPR are increased mucus 
production, sour taste, cough, or globus sensation. In a study by Cukier-Blaj et and colleagues 
(2008), 71% of patients with ELBD exhibited abnormal laryngopharyngeal sensitivity thresholds 
and reported abnormally high scores on the Reflux Severity Index (RSI), a patient-centered 
questionnaire targeting severity of reflux symptoms. Individuals with ELBD may also have 
concomitant postnasal drip (PND), allergic rhinitis, or vasomotor rhinitis. These nasal disorders 
include symptoms of sneezing, nasal discharge and obstruction, and rhinorrhea. Concomitant 
cough, bronchoconstriction, and hyper-secretion of mucus in the airways may also be present 
(Annesi-Maesano, 2003; Rajakulasingam & Durham, 2003).  
2.1.4 Multidisciplinary Nature of ELBD Differential Diagnosis  
The differential diagnosis of ELBD requires multidisciplinary collaboration. Distinctions between 
ELBD and structural abnormalities necessitate direct visualization of the larynx with laryngoscopy 
or bronchoscopy, which require a laryngology or pulmonology evaluation. A differential diagnosis 
                                                 
5 GERD can occur in ELBD either by gastric juices entering the laryngeal vestibule directly due to a relaxed lower 
esophageal sphincter (characteristic of GERD). Literature has also suggested GERD may also occur with ELBD with 
distal stimulation of laryngeal vagal afferents (Heatley & Swift, 1996).  
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between ELBD and allergic, inflammatory, or autoimmune processes (or the influence of one on 
the other) may involve an ear, nose, and throat (ENT) physician or allergy specialist. 
Differentiating between ELBD and pulmonary conditions usually warrants a pulmonary 
evaluation, and may even include an additional consult with a respiratory therapist, depending on 
whether lower respiratory tract pathology is suspected. Symptoms of many psychogenic disorders 
overlap with symptoms of ELBD; as a result, individuals with ELBD may find themselves sitting 
on the proverbial psychotherapist’s couch. To complicate matters further, a psychological 
assessment may actually be warranted if ELBD are influenced by psychogenic factors. If the 
ELBD are associated with exertion, the individuals with ELBD may also be referred for consults 
in the field of cardiopulmonary or sports medicine. ELBD that are triggered by endogenous 
irritants such as post-nasal drip or reflux disorders may require the expertise of an ENT physician 
or a gastroenterologist, depending on the source of irritation. When individuals with ELBD finally 
receive their correct diagnosis, they usually are referred to a speech-language pathologist for 
treatment (Appelblatt & Baker, 1981; Gimenez & Zafra, 2011; Mathers-Schmidt, 2001; Vasudev, 
2012). The speech-language pathologist typically continues to collaborate with other medical 
professionals when concurrent pharmacological management is provided. 
To add an additional layer of complication, all of these disciplines must be informed about 
the various clinical features and presentations involved in ELBD in order to appropriately manage 
this spectrum of conditions. Each specialty must not only know how to treat the underlying factors 
that may be related to etiology or may cause episodic triggers, but must also be able to understand 
the relationship of these factors in the presentation and etiology of ELBD, in and of themselves. 
These challenges highlight the fundamental need for multidisciplinary collaboration and a network 
of professionals with interdisciplinary knowledge to best manage ELBD. 
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2.2 CLINICAL FEATURE FRAMEWORKS IN ELBD 
Descriptions of ELBD in the medical literature go back as far as 1842, when Robley Dunglison 
first described symptoms in his book, The Practice of Medicine, as “hysteric croup” consisting of 
“a long-protracted, loud and convulsive cough, followed, at times, by the crowing inspiration, and 
by dyspnea so great as to threaten suffocation.” The role of the larynx in these presentations was 
noted by Sir Morell Mackenzie, who directly visualized the larynx with a laryngeal mirror and 
found “intermittent abnormal movement within the larynx” (Mackenzie, 1869). Since Dunglison’s 
and Mackenzie’s descriptions of ELBD over 140 years ago, over 200 clinical observations of 
ELBD have been documented in various bodies of literature (Maat et al., 2011) across a multitude 
of medical domains (see Table 2-2 for examples).  
Table 2-2. Multiple Disciplinary Contributions to the Study of Laryngeal Breathing 
Disorders 
Disciplines that study and manage episodic laryngeal breathing disorders (ELBD) 
Allergy Gastroenterology Pulmonary 
Alternative 
Medicine 
General Surgery Respiratory Therapy 
Anesthesiology Immunology 
Speech-Language 
Pathology 
Computational 
Biology 
Neurology Sports Medicine 
Emergency 
Medicine 
Nursing Sports Psychology 
Endocrinology Nutrition 
Otolaryngology 
Otorhinology 
Pediatrics 
Pharmacy 
Primary Care 
Psychiatry/
Psychology 
Thoracic 
Therefore, it is surprising that knowledge in this area has not evolved much beyond 
descriptive observations and expert opinion. The shortage of systematic studies on ELBD, 
combined with “siloed” knowledge according to medical domain, has made it nearly impossible 
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to identify clinical patterns and generalize findings across the ELBD spectrum. These gaps have 
left medical providers to diagnose ELBD based on differential exclusion and to make clinical 
decisions based on unsubstantiated claims. These substandard diagnostic approaches explain why 
individuals with ELBD are so frequently misdiagnosed (up to 90%) and why it takes so long for 
their condition to be correctly identified (average 7.5 years) (Bernstein, 2014; Newman, Mason, 
& Schmaling, 1995; Traister, Fajt, Whitman-Purves, Anderson, & Petrov, 2013; Koufman & 
Block, 2008; MacConnell & Danielsen, 20103.; Mikita & Mikita, 2006; Morris et al., 2006; 
Nascimento et al., 2013; Tilles & Inglis, 2009). The lack of diagnostic standards also brings into 
question appropriate inclusionary criteria for future studies that test hypotheses about underlying 
mechanisms and raises doubt on the validity of the few studies that have been conducted on ELBD 
in the past. 
To summarize, the extensive variation in clinical features across the ELBD spectrum, the 
involvement of multiple disciplinary concepts with little multidisciplinary cross-talk, and the lack 
of robust empirical evidence preclude a comprehensive appreciation of ELBD topography across 
the spectrum. The establishment of comprehensive concepts and methods of study would seem 
beneficial from both an academic and clinical perspective. From an academic perspective, the 
establishment of a comprehensive picture of ELBD will allow investigators to accurately identify 
appropriate cohorts of participants for research recruitment purposes. Such an establishment will 
also provide structure when identifying consensus and discrepancy within the literature needing 
further study. From a clinical perspective, these approaches would allow clinicians to recognize 
affected individuals with ELBD more readily, thereby reducing chances of misdiagnosis and 
mismanagement of patients with ELBD. 
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Theoretical frameworks can be used to identify various phenotypic—or the observable 
characteristics of a condition—variants from multiple disciplinary vantage points. Theoretical 
frameworks can also be used in the academic study of ELBD. Conceptual models are appropriate 
when no universal standards or guidelines exist in that they provide a schema and necessary 
groundwork from which to begin to understand or study a phenomenon. In the context of ELBD, 
conceptual models can be used to identify working (prototypic) definitions and inclusion criteria 
for ELBD; they can also provide a systematic method for identifying subgroups and studying 
phenotypic topography within the various clinical presentations. However, the downside to 
conceptual models is that they are based on assumption, and should therefore be treated as dynamic 
working paradigms that change and evolve with new empirical knowledge.  
Several conceptual models have been proposed within the ELBD literature. Unfortunately, 
these models are narrow in their concepts and either fail to address or exclude one or more ELBD 
feature variants, creating challenging for appreciation of the Gestalt of ELBD and the accurate 
study of its topography. Therefore, a more comprehensive conceptual framework was necessary 
to unify and synthesize various clinical feature observations and presentations (i.e., phenotypes). 
The first goal in this endeavor was to review and appraise, as well as to compare and contrast, 
available conceptual frameworks in the literature that addressed clinical presentations of ELBD. 
These three conceptual models have been summarized in Section 2.2.1. An analytic look at how 
to incorporate these models into a broader conceptual framework for clinical feature taxonomy has 
been provided in Section 2.2.2. Integrated concepts amongst these conceptual frameworks became 
part of a larger, comprehensive taxonomic framework of clinical features across the ELBD 
spectrum, described in Section 2.2.3.  
29 
2.2.1 Previous Conceptual Frameworks in the ELBD Literature 
2.2.1.1 Irritable larynx syndrome model 
Irritable Larynx Syndrome (ILS) is a conceptual model based on the etiological assumption the 
larynx becomes hyper-responsive with over-exposure to exogenous or endogenous irritants, 
causing long-lasting “neuroplastic” changes in the brain, and resulting in laryngeal muscle 
“misuse” (Morrison, Rammage, & Emami, 1999). Individuals with ILS experience episodic 
laryngospasms in which the “glottis closes down in such a way as to inhibit airflow” (Morrison et 
al., 1999). When these episodes occur, “patients complain of variants of laryngospasm6 or 
dysphonia, or both, and their symptoms are triggered by something definitive” (Morrison et al., 
1999). Individuals with ILS also exhibit symptoms of chronic cough, globus sensation, or throat 
clearing. Palpable evidence of accessory and strap muscle tension, as well as anterior-posterior 
contraction of the larynx (observed on laryngoscopy) may be present (Morrison et al., 1999). The 
noted symptoms lead to muscle “misuse” resulting in vocal cord dysfunction, muscle tension 
dysphonia, and chronic cough (Morrison et al., 1999).  
Any number of irritant-based triggers may precipitate these symptoms, including strong 
fragrances, noxious fumes, cleaning supplies, foods, odors, airborne particles, voice use, coughing, 
tobacco smoke, post nasal drip, reflux, cold air, and sudden temperature changes (Jaradeh et al., 
6 Although the term “laryngospasm” connotes a physiological presentation, Morrison and colleagues use the term to 
mean both a physical presentation (i.e., observable spasms of the larynx and resultant reflexive laryngeal obstruction 
on laryngoscopy), as well as a symptom (“patients complain of laryngospasms”). The discrepant terminology can lead 
to nomenclature and definition confusion. For the purposes of this review, the term dyspnea will be used to connote 
symptoms of laryngospasm, while the term laryngospasm will be reserved for laryngoscopic findings to minimize 
confusion. Interchanging dyspnea with laryngospasm in this situation is permissible because a.) Morrison and 
colleagues allude to the symptom multiple times in both their 1999 and 2010 publications, and b.) the standard 
definition of laryngospasm directly links laryngeal spasm (confirmed by laryngoscopy) to consequent impeding 
respiration (Alalami, Ayoub, & Baraka, 2008; Fink, 1956; Roy & Lerman, 1988). 
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2000; MacConnell et al., 2014; Morrison et al., 1999; Perkner et al., 1998; Powell et al., 2000). 
ILS is excluded when organic or “neurological” laryngeal pathology is present, or an identifiable 
psychiatric diagnosis can be made (Morrison et al., 1999). However, the authors acknowledge 
“emotions” may play a phenotypic or endotypic (underlying mechanisms driving clinical 
expression) role. 
These same investigators conducted a study involving 39 patients who had a working 
diagnosis of ILS. Results showed dyspnea and dysphonia were the two major symptoms of ILS, 
with secondary symptoms including globus, cough, and perilaryngeal pain. The most common 
triggers reported were airborne irritants and gastroesophageal reflux disease (GERD). Viral 
illnesses as precipitating factors were reported in half of the patients (e.g., flu, herpes, viral 
meningitis, Lyme disease), and GERD was a concomitant disorder in almost all individuals 
(Morrison et al., 1999).  
However, in a later publication, the authors reconsidered their position on cough as being 
a secondary symptom of ILS, and proposed it be considered a primary symptom, along with 
symptoms of dyspnea and dysphonia (Morrison & Rammage, 2010a). Addendums also included 
a bigger role of psychogenic factors in the ILS model, with reference to the authors’ patients who 
often presented to the clinic with accompanying symptoms of anxiety or depression, “especially 
with sudden and distressing episodes of laryngospasm or cough” (Morrison & Rammage, 2010a). 
Additional contributions in the latter publication involved (1) more specific details on supraglottic 
paradoxical patterns: anteroposterior and lateromedial compression, where the former involves the 
“draw[ing] together” of the epiglottis and arytenoids, and the latter involves “squeezing of either 
the glottis or supraglottic structures” and (2) improvement of the definition of laryngospasm: “term 
used to denote airway obstruction, more often inspiratory than expiratory, characterized by 
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adduction of the true vocal folds. Recurring or bothersome laryngospasm was also called ‘vocal 
cord dysfunction’ (VCD) or ‘paradoxical vocal fold motion disorder’ (PVFMD)” (Morrison & 
Rammage, 2010a). 
Conceptually, the ILS model may represent clinical presentations specific to certain 
phenotypic variants of ELBD, including irritant sensitivity and symptoms involving dyspneic, 
dysphonic, and cough patterns. Perkner and colleagues, as well as Andrianopolus and colleagues 
reported similar symptoms in patients with ELBD who had apparent irritant-based triggers. In the 
study by Perkner et al., (1998) irritant-associated ELBD was appreciated in 11 individuals within 
24 hours after exposure to smoke, dust, fumes, gas, and vapors. Common symptoms included 
dyspnea (100%), cough (100%), noisy breathing (70%), choking/throat tightness (90%), chest 
pain/tightness (100%), and voice changes (100%) (Perkner et al., 1998). 
In a retrospective study by Andrianopoulos and colleagues, irritant-variant ELBD was 
appreciated in 10 out of 27 participants with, what the authors referred to as episodic paroxysmal 
laryngospasm (EPL). Medical chart review included demographic information, diagnostic 
procedures used, medical management, comorbidities, and signs and symptoms. This medical 
information was included for any patient with documented “upper airway obstruction,” 
paradoxical vocal cord motion (PVCM), or paradoxical vocal cord dysfunction (PVCD). Triggers 
in this cohort included various foods, perfumes, air pollutants, and chemical agents. Common 
symptoms were acute respiratory distress (60%), dyspnea (44%), cough (60%), noisy breathing 
(70%), choking/throat tightness (60%), chest pain/tightness (16%), and voice changes (20%). 
Results of this study must be interpreted with caution for two reasons. First, symptom complaints 
of individuals with and without sensitivity to irritants were reported together, even after the authors 
acknowledged phenotypic differences. Second, the distinction between respiratory distress and 
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dyspnea was not clear. Regardless, somewhat alarmingly, complaints of respiratory distress and 
dyspnea7 only occurred in about half of individuals included in the study, suggesting the cohort 
chosen for this study may not have been the appropriate target (Andrianopoulos et al., 2000; 
Perkner et al., 1998). Third, it was unclear what kinds of laryngeal responses were considered 
“paradoxical” for the study’s inclusionary criteria. 
The ILS model as a conceptual model may be beneficial for investigations specific to 
individuals with irritant sensitivity. However, this model excludes other trigger variants, such as 
those relating to exertion, and is based on the unsubstantiated assumption that symptoms directly 
related to respiration (i.e., dyspnea) and their corollaries (i.e., cough, dysphonia) are all due to the 
same underlying mechanism (muscle misuse). Until direct causal relationships can be made,8 
inclusion of behaviors not directly related to respiration and laryngeal breathing pathology should 
be treated with caution. Additionally, the model does not distinguish primary/direct causal 
symptoms of ELBD from resultant symptoms of other pathology related to ELBD. For instance, 
dyspnea is a primary symptom of ELBD caused by laryngeal obstruction. Conversely, the inability 
to “catch one’s breath” is secondary to, or a result of, a coughing episode. (see Figure 2-5 for 
schematic representation). 
7 Hallmark symptoms of laryngospasms, PVCM, and PVCD (all terms used to connote laryngeal breathing disorders) 
8 Identifying muscle misuse on laryngeal electromyography (L-EMG), for example. 
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Figure 2-5. Irritable Larynx Syndrome schematic. Model divided into three subgroups: 
symptoms, laryngeal findings, and triggers. 
2.2.1.2 Dichotomous model 
The dichotomous model categorizes ELBD into one of two trigger-induced groups: exercise-
induced vocal cord dysfunction (EIVCD) and spontaneous vocal cord dysfunction (SVCD). The 
predominant symptom in EIVCD and SVCD is shortness of breath during inspiration, which may 
also include symptoms of noisy breathing (stridor). The model was developed based on a 
retrospective chart review of 49 pediatric patients (Doshi & Weinberger, 2006). In this review, 
patient demographics, concomitant diagnoses, treatment recommendations, criteria for the 
diagnosis of laryngeal obstruction, procedures performed, and post-treatment outcomes were 
gathered from patients’ charts. Based on history of recurrent symptoms, two phenotypic 
classifications were identified from this retrospective chart review: 20 in the spontaneous 
phenotypic group and 29 in the exercise phenotypic group. Once the categories had been identified, 
a decision was made to prescribe anticholinergic inhalers to the exercise-induced phenotypic group 
and “speech therapy” to individuals with the spontaneous phenotype (Doshi & Weinberger, 2006). 
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As far as general concepts go, the dichotomous model may be appropriate for individuals 
who experience dyspnea on exertion. Unfortunately, this model is flawed on multiple levels, from 
both a conceptual and an analytical perspective. Conceptually, as with the ILS model, the 
dichotomous model excludes other trigger stimuli variants. Because no further effort to identify 
phenotypic variables within the spontaneous vocal cord dysfunction group was made, it is unclear 
whether alternative clusters of phenotypic variants were present within this group. Additionally, 
the model was constructed using a pediatric cohort and must be interpreted with caution when 
applying it to the general ELBD population. Last, there was no mention of additional triggers in 
the exercise group that could contribute to episodes of ELBD. Analytically, data analysis methods, 
experimental protocol methods, and treatment protocols were not described, which can be 
problematic for future model appraisal, additional analysis, and replication of the study.  
The second concern relates to diagnostic inclusionary criteria. The study cohort was 
determined based on (1) direct laryngoscopy, (2) reversible inspiratory airflow obstruction with 
spirometry in symptomatic patients, or (3) “convincing history of episodic inspiratory stridor” 
(Doshi & Weinberger, 2006). However, only 59% of participants were diagnosed with 
laryngoscopy, and over a third received a diagnosis based solely on patient interview.  As a result, 
it is difficult to conclude all participants in this cohort had symptoms of dyspnea caused by 
laryngeal obstruction.  
For participants who did undergo laryngoscopy, there were no descriptions of laryngeal 
findings in the ELBD cohorts. Other previous studies using direct laryngoscopy suggest laryngeal 
presentation may differ with exercise-associated ELBD as compared to other variants. In a study 
by Christensen and colleagues, paradoxical glottal movement of the true vocal folds, as well as 
supraglottic prolapse of the arytenoids, were noted during a continuous laryngoscopy exercise 
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(CLE) test in the majority of 97 adolescent athletes diagnosed with ELBD (Christensen et al., 
2010). Abu-Hasan and colleagues (2005) also found paradoxical glottal movement, as well as 
arytenoid and epiglottal prolapse, but the latter presentation only occurred in 13 out of the 142 
participants with exercise-induced dyspnea during a similar exercise task. Conceptually, these 
laryngoscopic findings, coupled with identifiable triggers, may provide valuable information for 
identification of phenotypic variants or subgroups relating to athletes with ELBD. Analytically, 
variation in laryngoscopic findings can improve the sensitivity of phenotypic frameworks in 
general (see Figure 2-6 for schematic representation of the Dichotomous Triggers model). 
Figure 2-6. Dichotomous Triggers model. The model identified three issues: Symptoms, 
laryngeal findings, and triggers. Typical “paradoxical” laryngoscopic findings were described in 
the Introduction section of the paper on Dichotomous Triggers, and were therefore included in the 
model’s schematic. However, no descriptions of laryngeal patterns specific to the two ELBD 
cohorts were described in the study. 
2.2.1.3 Periodic occurrence of laryngeal obstruction (POLO) model 
The primary symptom in the Periodic Occurrence of Laryngeal Obstruction (POLO) conceptual 
model is dyspnea with exposure to triggers. Noisy breathing (stridor), chest/throat tightness may 
be associated with dyspneic symptoms (Christopher & Morris, 2010). Complaint of cough and 
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voice changes (dysphonia) in the POLO model is not uncommon. However, in direct contrast to 
the ILS model, Christopher and Morris propose treating symptoms of cough and dysphonia as 
discrete, concomitant entities, binning or “splitting” various laryngeal-based symptoms until 
further empirical study can elucidate their etiological relationships and phenotypic roles in the 
definition and inclusion of ELBD (Christopher & Morris, 2010). Positive laryngoscopic findings 
are corollary to symptoms of dyspnea in the model. Identified structural pathology on 
laryngoscopy (e.g., laryngomalacia), pathologies of known etiology (e.g., laryngospasm secondary 
to intubation), and obstructive airway lesions (e.g., Reinke’s edema) are considered exclusionary 
for the condition. 
The POLO model divides laryngoscopic findings into two categories based on locus of 
obstruction: glottic and supraglottic. Supraglottic obstruction usually occurs on inspiration, 
whereas glottic obstruction may occur during both inspiration and expiration. Locus of laryngeal 
obstruction is then further divided into three categories, based on trigger stimuli: irritants, exertion, 
or psychogenic. POLO classification based on locus of laryngeal obstruction will first be 
addressed; a description of classification based on trigger variants will follow (see Figure 2-7 for 
schematic representation of the POLO model).  
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Figure 2-7. Schematic representation of the POLO model. Three types of ELBD are identified: 
Vocal cord dysfunction, paradoxical vocal fold motion disorder, and intermittent arytenoid 
prolapse (adapted from Christopher and Morris, 2010).  
 
2.2.1.3.1 Locus of laryngeal obstruction  
In the POLO model, laryngeal obstruction at the supraglottic level is referred to as inter-arytenoid 
region prolapse, or IARP.9 Paradoxical supraglottic movement includes anterior or medial motion 
                                                 
9 Special care should be taken not to confuse laryngomalacia or arytenoid subluxation with IARP. Laryngomalacia is 
a structural abnormality involving the cartilaginous structure of the larynx that is too pliable. It is usually seen in the 
pediatric population. The latter involves disruption of the cricoarytenoid joint. It predominantly occurs with severe 
blunt force laryngeal trauma. Both require surgery to mitigate the obstructed airway.  
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of the arytenoids or arytenoid tissue during respiration, resulting in a prolapse of the arytenoids 
over the glottic region. Prolapsed arytenoids are thought to occur with substantial negative 
inspiratory pressures (i.e., Bernoulli effect, Venturi effect) or alteration in muscle tone, causing 
laryngeal tissues to draw together (Bent et al., 1996; Christopher & Morris, 2010). These 
significant pressure changes may occur during maximum exertion or strenuous physical activity, 
which may explain why supraglottic obstruction is thought to be prevalent in athletes (Christopher 
& Morris, 2010; Atsushi Nagai, Kanemura, & Konno, 1992; Pinho, Tsuji, Sennes, & Menezes, 
1997); however, prevalence of these findings has not been empirically studied in this cohort of 
individuals with ELBD. The stridor that sometimes accompanies IARP has been speculated to 
come from vibration of the corniculate cartilages (Christopher & Morris, 2010), although this 
hypothesis has also not been tested. Paradoxical movement of the true vocal folds may also 
accompany IARP, but yet again, this claim has not been tested and the rate of co-occurrence of 
glottal and supraglottic patterns are unknown. Although the arytenoids are mentioned as a locus 
of potential supraglottic obstruction, there is no other mention of supraglottic structures that may 
also cause obstruction, such as the epiglottis, aryepiglottic folds, or ventricular (false) vocal folds. 
Glottic obstruction in the POLO model is referred to as paradoxical vocal fold motion 
disorder (PVFMD) and vocal cord dysfunction (VCD). In both PVFMD and VCD, the true vocal 
folds abnormally adduct towards midline on inspiration. Lateromedial compression on inspiration 
(only) is classified as PVFMD; lateromedial compression with inspiration and expiration is 
classified as VCD according to the POLO model (Christopher & Morris, 2010).  
2.2.1.3.2 Trigger categories and conditions  
The POLO model is similar to the ILS and dichotomous models in that it identifies various stimuli 
that induce dyspneic episodes. The first category, irritant-induced POLO, is similar in concept to 
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the ILS model. As the name suggests, irritants are responsible for laryngeal obstruction and 
episodic dyspnea. Irritants in the POLO model can be further classified into “extrinsic” (from the 
environment) or “intrinsic” (from within the body) triggers. Extrinsic irritants are anything found 
in the environment that is noxious to olfaction, including (but not limited to) chemicals, fumes, 
perfumes, or cleaning supplies. The authors also mention “visual stimulants” as triggers, but what 
is meant by “visual” is unclear. Intrinsic irritants can either stem from supralaryngeal (e.g., 
postnasal drip) or sublaryngeal (e.g., LPR/GERD) sources (Christopher & Morris, 2010).  
The second category, exertion-induced POLO, parallels the dichotomous model. 
Exertional triggers include exercise, athletic competition, or even activities of daily living (ADL), 
especially in deconditioned individuals. Because this trigger variant is prevalent in athletes, the 
symptoms are often mistaken for exercise-induced asthma (EIA) (Christopher & Morris, 2010).   
The third category, psychogenic-induced POLO, is the least well defined of the three 
trigger categories. It is unclear whether psychosomatic factors actually trigger episodic ELBD or 
whether these factors are concomitant in individuals with ELBD. Nevertheless, psychogenic 
influences in the POLO model include (1) anxiety, (2) stress, (3) depression, (4) “somatoform 
disorder”10, (5) “conversion disorder,” (6) psychiatric history, (7) history of sexual abuse, and (8) 
“mass psychogenic illness” (Christopher & Morris, 2010).  
Conceptually, the POLO model is the most comprehensive of the three conceptual models, 
in that it considers other phenotypic presentations besides triggers, and makes attempts to compare 
laryngeal findings with respective triggers. As a result, a more comprehensive presentation of 
ELBD across multiple possible variants can be appreciated. However, because the prevalence of 
                                                 
10 “Somatoform disorder” was renamed in the DSM-5. Both “somatoform disorder” and “conversion disorder” are 
subcategories of somatic symptom disorder. 
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laryngeal findings with certain trigger variants has not yet been directly (prospectively) studied, 
placing triggers within the category of locus of obstruction may, at this time, be premature. The 
same can be said for classification of symptoms related to laryngeal behaviors. Symptoms of cough 
and dysphonia are treated as divergent entities within the POLO framework. The authors make a 
proposal to “split” these symptoms until otherwise noted, but do not provide rationale for their 
decision.  
Section 2.2.2 provides an analytic look at approaches to the classification of ELBD clinical 
features. These methods were used to inform the composition of the comprehensive taxonomy 
framework, described in Section 2.2.3.  
2.2.2 An analytical look at ELBD classification  
In their literature review on ELBD, Christopher and Morris (2010) discuss two approaches to 
categorizing ELBD concepts related to laryngeal behaviors: lumping and splitting. The lumping 
approach classifies and defines any clinical features in ELBD as primary symptoms based on the 
hypothesis they share clinical features and have the same anatomical or pathophysiological origin. 
The ILS model is a classic example of the lumping method. Laryngeal behaviors, including 
dyspnea, dysphonia, and cough, in the ILS model are assumed in the same inclusionary definition 
because they all come from the glottis (origin) and involve muscle “misuse” (pathophysiology). 
Although Christopher and Morris suggest treating symptoms of cough and dysphonia as separate 
entities, they do recommend the lumping approach for certain situations so as to not get “bog[ged] 
down with the process of classification and speculation regarding specific cause[s].” Laryngeal 
variations in locus of laryngeal obstruction, glottal patterns, and its triggers can be considered a 
form of lumping into the conceptual framework of the POLO model (Christopher & Morris, 2010). 
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The authors then suggest the predetermined classification system can be used to evolve concepts 
with better appreciation of what is “in the [classification] box” (Christopher & Morris, 2010).  
Conversely, the splitting approach classifies laryngeal behaviors (e.g., airway protection, 
communication, respiratory modulation) into separate categories in the POLO model. Within the 
framework of ELBD, laryngeal behaviors that beget dyspnea are considered inclusionary, while 
behaviors related to coughing or communication fall into distinct categories. Splitting focuses on 
the study of differences in clinical features and their underlying mechanisms in relation to 
dyspneic-inducing laryngeal behaviors. Christopher and Morris advocate first lumping laryngeal 
characteristics related to dyspnea into the same inclusionary definition of ELBD and then 
appraising the differences among their associated signs and symptoms (i.e., locus of obstruction, 
trigger types that induce obstruction) (Christopher & Morris, 2010).  
The splitting approach may be a preferable method for building a framework for ELBD. 
Conceptually, splitting laryngeal behaviors (e.g., airway protection, communication, respiratory 
modulation) may be sensible when underlying pathophysiological mechanisms are largely 
unknown and normal physiological mechanisms are not well understood. Otherwise the 
framework may be erroneously built on false pretense if the underlying assumption is incorrect. 
Analytically, studying mechanisms separately for each laryngeal behavior and its associated 
pathological symptom(s) provides a systematic approach to understanding physiological and 
pathophysiological mechanisms and their relationships in laryngeal behavior. In other words, 
studying laryngeal behaviors separately and then considering their overlap once mechanisms are 
better understood yields less error as compared to starting with an assumption and delineating 
mechanistic differences from said assumption.  
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Figure 2-8 is a visual representation of a proposed analytical framework to systematically 
evaluate mechanisms involved in laryngeal behaviors and resultant pathological symptoms. The 
schematic is by no means comprehensive; the goal is to illustrate the benefit of using the splitting 
analysis method. The splitting approach starts with (1) normal physiological mechanisms involved 
in laryngeal behaviors (respiratory modulation, airway protection, and communication), the (2) 
influences of structural or anatomical origin (at the supralaryngeal, laryngeal, and sublaryngeal 
levels), (3) examples of pathological causal mechanisms (white boxes), and (4) resultant 
pathophysiological symptoms (dyspnea, cough, dysphonia).  
 
Figure 2-8. Physiological and pathophysiological mechanisms involved in various laryngeal 
behaviors including ELBD and other voice and laryngeal-associated symptoms. 
 
2.2.3 Comprehensive Taxonomy Framework  
Previously proposed conceptual frameworks in ELBD presentation may be myopic when used in 
isolation, but when considered together, provide a nice blueprint for comprehensive taxonomy 
frameworks in the study of ELBD. Integrating the three previously proposed conceptual models 
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in the ELBD literature increases reliability of reported clinical features in ELBD across various 
disciplines, and reduces the potential for “unknown unknowns.” Conceptually, integration of the 
three models provides a more comprehensive platform than consideration of any of the models 
alone for working definitions, inclusion criteria, and identification of subgroup clusters that may 
otherwise have been missed without a systematic approach. Analytically, the integrated models 
can be used to systematically appraise current literature, can identify areas of discrepancy and gaps 
requiring further investigation, and can provide a springboard for future interdisciplinary 
discussion and consensus.  
Consensus across the models provided a springboard for a working definition of ELBD, as 
well as identification of applicable inclusion criteria and potential subgroups for the dissertation 
study. Inconsistencies and discrepancies in concepts across the conceptual models provided an 
analytical platform for an additional literature review and future study investigations. The second 
literature review (Section 2.2.3.2) culminated in an updated comprehensive framework (Section 
2.2.3.3) and drove the dissertation study’s research design (Chapter 3). 
2.2.3.1 Original Comprehensive Taxonomy Framework 
Figure 2-9 is a schematic representation of an original comprehensive taxonomy framework, based 
on integration of the three previously proposed conceptual models: Irritable Larynx Syndrome 
(ILS), Dichotomous Triggers (DT), and Periodic Occurrence of Laryngeal Obstruction (POLO). 
This framework was lumped into three categories: (1) characteristics of laryngeal-respiratory 
kinematics (“Laryngoscopic Findings” in Figure 2-9), self-reported symptoms (“Symptoms” in 
Figure 2-9), and episode-inducing triggers (“Triggers” in Figure 2-9). Integrated concepts found 
across all three models are represented in grey boxes (solid borders). The grey boxes show that all 
three previously proposed models (ILS, DT, and POLO) reported episodic periods of inspiratory 
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dyspnea as the primary symptom in ELBD. All three models also agree that this primary dyspneic 
symptom is a direct result of laryngeal obstruction at the glottal level, with abnormal lateromedial 
adduction occurring within the inspiratory respiratory cycle. Last, the three models recognize 
stimuli of various kinds trigger these acute clinical presentations of dyspneic symptoms and 
correlative laryngeal findings. Conceptual overlap in the models can be constructed into the 
following operational definition of ELBD: trigger-induced glottic obstruction presenting as 
episodic inspiratory dyspnea. This operational definition was used to inform the dissertation 
study’s experimental design.  
 
Figure 2-9. Original comprehensive taxonomy framework. The framework is based on the 
following three models: Irritable Larynx Syndrome (ILS), Dichotomous Triggers (DT), and 
Periodic Occurrence of Laryngeal Obstruction (POLO). Grey (solid) boxes represent clinical 
features common across the three ELBD models (ILS, DT, and POLO). Colored (dotted) boxes 
represent feature discrepancies across the models. ELM = extrinsic laryngeal muscle. ILM = 
intrinsic laryngeal muscle. Ant-post. = anterior-posterior. Lat-med. = lateral-medial. 
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Colored boxes (dotted borders) in Figure 2-9 represent inconsistency and discrepancy 
across the three conceptual models. These boxes provide a systematic visual method to identify 
areas requiring further investigation. In some situations, clinical features were not addressed across 
all the models, including symptoms of dyspnea on expiratory phase, upper body tightness, or 
stridor. The presence of supraglottic obstruction, expiratory patterns within the respiratory cycle, 
and anteroposterior laryngeal muscle patterns were also not universal across all models. Last, the 
variety in reported triggers across the model suggest there are different stimuli that cause these 
acute presentations of clinical signs and symptoms.  
A few hypotheses may provide explanation for these findings.  First, it could be that the 
clinical features variably described are not common across all types of ELBD within the condition 
spectrum. The second reason could have to do with “unknown unknowns.” Some clinical features 
may not have been reported simply because they were not considered. As the authors of the POLO 
models mention, “if you don’t think about it, you can’t diagnose it” (Christopher & Morris, 2010). 
A third reason for inconsistencies or discrepancies across the models could be due to clinical 
feature over-reporting where some of the mentioned features may not be indicative of ELBD, but 
may instead represent other co-occurring conditions. For example, psychogenic disorders, 
addressed in the POLO model, may co-occur with ELBD but may not actually be a trigger that 
induces episodes. Expiratory vocal fold adduction may be a normal variant in commonly co-
occurring pulmonary disorders, but are not indicative of ELBD pathophysiology. Symptoms of 
cough or dysphonia in the ILS and POLO models may co-occur with ELBD, and may signify a 
separate but concomitant disorder. Referring back to Figure 2-9, the colored boxes also show 
discrepancy in interpretation of clinical features across the three models. Specifically, the POLO 
model treats symptoms of cough and dysphonia as concomitant, yet distinct entities, while in the 
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ILS model, these symptoms are considered primary symptoms of ELBD. Further study involving 
physiological and pathophysiological mechanisms relating to the larynx in various laryngeal 
behaviors, combined with patient-centered symptom reporting, is needed to elucidate the role of 
laryngeal behaviors in the ELBD framework. 
The next sections will focus on the current literature in ELBD presentation using the three 
lumped categories of clinical feature classification as a guide: laryngeal-respiratory dynamics, self-
reported symptoms, and episodic triggers. The ways in which these categories can be used to study 
the role of various split features in ELBD presentation and pathophysiology will also be addressed. 
2.2.3.2 Additional Literature Review for Updated Comprehensive Taxonomy Framework 
2.2.3.2.1 Laryngeal-respiratory dynamics 
The majority of research on laryngeal-respiratory kinematics can be found in the voice, speech, 
and swallowing literature. However, because breathing patterns for these tasks have kinematic 
properties distinct from those for vegetative breathing at rest and with different ventilatory 
demands (e.g., exercise) (Moore, Caulfield, & Green, 2001), extrapolating findings from these 
other areas of work to the ELBD population can be problematic. There is a common misconception 
that glottal configuration remains constant in respiratory dynamics within healthy populations 
(Scheinherr et al., 2015). Furthermore, the majority of work in laryngeal function for breathing has 
been conducted in quadrupedal, anesthetized, and tracheotomized animal models. The downside 
to generalizing findings directly from these animal models, without taking into account differences 
between subject types and study protocol methods, can result in misunderstanding of laryngeal-
respiratory dynamics in awake, behaving humans. First, respiratory biomechanics in quadrupedal 
animals likely differ from those of bipedal animals (i.e., humans), due to variations in gravitational 
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pull of respiratory muscles (caudal versus ventral positioning). Gravitational differences could 
mean different muscle combinations are involved in laryngeal-pulmonary coupling. Second, 
pharmacological agents used in anesthesia, such as ketamine and xylazine, have been shown to 
affect respiratory patterns (Erhardt, Hebestedt, Aschenbrenner, Pichotka, & Blümel, 1984). 
Therefore, whether (and how) these breathing patterns differ in eupneic humans versus 
anesthetized animals is largely unknown. How airflow affects laryngeal configuration and 
laryngeal-pulmonary muscle coordination has yet to be compared in tracheotomized and non-
tracheotomized subjects. 
Having said as much, what is known of laryngeal dynamics during tidal breathing in 
humans is that laryngeal breathing involves stereotypic, phasic, synchronized movement patterns 
controlled by respiratory musculature (Nagai et al. 2005). The larynx acts as a respiratory conduit 
during these cyclical laryngeal-pulmonary dynamics, working to modulate airflow and airway 
resistance. During quiet, vegetative inspiration, the vocal fold abduct. The increase in glottal 
aperture is thought to facilitate greater airflow and oxygen intake (Brancatisano, Collett, et al., 
1983; Brancatisano, Dodd, & Engel, 1983). These patterns primarily involve the cricothyroid (CT) 
and posterior cricoarytenoids (PCA) laryngeal muscles (Helou, 2014; Hillel, 2001; Hlastala & 
Berger, 2001).  
Right before the start of the expiratory phase for tidal breathing, the vocal folds begin to 
move passively towards midline and the glottis continues to narrow through 95% of the expiratory 
cycle (Brancatisano et al., 1983; Collett, Brancatisano, & Engel, 1983). This pattern is thought to 
occur as a direct result of CT and PCA deactivation (Helou, 2014; Hillel, 2001; Hlastala & Berger, 
2001) and is believed to play a role in optimizing ventilatory gas exchange required to maintain 
metabolic homeostasis (Hlastala & Berger, 2001). Literature has shown the glottis typically 
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narrows between 10-14% throughout most of the expiratory phase in healthy normals during quiet 
breathing (Brancatisano et al., 1983; Collett, Brancatisano, & Engel, 1983).  
However, the vocal folds can adduct by as much as 40% during expiration, depending on 
the individual’s ventilatory needs. For example, these expiratory patterns occur when the 
pulmonary system needs more time to exchange oxygen with carbon dioxide in the presence of 
lung irritants, resistive load, or lung obstruction (England & Bartlett, 1982; Hoyte, 2013; Ibrahim 
et al., 2007; Jain et al., 2006; Kenn & Balkissoon, 2011; Murakami & Kirchner, 1972). This 
phenomenon, commonly seen in individuals with asthma and other obstructive conditions, is 
known as positive end-expiratory pressure, or auto-PEEP. In addition to auto-PEEP maximizing 
the duration of exposure of the respiratory membrane to gases within the alveoli, the laryngeal 
response is also thought to, in turn, reduce respiratory muscle load, prevent hyperventilation, and 
decrease chronic lung inflation that can occur over time (Jamilla, Stevens, & Szidon, 2000). These 
findings suggest increased expiratory vocal fold narrowing, in certain contexts, is a normal 
response (Collett, Brancatisano, & Engel, 1986; England, Ho, & Zamel, 1985; Hicks et al., 2008; 
Higenbottam, 1980; Hoyte, 2013; Jamilla et al., 2000; Kenn & Balkissoon, 2011; Martin et al., 
1987; O’Donnell, Sanii, Anthonisen, & Younes, 1987; Patterson & O’Connell, 1994). The take-
home point may that in the case of ELBD, adductory patterns during expiration should not be 
deemed pathological in certain situations, such as in the 30-40% of individuals with ELBD with 
concomitant asthma or with respiratory muscle fatigue or discoordination (Christopher & Morris, 
2010; Hicks et al., 2008; Hoyte, 2013). 
Below the level of the larynx, muscles within the lung-thoracic unit during quiet, non-
phonatory breathing appear to correlate, at least partially, with laryngeal movement. Slight 
activation of the diaphragm and external intercostals occurs immediately after the onset of glottal 
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opening, and becomes passive during expiration, allowing elastic forces within the lung-thoracic 
unit to recoil to resting expiratory level before another respiratory cycle is initiated (Zemlin, 1998). 
The delicate interplay between the larynx and pulmonary system during inspiration increases 
negative pressures within the thoracic cavity, causing atmospheric air to enter the lungs. Increasing 
glottic aperture during inspiration also decreases airway resistance, thereby decreasing respiratory 
system effort and optimizing ventilation. 
With exposure to strong irritants or other chemo- or mechano-sensory stimuli, the larynx 
takes on the role of airway gatekeeper, abruptly and reflexively adducting the vocal folds to protect 
the lower airways and lungs (Butani & O’Connell, 1997; Hoyte, 2013; Kenn & Balkissoon, 2011; 
Sasaki & Weaver, 1997). These patterns play a key role in tasks such as cough, swallowing, and 
diving and can occur during inspiration or expiration, depending on when the instigating stimulus 
occurs (Arteaga-Solis et al., 2013; Dempsey & Pack, 1995; Mukhopadhyay, Bates, Manney, & 
Ayres, 2007). Laryngeal adductor response to sensory stimuli is a physiologically normal means 
to protect the lower airways. These adductory patterns are also thought to compensate for 
ventilatory needs by increasing resistive load and modulating duration of volume-time courses of 
lung volumes to maximize ventilatory gas exchange. Unfortunately, these physiological patterns 
are often erroneously deemed “paradoxical” in the ELBD population. This is especially the case 
in patients with “laryngospasms” where complete glottal spastic adductory responses occur with 
sensory stimuli. 
In addition to CT and PCA activation, the thyroarytenoid (TA), intrarytenoids (IA), and 
lateral cricoarytenoids (LCA) are thought to play a role in airway protection during inspiration. 
During expiration, the same list of intrinsic laryngeal muscles, in addition to the oblique transverse 
arytenoids and aryepiglottic folds, all activate to protect the lower airways from foreign 
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particulates. Within the pulmonary system, the diaphragm, external intercostals, scalenes, 
sternocleidomastoid, upper trapezius, levator costorum, paraspinals, and subclavius are active 
during the inspiratory phase. During expiration, the transversus thoracic, internal intercostals, 
rectus abdominus, transverse abdominus, external and internal obliques, pectoralis, serratus 
anterior posterior, and latissimus dorsi activate (Hlastala & Berger, 2001) to protect the lower 
airways as well by contracting in synchrony to expel foreign substance from the airways and into 
the oral cavity.  
Alternately, with exposure to mechanical stimuli—such as with strenuous physical 
activity—the larynx takes on the role of respiratory modulator. Instead of adducting the vocal folds 
to protect the lower airways (i.e., gatekeeping in response to instigating sensory stimuli), the vocal 
folds during exercise abduct even more with inspiration (compared to resting state) to 
accommodate increased ventilatory demands (Brancatisano, Collett, et al., 1983). During 
expiration, the vocal folds are also thought to abduct with, on average, 74% increases in glottal 
configuration, as compared to rest, resulting in a 67% decrease in laryngeal resistance (Hurbis, 
Schild, & others, 1991; Maat, 2011; Maat et al., 2011). However, previous studies have also shown 
expiratory laryngeal responses can decrease (adduct) with high ventilatory demands. These 
patterns may be compensatory to prevent speed of thoracic collapse and reduce extrathoracic 
muscle load during exercise (Collett et al., 1986, 1983).  
Part of the variability in findings for expiration may have to do with methodological 
inconsistencies across studies. In only a handful of cases were laryngeal patterns directly 
visualized during provocation challenges (e.g., irritants, exercise). In the few instances where 
laryngeal responses were evaluated in conjunction with stimuli, the larynx was visualized after the 
provocation was presented, making it unclear whether laryngeal response patterns were a direct 
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result of provocation (Echternach, Verse, Delb, & Richter, 2009; Matthias Echternach, Delb, 
Verse, & Richter, 2008; El-Kersh, Gauhar, Cavallazzi, & Perez, 2014; Fowler, Gore, Vyas, & 
Haines, 2010; Murry, Cukier-Blaj, Kelleher, & Malki, 2011).  
The clinical culture of describing “pathology” without direct comparisons to normal 
physiological response to stimuli in the field of clinical voice disorders has left what is considered 
“abnormal” open to interpretation. For example, in a study by Treole and colleagues (1999), the 
term laryngeal “shakes” was used to describe atypical laryngeal kinematics in a cohort with 
supposed ELBD (Treole et al., 1999). However, in another study by Brancatisano and colleagues 
(1983), this same pattern was observed during laryngoscopy in healthy normal individuals and was 
attributed to a normal response to a foreign object (i.e., laryngoscope) near the laryngeal vestibule 
(Brancatisano et al., 1983). Tervonen and colleagues (2009) found “physiological slight and fast 
adduction of the vocal cords during expiration” in 13 of 15 control participants with no laryngeal 
dyspneic pathology, soon after laryngoscopy was initiated, in the absence of other provocation. 
While some consider a “twitchy” or “shaky” larynx a sign of pathology (Corey, Gungor, & Karnell, 
1998), other investigators consider these patterns no more pathological than a reactionary eye blink 
(Brancatisano, Collett, et al., 1983; England & Bartlett, 1982; Tervonen et al., 2009; Wood & 
Milgrom, 1996). The benchmark for pathology could depend on the threshold or amount of 
laryngeal response, not by the pattern or presence of the response. 
In addition to the variability in glottal configuration patterns, supraglottic patterns and their 
interpretations have also been shown to vary across studies. In general, during normal at rest tidal 
breathing, the epiglottis, arytenoids, and ventricular folds remain stationary in their abducted 
position. Intrinsic muscles of the larynx during physical activity help stabilize these supralaryngeal 
structures. The stylopharyneus, palatopharyngeaeus, and hyglossus muscles also work with the 
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laryngeal muscles to maintain laryngeal inlet dilation, forward epiglottic tilt, and aryepiglottic fold 
lengthening (Belmont & Grundfast, 1984; Maat, 2011; Maat et al., 2011). Inefficient innervation 
to any of these muscles can contribute to reduced laryngeal tension resulting in inspiratory inward 
suction of the laryngeal structures.  Paradoxical supraglottic patterns can involve anterior or medial 
motion or the arytenoids or arytenoid tissue, resulting in a prolapse of the arytenoids over the 
glottic region. Arytenoid prolapse is thought to be more prevalent in the adolescent athlete 
population, and a 0-3 severity scale (see details in Section 3.2.2.2), previously validated in 
individuals with exercise-induced ELBD, has been used to identify severity of pathological 
supraglottic features (Maat, 2011). However, whether this supraglottic pattern is indicative of 
ELBD is unknown due to the lack of normative comparisons and therefore warrants prospective 
study. Another example of laryngeal pattern discrepancy has to do with the presence of a posterior 
glottal gap, or “chink,” thought to be pathognomonic of ELBD. This hallmark clinical feature was 
first referenced in a case series by Christopher and colleagues (1983), and has since been cited in 
various bodies of literature (Chiang et al., 2008; Gallivan, 2001; Morris & Christopher, 2010; 
Nacci et al., 2010; Sullivan et al., 2001). However, in a literature review spanning 36 years of 
publications relating to ELBD, Brugman (2003) found account of posterior glottal gap in only 5-
6% of cases.  
Overall, the discrepancies across the literature on laryngeal-respiratory dynamics have to 
do with (1) the probable variance in presentations across the ELBD spectrum, (2) poor appreciation 
for normal physiological laryngeal movement, (3) lack of standardized methods for defining 
normal from abnormal, and (4) general scarcity in well-controlled studies. These gaps have 
resulted in unsubstantiated, qualitatively-based assumptions and reliance on idiosyncratic 
descriptors in diagnosis. Such methodological and conceptual gaps are concerning considering 
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qualitative descriptors of laryngoscopic findings are the current “gold standard” in diagnosing 
ELBD. Therefore, better defined models are needed of normal and disordered breathing at rest and 
with sensory and mechanical stimuli delivered to the laryngeal-respiratory system. As stated by 
Getty, “If we are to know physiologic and pathologic changes, we must know the normal” (Getty, 
1975). 
One method to address concerns surrounding the lack of robust methods to delineate 
pathology is through the use of quantitative approaches to laryngeal pattern responses. A recent 
study by Shembel and colleagues (2015) validated the use of anterior glottal angle measurements 
to study non-phonatory laryngeal configurations in an animal model (Shembel, Kolouri, Xu, & 
Abbott, 2015). In this study, measures of digital still images of 24 excised canine cadaver larynges 
were compared to measures of each corresponding physical canine larynx. The effects of (1) glottic 
aperture, (2) fiber-optic barrel distortion, and (3) camera lens perspective on the accuracy of 
laryngeal morphometry estimates were also evaluated. Results showed anterior glottal angle 
measurements for the quantification of non-phonatory laryngeal patterns to be reliable across 
raters. Results also showed accuracy on the same parameter between physical larynges and 
corresponding digital images (see Figure 2-10 for visual representation of anterior glottal angle 
method). Of note, anterior glottal angle was used as one of the primary outcome variables for the 
dissertation study. The method was further validated as a viable quantification method for studying 
laryngeal responses at rest and with exercise challenge in participants with and without ELBD. 
The method and its application to the dissertation study is further described in Section 3.1.1. 
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Figure 2-10. Anterior glottal angle measurements (Shembel et al., 2015). 
 
2.2.3.2.2 Self-reported symptoms 
Dyspnea is considered to be the hallmark symptom in patients with ELBD (Shembel et al., 2017). 
However, this sensation is not specific to ELBD; anyone with respiratory or pulmonary pathology 
can experience dyspnea. In fact, dyspnea may not even indicate pathology. Who among us has not 
experienced shortness of breath while running up a steep hill? If everyone gets short of breath 
when they exercise, what makes “normal” dyspnea different from “abnormal” dyspnea? To 
complicate matters further, the types of dyspnea perceptions can vary (e.g., breathing “difficulty” 
does not equate to breathing “discomfort”) and can be influenced by social and cultural norms, 
previous experiences, and the individual’s lexicon (Banzett et al., 2015; Crisafulli & Clini, 2010).  
Descriptions of dyspnea include shortness of breath, difficulty breathing, breathlessness, 
respiratory distress, inability to get a “good breath in,” rapid or shallow breathing, and sensations 
of choking or suffocation (Christopher & Morris, 2010; Hicks et al., 2008; Hoyte, 2013; 
MacConnell et al., 2014; Scano, Stendardi, & Grazzini, 2005). Dyspnea can include an array of 
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perceptions including air hunger, respiratory load, and throat/chest constriction (Parshall et al., 
2012; Scano et al., 2005). In individuals diagnosed with ELBD, reports of dyspnea can range from 
mild discomfort to severe respiratory distress. What is known of dyspnea in ELBD is that 
symptoms are episodic, with a sudden onset. It is not uncommon for these symptoms to elicit panic 
and fear of asphyxiation, where fear continues to perpetuate or worsen symptoms (Hoyte, 2013; 
Newman, 2003). Although dyspnea in and of itself is not an indicator of pathology, the language 
patients use to describe their dyspnea could help differentiate ELBD from other disorders, and 
could even be used to classify clusters of pathology within the ELBD spectrum (Intarakamhang & 
Wangjongmeechaikul, 2013). For example, shortness of breath could be more characteristic of 
ELBD while breathlessness could be a better indicator of exercise deconditioning or restrictive 
lung disease (e.g., COPD). This question can be pursued in later studies, once diagnostic criteria 
for ELBD have been more clearly established. 
Additionally, quantifying the intensity of dyspnea through validated tools can help 
determine benchmarks for pathology, level of disability, and to assess treatment outcomes. Such 
quantification scales can be direct (e.g., symptomatic visual analog scales [VAS] that assess 
current levels of perceived symptoms during provocation challenge). Scales can also be indirect 
(e.g., psychophysical severity scale, such as the Dyspnea Index [DI]), addressing how dyspnea 
impacts activities of daily life (Crisafulli & Clini, 2010; Gartner-Schmidt et al., 2014). The DI is 
one of the only scales validated for the ELBD population. However, although this symptom-
specific index is a good indicator of impact of ELBD on quality of life, it is not a good 
measurement tool to assess symptom severity during ELBD episodes. Conversely, the benefit to 
using a VAS is that it has been shown to represent physical exertion in the moment, and has strong 
linear relationships between levels of dyspnea and exercise intensity (Atiken, 1969; ATS, 1999; 
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De Torres et al., 2002; Foglio et al., 1999; Intarakamhang & Wangjongmeechaikul, 2013; Martinez 
et al., 1997; Ries, 2005). Although the VAS has been validated in various cohorts (e.g., COPD), 
its validity has not been explicitly tested in patients with ELBD. Therefore, the first specific aim 
of this dissertation was to confirm the validity of the VAS in patients with E-PVFM and provide 
benchmarks for comparisons with healthy athletic controls.  
In addition to dyspnea, other ancillary symptoms thought to indicate ELBD have also been 
extensively reported across multiple domains of literature: noisy breathing (stridor), 
lightheadedness, syncope, paresthesia, dyspnea on expiration, throat/upper chest/accessory muscle 
tightness/tension, extrinsic/intrinsic laryngeal muscle tension, and other laryngeal-based behaviors 
and symptoms such as cough, throat clearing, globus sensation, dysphagia, or dysphonia 
(Balkissoon & Kenn, 2012; Christopher & Morris, 2010; Dunn, Katial, & Hoyte, 2015; Hoyte, 
2013; Morrison & Rammage, 2010a; Vertigan, Gibson, et al., 2007). Interestingly, not all 
symptoms from this extensive list appear in all clinical cases, and reported patterns are somewhat 
specific to medical domain. Additionally, whether these ancillary symptoms are actually indicative 
of ELBD or reflect concomitant pathology (e.g., muscle tension dysphonia, chronic cough) 
remains unclear. Therefore, methods to categorize and quantify these various symptoms, in context 
of etiological theories, should be used to discriminate these pathologies. Methods involving the 
study of ELBD symptoms in the exercise-induced variant are described in Chapter 3. 
 
2.2.3.2.3 Episodic triggers 
One of the hallmarks of ELBD are their sudden, periodic, and transient nature when the larynx is 
exposed to provoking triggers. Triggers can be exogenous (outside the body) or endogenous 
(within the body). Exogenous triggers can be irritants from the surrounding environment (e.g., 
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noxious fumes or chemicals, cigarette smoke, or perfumes) or they can be triggers relating to 
temperature or weather (e.g., dry air, cold temperatures, drastic changes in weather) (de la Hoz et 
al., 2008; Herin et al., 2012, 2012; Perkner et al., 1998). Exogenous triggers can also be 
psychological stimuli, related to the “state” of the individual’s surrounding environment (e.g., 
stressful work or home environment) (Forrest et al., 2012; Gavin et al., 1998; Husein et al., 2008; 
Leo & Konakanchi, 1999; Nascimento et al., 2013; Selner et al., 1987). Endogenous triggers 
include physiological or systemic irritants (e.g., post nasal drip, laryngopharyngeal reflux, 
inflammatory diseases), psychogenic factors related to the individual’s “trait” (e.g., depression, 
high arousal, anxiety), or sudden aerodynamic changes within the respiratory system (e.g., 
abnormally high negative inspiratory pressures) (Cukier-Blaj et al., 2008; Heatley & Swift, 1996). 
The list of potential exogenous and endogenous triggers is extensive, and the types of 
stimuli that trigger episodes are specific to individuals. To complicate things further, precipitating 
factors that initially influence ELBD development may be different from those that perpetuate the 
condition. For example, individuals acutely exposed to a noxious irritant (e.g., debris at World 
Trade Center) can find themselves hyper-responsive to any number of dyspnea-inducing irritant 
provocations after the initial event (Rafael, Shohet, & Cohen, 2010). Christopher and Morris 
(2010) were the first to classify the host of ELBD triggers variably described within the literature 
under the umbrella Periodic Occurrence of Laryngeal Obstruction (POLO) into the following 
three categories: (1) exertion-induced, (2) irritant-induced, and (3) psychologically-associated. 
The POLO model recognizes the heterogeneous nature of triggers presenting across the ELBD 
population. The three categories under “Triggers” in the original comprehensive taxonomy 
framework—“Exertional, “Psychological” and “Irritant”—also correspond to the POLO model.  
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It is important to not the distinction between acute trigger stimuli reflective in the 
comprehensive taxonomy framework and the influence of concomitant or underlying etiological 
factors in ELBD, described in the Etiological Frameworks section (Section 2.3). Asthma as a 
disease process can be used to illustrate these differences. Just as with ELBD, asthma is triggered 
by any number of endogenous and exogenous stimuli. Triggers initiate acute (reversible) episodes 
of active lower airway obstruction (i.e., bronchoconstriction). However, the underlying 
mechanisms that predispose or cause asthma to occur in the first place are a complex combination 
of various systemic (e.g., genetic predisposition, obesity) and environmental (e.g., microbial 
exposure) factors that lead to chronic inflammation of the lower airways, even in the absence of 
triggers (Ege et al., 2011; Zhang et al., 2010). An individual whose asthma is triggered by stress, 
for example, most likely did not develop asthma from said stress. In other words, although stress 
can influence inflammatory processes, other underlying factors are most likely responsible for this 
inflammatory origin. Unlike in asthma, the underlying cause(s) in ELBD has not yet been 
determined. However, in the meantime, caution should be taken to not confuse trigger stimuli from 
mechanisms involved in underlying pathophysiology of this clinical presentation.  
2.2.3.3 Updated Comprehensive Taxonomy Framework 
Figure 2-11 is the updated comprehensive taxonomy framework in its entirety. Several 
modifications were made based on current knowledge from the previous literature review 
described in Section 2.2.3.2. The first addendum involves an updated approach to the study of 
laryngeal response patterns. A more systematic method involving splitting laryngeal dynamics by 
locus of obstruction, respiratory cycle (inspiration/expiration), and the type of muscle patterns may 
provide a more organized platform for quantifying patterns of laryngeal obstruction and 
identifying these patterns within different feature variants across the ELBD spectrum. A visual 
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representation of the updated format to the comprehensive taxonomy framework for the category 
“Laryngoscopic Findings” can be found in Figure 2-11. 
 
Figure 2-11. Laryngoscopic findings classification from the original comprehensive 
taxonomy framework (Left) and the proposed changes to the comprehensive framework 
(Right). Features common across the three models (ILS, DT, and POLO), represented in grey 
(solid) boxes, include inspiratory vocal fold adduction. Other variably reported features, 
represented in colored (dotted) boxes, include supraglottic medial and antero-posterior patterns 
(e.g., ventricular compression and arytenoid prolapse, respectively) and true vocal fold adduction 
on expiration. A-P comp. = antero-posterior compression. 
 
 
The second addendum to the comprehensive taxonomy framework involved adding 
potential symptoms features indicative of ELBD to the previous list of features—
lightheadedness/dizziness, limb paresthesia, syncope, systemic fatigue—across the three 
conceptual models. A schematic of how the symptoms category was updated in the comprehensive 
taxonomic framework is represented in Figure 2-12. 
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The third addendum to the comprehensive taxonomy framework was in the classification 
of trigger categories. Each category was further divided into endogenous and exogenous factors 
that can trigger ELBD. This addition can help parse out endogenous mechanistic influences and 
contributory exogenous factors to more directly identify each of their contributions to trigger 
presentations. From a treatment management perspective, systematic identification of endogenous 
and exogenous influences encompassing trigger variants can guide personalized medicine in the 
future. A schematic of how the trigger category was updated in the comprehensive taxonomic 
framework is represented in Figure 2-13. 
Figure 2-12. Symptoms from the original comprehensive taxonomy framework (Left) and the 
proposed changes to the symptoms category in the updated comprehensive framework 
(Right). Features common across the three models (ILS, DT, and POLO), represented in grey 
(solid) boxes, include episodic inspiratory dyspnea. Other variably reported features, represented 
in colored (dotted) boxes, include dysphonia, cough, globus sensation, throat clearing, 
perilaryngeal muscle tension, dyspnea on expiration, stridor, throat tightness, lightheadedness, 
dizziness, limb paresthesia, syncope, systemic fatigue. ELM = extrinsic laryngeal muscle. ILM = 
intrinsic laryngeal muscle. 
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Figure 2-13. Triggers classification from the original comprehensive taxonomy framework 
(Left) and the proposed changes to the comprehensive framework (Right), further divided 
into endogenous and exogenous subcategories. Triggers across the three models (ILS, DT, and 
POLO) have been classified as exertional, psychological, and irritant. The “Triggers” category to 
the left of the arrow is the schematic representation in the original comprehensive taxonomy 
framework. The “Triggers” category to the right of the arrow is the updated version of the 
comprehensive taxonomy framework. Each trigger variant on the right can be further described as 
endogenous (e.g., high negative inspiratory pressures, temperament, reflux [GERD, LPR], and 
post-nasal drip [PND]), or exogenous (e.g., heat and humidity, stressful situations, and chemicals). 
PND = post-nasal drip. LPR = laryngopharyngeal reflux disease. GERD = gastroesophageal reflux 
disease. 
  
 
Figure 2-14 is the schematic representation of the entire updated comprehensive taxonomy 
framework. The framework informed research questions and study design for the dissertation 
study. Because reported features in the literature are primarily based on descriptions of small 
sample sizes and expert opinion, the goal of the dissertation study was to prospectively identify 
participants with ELBD using the common features identified in the comprehensive framework 
and to measure pathological benchmarks using identified diagnostic indicators. The other goal was 
to assess the role of other reported auxiliary features to determine how they fit into one ELBD 
trigger variant—exercise-induced ELBD (E-ELBD)—using the comprehensive taxonomic 
framework. Identified features were then used to evaluate how variably presented features across 
different literature domains fit into the diagnosis of ELBD (or whether these features better reflect 
other concurrent pathology). Finally, the comprehensive taxonomy framework was used to study 
 62 
the merit of two potential underlying mechanisms driving clinical expression in E-ELBD. These 
potential mechanisms—autonomic nervous system dysfunction and temperament (stress 
reactivity) are described in the final section of this chapter (Section 2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-14. Updated comprehensive taxonomy framework. Based on the following three models: Irritable Larynx Syndrome, 
Dichotomous Triggers, and Periodic Occurrence of Laryngeal Obstruction and a comprehensive literature review. Grey (solid) 
boxes represent clinical features common across the three ELBD models (ILS, DT, and POLO). Colored (dotted) boxes represent 
feature discrepancies across models. 
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2.3 ETIOLOGICAL FRAMEWORKS 
Mechanisms underlying dysfunctional breathing remain unclear. However, we can assume that 
clinical presentations of ELBD most likely involve some constellation of physiological, 
psychological, biomechanical, neurological, genetic, and immunological factors that interact and 
influence each other (Chaitow, Bradley, & Gilbert, 2013; Courtney, Greenwood, & Cohen, 2011; 
Gardner, 1996; Gimenez & Zafra, 2011; Johansson, 2013). Understanding what causes these 
clinical presentations is beneficial for several reasons. First, it can help identify individuals 
susceptible to developing ELBD. Second, it can be used to better identify individuals with the 
condition, streamline diagnostic procedures, and predict prognosis. Third, it can guide 
personalized therapeutic interventions. Although well-developed etiological hypotheses lack in the 
ELBD literature, three theories have been proposed: (1) Altered Autonomic Balance, (2) Primary 
Psychosomatic, and (3) Laryngeal Hyperresponsiveness. The latter two theories are described in 
the Future Directions Section (Section 6.3.2) as potential mechanisms underlying psychologically-
associated and irritant-induced ELBD, respectively. A description of the autonomic balance 
theory, and one component of the psychosomatic theory—temperament—will be addressed in the 
following sections to set the stage for the proposed study’s exploratory aims.  
2.3.1 Autonomic nervous system dysfunction 
The autonomic nervous system (ANS) is the primary driver for breathing (Undem et al., 1999). 
The ANS maintains homeostatic stability below the level of consciousness by controlling airway 
muscle tone, reflexes, blood flow, and secretions (Barnes, 1990, 1996; Baroody & Canning, 2003; 
Canning & Undem, 1994; Critchley, 2005; Hlastala & Berger, 2001; Loehrl et al., 2002; Martínez-
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Lavín & Hermosillo, 2000; Mukhopadhyay et al., 2007; Noback et al., 2005; Weigand & Undem, 
2012). The two subsystems of the ANS—the parasympathetic (PNS) and sympathetic (SNS) 
nervous systems—work together to regulate various cardiovascular functions such as heart rate 
and heart contraction/relaxation. The symbiotic relationship of these subsystems  is especially 
critical during allostatic11 activities such as exercise (Coote, 2010; Mador & Acevedo, 1991; 
Younes & Burks, 1985). 
Specifically, with initiation of exercise, there is an immediate decrease in vagal tone 
associated with PNS inhibition, resulting in increased heart rate (Eryonucu, Bilge, Güler, & Uygan, 
2000). Once heart rate reaches about 100 BPM, cardiac sympathetic fibers activate, causing 
increased left ventricle contraction and augmented stroke volume. This action yields up to a 39 (± 
18) mmHg increase in systolic blood pressure (SBP). These patterns are then followed by further 
vagal withdrawal. Systolic blood pressure (SBP) is thought to be primarily mediated by the SNS 
during vigorous exertion, whereas heart rate (HR) results from sympathovagal balance in both 
submaximal and maximal exertion conditions (Coote, 2010; Eryonucu et al., 2000).  
Post exertion, continued efficient sympathovagal balance is needed to return the body back 
to homeostatic baseline. The ANS helps the body recover via parasympathetic reactivation at about 
44 (± 37) seconds post-exertion and sympathetic withdrawal at about 65 (± 56) seconds post-
exertion (Pierpont & Voth, 2004). Sympathetic withdrawal results in vasodilation and a decrease 
in blood pressure (especially SBP), while simultaneous sympathetic withdrawal and 
parasympathetic reactivation reduces heart rate. The difference between heart rate at peak exercise 
and 2-minutes post-maximum exercise—referred to as heart rate recovery (HRR)—is thought to 
                                                 
11 The process of regaining homeostatic stability after the body has been introduced to physiological or behavioral 
perturbations to the system. 
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be a robust indicator of the efficiency of this sympathovagal balance with exertive activity 
(Dishman et al., 2000; Eryonucu et al., 2000; Langdeau, Turcotte, Desagné, Jobin, & Boulet, 2000; 
Tunnicliffe, Hilton, Harrison, & Ayres, 2001). HRR latency has been shown to indicate a variety 
of morbidities including asthma, generalized anxiety disorders, and overtraining syndrome (among 
others) (Ayres & Gabbott, 2002; Dishman et al., 2000; Pierpont & Voth, 2004; Tunnicliffe et al., 
2001). Beauchaine (2001) found inadequate vagal modulation in children prone to anxiety, and 
suggested these patterns may be indicative of emotional lability and increased fight/flight response, 
which can lead to, or at the very least be associated with, generalized anxiety disorders 
(Beauchaine, 2001). Figure 2-15 represents typical (average) SBP and HR responses and trends in 
healthy adolescent athletes (Al Haddad, Laursen, Chollet, Ahmaidi, & Buchheit, 2011; Becker, 
Silva, Moreira, & Victor, 2007; Buchheit et al., 2008; Muntner P, He J, Cutler JA, Wildman, & 
Whelton, 2004; Singh, Rhodes, & Gauvreau, 2008).  
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Figure 2-15. Trends in systolic blood pressure and heart rate responses in adolescent athletes. 
SBP = systolic blood pressure. HR = heart rate. Trends show an increase in SBP with rigorous 
(max) exercise and a gradual decrease with exercise cessation. Heart rate trends show a spike in 
HR at maximum exertion and a more pronounced decrease in recovery compared to SBP.  
 
 
Although laryngeal-respiratory interactions are known to be mediated by the ANS for 
various biological functions including breathing, coughing, and swallowing, exactly how these 
interactions relate to laryngeal breathing pathophysiology is not well understood. In a brief 
editorial piece by Ayres and Gabbott (2002), the authors proposed ANS dysfunction correlates 
with ELBD, based on high prevalence of ANS dysfunction found in individuals with asthma. 
Additionally, recent studies have shown a positive correlation between increased intrinsic 
laryngeal muscle activity and heightened autonomic response to psychological stressors in healthy 
control subjects (Helou, 2014; Helou, Wang, Ashmore, Rosen, & Abbott, 2013). However, the 
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efficiency of sympathovagal balance in relation to the larynx has yet to be studied with exertion 
tasks, in general, or in the E-ELBD population, specifically.  
Therefore, investigation into whether autonomic balance even plays a role in underlying 
pathophysiology driving ELBD clinical expression (and if so, what kind of sympathovagal balance 
patterns can be expected) is warranted. Table 2-3 is a summary of five hypothetical laryngeal-
autonomic relationship outcomes.  
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Table 2-3. Laryngeal-Autonomic System Hypotheses of Underlying Potential Study 
Outcomes. Hypotheses stem from work by Ayres & Gabbott, 2002; Dishman et al., 2000; Helou, 
2014; Helou et al., 2013; Kreher & Schwartz, 2012; Lehmann, Foster, Dickhuth, & Gastmann, 
1998; Pierpont & Voth, 2004. 
AUTONOMIC FUNCTION 
LARYNGEAL  
ACTIVITY 
CARDIO-
VASCULAR 
OUTCOMES FOR 
EXERTION 
CLINICAL 
PRESENTATION 
EXAMPLES 
ANS output 
Underlying 
Mechanism(s) 
I. SNS < PNS 
 
Hypothesis 1: 
attenuated/blunted SNS 
response; normal PNS 
response 
 
↑vagal tone = 
 
↑ILM adductor 
activity (TA, IA, 
LCA) 
Blunted ΔSBP12 
Normal HRR 
Adrenergic 
depletion; 
overtraining 
syndrome 
 
Hypothesis 2: 
↑SNS response; 
↑↑increase PNS 
response 
 
Increased ΔSBP 
Accelerated HRR 
Vagal 
overcompensation 
syndrome; 1° 
Depression & 2° 
Anxiety Disorder 
II. SNS > PNS 
 
Hypothesis 3: 
↑SNS response; normal 
PNS response 
 
↓vagal tone = 
 
↓ILM abductor 
activity (PCA) 
Increased ΔSBP 
Normal HRR 
Anxiety/Panic 
Disorders 
 
Hypothesis 4: 
↓SNS response to 
exertion; 
↓↓attenuated/blunted 
PNS response 
 
Blunted ΔSBP 
Slow HRR 
Mood (depression) 
Disorders 
 
Hypothesis 5: 
↑↑↑SNS response; 
↑↑increase PNS 
response (vagal 
overcompensation) 
 
Increased ΔSBP 
Normal or 
accelerated HRR 
1° Anxiety 
Disorder & 2° 
Depression 
 
                                                 
12 ΔSBP determined by the magnitude difference between rest (baseline) and exercise SBP. 
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2.3.2 Personality, Temperament, and Stress Reactivity 
There has been little studied on associations between temperament, mental/behavioral disorders, 
and ELBD, despite frequent references to their connection (Al-Alwan & Kaminsky, 2012; Anbar, 
2012; Appelblatt & Baker, 1981; de la Hoz et al., 2008; Dunglison, 1842; Kuppersmith, Rosen, & 
Wiatrak, 1993; McGrath, Greenberger, Zeiss, & others, 1984; Morris, Oleszewski, Sterner, & 
Allan, 2013; Nagai, Yamaguchi, Sakamoto, & Takahashi, 1992; Niven, Roberts, Pickering, & 
Webb, 1992; Patterson et al., 1974; Pitchenik, 1991; Richards-Mauzé & Banez, 2014; Ringsberg, 
Löwhagen, & Sivik, 1993; Rothe & Karrer, 1998; Smith, Darby, Kirchner, & Blager, 1993; Smith, 
1983). Unfortunately, most of the literature in this domain is riddled with bias, and claims of 
interconnections between psychopathology and ELBD are generally couched in observational case 
series, descriptive case reports, and expert opinion. One literature review on ELBD (consisting of 
case reports and case series) alleged ELBD was “associated with severe psychosocial stress and 
difficulties with modulation of intense emotional states.” Findings were attributed to the “higher” 
prevalence of a variety of “psychological disturbances” within the ELBD population. However, a 
direct comparison of psychological prevalence between individuals with ELBD and the general 
public, generally suggests otherwise (see Table 2-4 for details). 
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Table 2-4. Prevalence of Psychological Disturbances in The General Population Compared 
to The ELBD Population. 
Psychopathology 
Prevalence in general 
population13 
Prevalence in ELBD 
population14  
Conversion disorder15 0.5% 12% 
Anxiety disorder 11-17% 11% 
Histrionic and other 
personality disorders 
15% 6% 
Family/school conflicts 7% 4% 
Depression 4-7% 4% 
Psychosomatic disorders 2% 2% 
Factitious disorders 0.7-2.0% 2% 
Somatization/somatoform 
disorders 
0.2-2% 1% 
 
The bias in the belief psychogenic conditions cause ELBD is especially prevalent in the 
literature on exercise-induced ELBD, particularly with adolescent female athletes. In a case study 
by Maschka and colleagues (1997), the cause of exercise-induced ELBD in a female athlete was 
attributed to an underlying “non-organic somatization/conversion disorder” due to her “high 
achieving, competitive, and mildly anxious” nature (Maschka et al., 1997). However, anyone who 
has interacted with the adolescent female athletic population can speak to their similar 
temperament as that described by Maschka and colleagues. Yet, not all female athletes develop 
somatization disorders or E-ELBD. Further study of causal relationships (if they do exist) 
addressing the merit of poorly-controlled temperament (e.g., Type A, anxious, neurotic, highly 
                                                 
13
 Sources: Carter, Briggs-Gowan, & Davis, 2004; deGruy, Columbia, & Dickinson, 1987; Fliege et al., 2007; Gordon, 
1987; Grant et al., 2004; Lichstein, 1986; Oyama, 2011; Somers, Goldner, Waraich, & Hsu, 2006. 
14 Results of literature review by Leo and Konakanchi, 1999 
15 ICD-10 classifies conversion disorders as dissociative disorders while DSM-IV classifies conversion as somatoform 
disorders. Interestingly, Leo and Konakanchi found “conversion” disorder in 12% of individuals with ELBD and only 
1% with “somatoform” disorder. The 11% discrepancy in what appears to be the same diagnosis is perplexing. 
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stress reactive) and psychogenic correlates (e.g., somatization/conversion disorder, anxiety 
disorders) as a mechanism underlying E-ELBD is warranted. To address the validity of this theory, 
the etiology of E-ELBD as psychogenic in nature was also explored in the dissertation study. 
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3.0 STUDY DESIGN 
The goal of the study was to identify clinical features and underlying mechanisms in one type of 
ELBD, Exercise-induced ELBD (herein referred to as E-ELBD). Primary features of dyspnea 
severity and glottal configuration, informed by the comprehensive taxonomy framework addressed 
in Chapter 2 were used to identify pathological benchmarks between adolescent athletes with and 
without E-ELBD. The prevalence of other (auxiliary) features, previously implicated in ELBD, 
were also identified and compared between the two athletic groups to determine which of these 
features were indicative of E-ELBD. Finally, the merit of two potential mechanisms underlying 
the E-ELBD variant—autonomic dysfunction and stress reactivity (temperament)—was 
investigated to determine their role for future investigations. The study design was first validated 
in individuals with the E-ELBD variant. The rationale for this decision was that this variant is 
thought to involve the most homogenous group of the trigger variants (exercise, irritant, 
psychological), thereby reducing the possibility of confounding variables in study designs. Future 
investigations will apply validated study methods from this dissertation study to other ELBD 
trigger variants (i.e., irritant-induced, psychosomatically-associated). 
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3.1 SPECIFIC AIMS 
3.1.1 Primary Aims 
The primary aim (SA1) was to quantify magnitude differences in glottal configuration at height of 
inspiration and perceived dyspnea from rest to exercise in athletic adolescents diagnosed with E-
ELBD, compared to healthy athletic adolescent volunteers without complaint of breathing 
affecting athletic performance.  
3.1.1.1 Inspiratory glottal configuration   
SA1(A): Quantify magnitude of change in true vocal fold adduction (anterior glottal angle) on 
inspiration from rest to exercise in adolescents diagnosed with E-ELBD, compared to findings for 
healthy athletic volunteers of the same age range.  
H1: An exertion by group interaction will be shown. Participants with E-ELBD will show a 
significant change (increase) in inspiratory vocal fold adduction from baseline rest to exercise 
conditions, compared to healthy athletic volunteers.   
H0: No significant differences in magnitude of change from rest to exercise conditions will be 
shown between E-ELBD and control groups. 
3.1.1.2 Self-reported dyspneic symptoms 
SA1(B): Quantify perceived dyspnea at rest and with exercise challenge and compare scores in 
the same subjects as for SA1(A).    
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H1: Participants with E-ELBD will have a statistically significant increase in dyspnea severity 
from baseline (rest) to exercise conditions compared to control participants.  
H0: No significant difference will be shown for dyspnea severity ratings on the 0-100 VAS. 
3.1.2 Secondary Aims 
A secondary aim was to identify ancillary laryngeal respiratory dynamic patterns and perceived 
symptoms indicative of E-ELBD and determine quantitative benchmarks for pathology, as means 
to improve diagnostic specificity.  
3.1.2.1 Supraglottic laryngeal-respiratory kinematics  
SA2(A): Identify and quantify patterns of ancillary supraglottic laryngeal dynamics (arytenoid 
prolapse, epiglottic collapse, ventricular compression) on a 0-3 severity scale and expiratory glottal 
responses using anterior glottal angles, and determine group differences.  
H1: Arytenoid prolapse will be found in one-third of individuals diagnosed with E-ELBD in the 
exercise challenge. This hypothesis is informed by a retrospective study showing that 32% (7/22) 
of adolescent participants with E-ELBD showed “paradoxical” arytenoid movement (Powell et al., 
2000; Bittleman et al., 1994; Christensen et al., 2010; Christopher & Morris, 2010; Fahey et al., 
2005; Atsushi Nagai, Kanemura, & Konno, 1992).  
H0: Prevalence of arytenoid prolapse will be similar between E-ELBD and control groups during 
the exercise challenge. These patterns could be due to a combination of negative inspiratory 
supraglottic pressures (i.e., Bernoulli Effect, Venturi Effect) and systemic fatigue and may not be 
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indicative of E-PVFM. Although arytenoid prolapse has been seen in individuals with E-ELBD, 
laryngeal movement in athletic cohorts without the condition has been little studied.   
3.1.2.2 Ancillary self-reported symptoms.  
SA2(B): Identify auxiliary symptoms most prevalent in the E-ELBD cohort from a list of potential 
symptoms (see Section 3.1.2.2 for complete list), quantify severity of these features, and compare 
severity ratings between individuals with E-ELBD to those without the condition.   
H1: Individuals with E-ELBD will report stridor more often than athletic adolescent volunteers, as 
this auxiliary symptom has been suggested to be more prevalent in E-ELBD than other ELBD 
variants (Christopher & Morris, 2010; Hicks et al., 2008; Powell et al., 2000). Christopher and 
Morris (2010) suggested the source of stridor is vibration of the corniculate cartilages with 
increased inspiratory supraglottic pressures, which can occur with rigorous physical activity. 
Hypotheses regarding other findings again, at this point, remain more speculative. 
H0: No significant difference will be found in the prevalence of stridor between individuals with 
E-ELBD and athletic volunteers.   
3.1.3 Exploratory Aims  
The exploratory aim (SA3) will investigate two previously proposed potential mechanisms 
involved in E-ELBD pathoetiology in the ELBD literature: altered autonomic balance (Ayres & 
Gabbott, 2002; Balkissoon & Kenn, 2012; Helou et al., 2013) and stress reactivity (temperament) 
(Al-Alwan & Kaminsky, 2012; Ferris et al., 1998; Husein et al., 2008; Kaufman et al., 2004; Lund 
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et al., 1993; Nayar et al., 2003; Niggemann, 2010; R. Patterson et al., 1974; Powell et al., 2000; 
M. S. Smith, 1983; H. S. Snyder & Weiss, 1989). 
3.1.3.1 Altered autonomic balance.  
SA3(A): Investigate autonomic (sympathovagal) balance in adolescents with E-ELBD and athletic 
volunteers using two proxy measurements of autonomic function: magnitude of change in systolic 
blood pressure from rest to exercise (ΔSBP) and heart rate recovery from maximum exertion with 
exercise challenge to 2-minutes post-maximum exertion (HRR).  
H1:  Any of the following outcomes could occur: (1) ΔSBP (magnitude change based on SBP at 
rest and SBP during maximum exertion) will be significantly blunted in the E-ELBD group 
(compared to athletic volunteers) during exercise due to attenuated SNS response or slow PNS 
withdrawal; (2) ΔSBP will be significantly greater in the E-ELBD group during exercise due to 
substantial increase in SNS activation, likely to occur in conjunction with heightened sympathetic 
response to provoked ELBD episode; (3) HRR will be significantly accelerated in the E-ELBD 
group during recovery due to increased vagal tone (or overall sluggish SNS response, also seen 
with blunted SBP response during exertion); (4) HRR will be significantly lower post-exertion in 
the E-ELBD group due to sluggish PNS response in reactivation (or overall heightened SNS 
response, also seen with greater SBP response during exertion).  
H0: No significant differences in ΔSBP or HRR between patients with E-ELBD and athletic 
volunteers, suggesting normal sympathovagal balance in the E-ELBD group. 
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3.1.3.2 Personality and stress reactivity (temperament).  
SA3(B): Investigate temperament differences across individuals with E-ELBD and healthy athletic 
volunteers using the Fear Subscale of the Early Adolescent Temperament Questionnaire – Revised 
(EATQ-R) (see Appendix B: Early Adolescent Temperament Questionnaire – Fear Subscale). 
H1: A statistically significant difference on the Fear Subscale of the EATQ-R will be shown 
between the two groups, suggesting greater proclivity for stress reactivity and trait anxiety in the 
E-ELBD group.  
H0: Differences in the EATQ-R Fear Subscale will not reach statistical significance between the 
two groups. This null hypothesis is based on the concept that competitive athletic adolescents 
within this age range, in general, share similar dispositions and temperaments (e.g., proclivity for 
perfectionism) (Bartulovic, Young, & Baker, 2017; Hill & Madigan, 2017; Weinberg & Gould, 
2011), and both control and E-ELBD participants will be athletes. 
3.2 STUDY VARIABLES 
3.2.1 Independent Variables 
Independent variables remained the same across all three study aims. There were two independent 
variables (1) and (2), each with two distinct levels (a) and (b). The first independent variable was 
(1) level of exertion with the following two levels, (a) baseline (rest) and (b) maximum exertion 
(exercise challenge). The second independent variable was (2) group with two levels, (a) patients 
diagnosed with E-ELBD and (b) athletic adolescent volunteers without breathing complaints.   
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3.2.2 Dependent Variables 
3.2.2.1 Primary variables 
Inspiratory glottal configuration. The dependent variable for the first primary aim SA1(A) was 
anterior glottal angle (Figure 3-1). Anterior glottal angle estimates were used to quantify glottal 
configuration (aperture) during inspiration. Measurements from digital still images, acquired from 
dynamic videoendoscopic examinations, were taken at the height of inspiration, immediately prior 
to the start of expiration during laryngoscopy (see Appendix C: Anterior Glottal Configuration 
Instructions for Raters for details). 
 
Figure 3-1. Anterior glottal angle measurements 
 
Self-reported dyspneic symptoms. The dependent variable for the second primary aim SA1(B) 
was inspiratory dyspnea severity, based on self-reported symptom ratings at (a) baseline (rest) and 
in (b) maximum exercise conditions. Severity was determined using a 0-100 continuous visual 
analog scale (VAS) (see Appendix D: Visual Analog Scale Perceptual Ratings for details). 
3.2.2.2 Secondary variables 
Supraglottic laryngeal kinematics. There were 4 dependent variables for the first secondary aim 
SA2(A). Variables were magnitude of airway obstruction caused by (1) arytenoid prolapse (DV1), 
3
1° 
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(2) epiglottic collapse (DV2), (3) ventricular (false) fold compression (DV3), and (4) expiratory 
vocal fold adduction (DV4). The selection of these variables was based on literature review and 
comprehensive taxonomy framework (Shembel et al., 2017). All four parameters were assessed 
based on visual inspection of laryngoscopic videos acquired during both baseline (rest) and 
maximum exertion (exercise challenge) conditions. Ratings were conducted by seven naïve raters 
blinded to group and condition. Years of experience with laryngoscopy examination interpretation 
ranged from 3 to 20 years amongst the raters. The first three DVs (DV1-3) were each rated on a 0-
3 scale as detailed in Table 3-1. DV4 was measured using anterior glottal angle measurements, 
mentioned previously with the first primary aim (c.f., Section 3.1.1.1) (see Appendix E: 
Supraglottic Movement Instructions for Raters for details) 
 
Table 3-1. Rating System for Supraglottic Laryngeal Kinematics 
Obstruction 
Type 
0 1 2 3 
Arytenoid 
prolapse (DV1)1 
Expected maximal 
abduction of the 
aryepiglottic folds 
with no visible 
medial rotation 
(top of cuneiform 
tubercles pointed 
vertical or slightly 
lateral) 
 
Visual medial 
rotation of the 
cranial edge of the 
aryepiglottic folds 
and tops of the 
cuneiform 
tubercles 
Further medial 
rotation of the 
cuneiform 
tubercles with 
exposure of the 
mucosa on the 
lateral sides of the 
tubercles 
Medial rotation 
until near 
horizontal 
position of the 
cuneiform 
tubercles and 
tops of the 
cuneiform 
tubercles move 
towards the 
midline 
Epiglottic 
Collapse (DV2)2 
Petiole and 
purslane of the 
epiglottis hugs the 
tongue 
 
Epiglottis between 
0-45° 
Epiglottis between 
45-90° 
Epiglottis over 
90° 
Ventricular 
(False) Fold 
compression 
(DV)3 
Absent 1/3 of the true 
vocal folds 
covered 
2/3 of the true 
vocal folds 
covered 
True vocal folds 
completely 
hidden 
1Validated by Maat (2011); 2validated by Catalfumo et al., (1998); 3validated by Schonweile et al (1998) 
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Ancillary self-reported symptoms. The second secondary aim involved dependent variables 
based on additional symptoms implicated in ELBD using the comprehensive taxonomy framework 
and literature review as a guide (Shembel et al., 2017):  
Chest tightness 
Cough 
Dysphagia (swallowing complaints) 
Globus sensation  
Lightheadedness/dizziness 
Limb paresthesia 
Shortness of breath with expiration 
Shortness of breath with inspiration 
Stridor (noisy breathing) 
Syncope 
Systemic fatigue 
Throat clearing 
Throat tightness/constriction 
Voice complaints (dysphonia/hoarseness) 
 
The most common features reported in the E-ELBD cohort were identified and their respective 
severities were rated on a 0-100 continuous visual analog scale at (a) baseline (rest) and (b) 
maximum exertion (exercise challenge) conditions. All participants were asked to rate each of the 
following symptoms: 
(1) expiratory dyspnea (How difficult is/was it to breathe out? [DV1]) 
(2) stridor (“How noisy was/is your breathing in” [DV2]) 
(3) throat tightness (“How tight was/is your throat?” [DV3]) 
 
Baseline ratings were taken during baseline laryngoscopy; exercise ratings were acquired 
retrospectively immediately after the exercise challenge to ensure safety of participants pedaling 
on the cycle trainer and to maximize exertion levels. 
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3.2.2.3 Exploratory variables 
3.2.2.3.1 Altered autonomic balance.  
The first exploratory aim had two dependent variables. The first was magnitude of SNS response 
(ΔSBP), determined by the difference between systolic blood pressure (SBP) measurements at 
baseline (rest) and during maximal exertion (exercise challenge) conditions. The second was 
efficiency of PNS response, determined by heart rate recovery (HRR), calculated as the difference 
between heart rate taken at maximum exertion (during exercise challenge) and 2 minutes after 
strenuous pedaling on the stationary trainer had been terminated.  
 It is important to note SBP and HRR parameters were not measuring pure SNS and PNS 
responses, respectively. Instead, the SNS and PNS work in conjunction for both SBP and HRR 
parameters. What was actually being measured was the overriding autonomic subsystem’s output. 
Specifically, during rigorous physical activity SNS should prevail over the PNS as the SNS 
increases and PNS withdraws. However, there is still some PNS activity present during exercise 
to control beat-by-beat heat rate variability. Conversely, during recovery, the PNS should prevail 
over the SNS, although some SNS activity may still be present. In cases where there is slow SNS 
reactivity or sluggish PNS withdrawal with exercise, the SBP output during the exercise challenge 
will be lower than expected. Latent HRR output post-exercise is suggestive of either sluggish SNS 
withdrawal or slow PNS reactivation response once the participants stop pedaling on the stationary 
bike. With that in mind, the noted measurement outcomes for SA3(A) identified whether there was 
some degree of sympathovagal imbalance or inefficiency. However, the measures did not afford 
exact information on the instigating subsystem(s) of said inefficiency (i.e., SNS, PNS, or both). 
More intricate and invasive methods or use of animal models are required to identify specifics of 
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autonomic balance.  If some degree of inefficiency or imbalance is demonstrated, more involved 
methods warrant future study, but did not lend themselves to exploration in the present study. 
3.2.2.3.2 Stress reactivity (temperament) 
The Fear Subscale on the Early Adolescent Temperament Questionnaire – Revised (EATQ-R) 
represented the dependent variable. The EATQ-R is a psychometric self-reported questionnaire 
that assesses excitability, emotionality, arousability, and self-regulation in children and 
adolescents. Each of the 11 subscales of the EATQ-R are thought to represent a subset of 
temperament constructs. Measures of temperament were chosen for this study aim since the 
concept of temperament has been linked to the development of psychopathological syndromes in 
general (Muris et al., 2009; Muris and Ollendick 2005; Nigg 2006). The subscale Fear targets the 
“unpleasant affect related to anticipation of the distress” (e.g., “I worry about getting into trouble”) 
(Capaldi & Rothbart, 1992; Muris & Meesters, 2009). Previous studies have shown this subscale 
is a good indicator of stress-reactivity and is associated with higher levels of anxiety (Muris & 
Meesters, 2009).  
3.3 PARTICIPANTS 
The study was conducted with adolescent athletes, as E-ELBD is most commonly seen in 
physically active juveniles (Abu-Hasan et al., 2005; Al-Alwan & Kaminsky, 2012; Guglani, 
Atkinson, Hosanagar, & Guglani, 2014; H. Johansson et al., 2015; Landwehr et al., 1996; Mahut 
et al., 2013; Røksund et al., 2009; Tilles, 2010; Tilles, Ayars, Picciano, & Altman, 2013). 
Recruitment of a homogenous cohort helped minimize variance and increase internal validity, 
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which was especially important for the assessment of autonomic and temperament parameters 
(SA3). Two groups of participants between the ages of 12 and 18 years were recruited. The first 
group (experimental group; E-ELBD) were individuals who presented to the Voice and Speech 
Laboratory at the Massachusetts Eye and Ear Infirmary (MEEI) with complaints of atypical 
inspiratory dyspnea on exertion resulting in diminished athletic performance and who scored more 
than a 10 out of 40 on the Dyspnea Index, a symptom severity questionnaire previously validated 
in individuals with upper airway breathing pathology. The second group (healthy control group; 
HC) had no complaints of atypical exertional dyspnea over the past 6 months. The latter group 
was recruited from sports teams and local schools in the greater Boston region. 
3.3.1 Sample Size 
The original target sample size, prior to the start of enrollment, was n = 50 participants who 
satisfied inclusion criteria and who would complete the entire protocol (25 E-ELBD and 25 healthy 
controls). These numbers were based on power analysis, according to which 46 participants (23 
E-ELBD and 23 healthy controls) were needed to provide 80% statistical power to detect a
clinically significant difference between dyspneic symptom severity parameters (VAS), using 
Analysis of Variance (ANOVA) with an alpha level of 0.05 (Cohen’s d = 0.4). This target sample 
size was thought to be feasible as there was report, based on an electronic medical database, of 
over 125 patients ages 12-18yo with laryngeal breathing disorders seen annually at the 
Massachusetts Eye and Ear Infirmary. The original estimated attrition was as follows: on average, 
100 patients (80%) who received a formal diagnosis of E-ELBD typically consent to participation 
in research protocols of this type (MEEI database, unpublished data). An estimated 30-40 out of 
100 patients (30-40%) with an E-ELBD diagnosis would have concomitant asthma that was not 
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well-controlled, characterized as a predicted FEV1 < 80% (Christopher & Morris, 2010; Hicks et 
al., 2008; Hoyte, 2013), an exclusion criterion for the present study. The projected 60-70 possible 
E-ELBD participants for recruitment made the targeted enrollment sample size of n = 50 in the E-
ELBD group (and n = 35 in the control group), with a targeted final sample size of n = 25 in each 
group, feasible. The flowchart in Figure 3-2 illustrates the projected enrollment sample size, taking 
into account various factors that could cause attrition. 
Figure 3-2. Original estimated enrollment and attrition flowsheet. 
 Unfortunately, available patients for recruitment in the E-ELBD (experimental) group 
were vastly fewer than anticipated (~20 per year in 2016-2017 versus ~100 per year in previous 
years) for unknown reasons. In an attempt to improve recruitment, local physicians were contacted 
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once a week to remind them of potential referrals for the study. Flyers and advertisements were 
reposted around MEEI and the surrounding areas weekly. Athletics directors and coaches across 
35 different middle and high schools in the New England region were contacted via phone and 
email. Local Boston Craigslist ads were updated biweekly. And previous cancellations and no-
shows were contacted for initial consultation and potential study recruitment at the Voice and 
Speech Laboratory at MEEI. However, recruitment continued to be substantially less than 
anticipated due to low patient referrals with suspected E-ELBD. Therefore, interim power analysis 
on n = 11 in the E-ELBD group and n = 13 in the control group was run in mid-June 2017 (8 
months after the enrollment period began) using data on the primary outcome variables16 to 
determine whether the current sample size was sufficiently powered. The interim (second) power 
analysis showed the current n = 24 sample size to be enough to achieve the statistical power needed 
to stop enrollment (total needed for main effect: n = 6; total needed for interactions: n = 12). 
Therefore, enrollment was discontinued at the end of the targeted recruitment period in the 
beginning of July 2017 with a total of n = 27 participants recruited (n = 13 E-ELBD; n = 14 
control).  
Of note, although the study was sufficiently powered for the primary aims, it was not 
powered for the autonomic parameters, to which 788 participants (394 E-ELBD and 394 healthy 
controls) were needed to provide 80% statistical power to detect a clinically significant difference 
between magnitude of change in systolic blood pressures using independent t tests with an alpha 
level of 0.05 (Cohen’s d = 0.2). For the 2-minute heart rate recovery parameter, 352 total 
participants (176 E-ELBD and 176 healthy controls) would have been needed to provide 80% 
16 Based on 2x3 mixed-model ANOVA: IV1: group (E-ELBD, control); IV2: condition (pre-baseline, baseline, 
exercise); DV1: inspiratory dyspnea severity (VAS) and DV2: anterior glottal angle. 
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statistical power to detect a clinically significant difference between magnitude of change in 
systolic blood pressures using independent t tests with an alpha level of 0.05 (Cohen’s d = 0.3). 
3.3.2 Inclusion Criteria 
All participants had to be adolescents (ages 12-18yo) who exercise regularly (at least 40 min 
3x/week).  
Inclusion criteria specific to E-ELBD group. Any participant who presented to the clinic 
reporting atypical dyspnea during exertion and associated decrements in athletic performance for 
more than 2 weeks prior to presentation was considered for the study. Participants in the 
experimental group also had to score at least a 10 out of 40 on the Dyspnea Index (score of 8 or 
more has been shown to be significant for E-ELBD in a previous study [De Guzman V et al., 
2014]).  
Inclusion criteria specific to healthy control group. In addition to meeting general 
inclusionary criteria, participants in the control group had to have no symptoms of atypical dyspnea 
over the past 6 months and had to score less than 7 out of 40 on the Dyspnea Index.  
3.3.3 Exclusion Criteria 
Table 3-2 includes a list of general exclusion criteria across the two groups, with rationales for 
exclusions provided. In addition, for the E-ELBD group only, data was excluded from analysis if 
there was absence of signs or symptoms of ELBD, either at baseline (e.g., “twitchy” laryngeal 
responses to endoscope in laryngeal vestibule) or an acute ELBD attack with exercise provocation 
challenge at maximum exertion. Positive E-ELBD provocation was based on participant report of 
symptoms they typically experienced with their athletic performance on the exercise trainer 
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(indicated by a “thumbs up” sign) and concurrent “atypical” glottic or supraglottic responses. 
Participant eligibility was determined by two licensed Speech-Language Pathologists. 
Table 3-2. General Exclusion Criteria and Rationale for Exclusion 
EXCLUSION RATIONALE 
(1) Developmental or cognitive
disorder precluding ability to
follow direction or read
instructions
Participants will need to be able to comprehend questions on the DI 
and EATQ-R17 Fear Subscale questionnaires and to follow 
directions in rating exertion perception with the physical exertion 
scale. Additionally, inability to fully understand the exercise 
laryngoscopy protocol can put participants at risk for overexertion 
or injury. 
(2) Behavioral disorder that
would disrupt study protocol or
potentially affect outcome
parameters (e.g., attention-
deficit/hyperactivity disorder
[ADHD], oppositional defiant
disorder [ODD]).
Various studies have correlated autonomic under-arousal with 
behavioral disorders. For example, a study by Crowell et al., 2006 
showed children with ADHD and ODD exhibited fewer 
electrodermal responses, lengthened cardiac pre-ejection periods, 
and heart rate changes suggestive of abnormal levels of 
parasympathetic withdrawal without sympathetic contributions. 
Therefore, behavioral disorders will be excluded to reduce a 
potential confound in autonomic function parameters in SA3(A). 
Behavioral disorders could also skew temperament parameters in 
SA3(B). Last, disruptive behaviors could put participants at risk for 
injury from the exercise protocol or could confound severity rating 
outcome parameters.  
(3) Neuromuscular disorders
affecting the respiratory or
phonatory system (e.g., ALS,
Myasthenia Gravis)
Neuromuscular disorders affecting laryngeal/respiratory systems 
could have a negative influence on laryngeal movement or 
laryngeal-pulmonary coordination, and could affect laryngeal 
configuration, symptom perception, or autonomic response 
parameters (SA1-SA3). 
(4) Supralaryngeal anatomical
defects impeding airflow
Changes in airflow from supraglottic obstruction could influence 
laryngeal movement and confound laryngeal configuration 
parameters (SA1[A], SA2[A]). 
(5) Cardiovascular
conditions/disorders (e.g.,
hypertension)
Cardiovascular conditions can influence SBP and HR 
measurements (SA3[A]) and moreover, put subjects at risk during 
exercise. 
17 DI = Dyspnea Index; EATQ-R = Early Adolescent Temperament Questionnaire – Revised. 
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Table 3-2 (Continued) 
(6) Obstructive pulmonary 
disorders (not well-controlled) 
Disorders such as not well-controlled asthma can confound 
laryngeal configuration parameters (SA1[A]; SA2[A]). Studies 
have shown the glottis narrows when air is trapped within the 
alveoli, as is the case in individuals with obstructive lung disease, 
especially during the exhalatory respiratory phase (Collett, 
Brancatisano, & Engel, 1986; England, Ho, & Zamel, 1985; Hicks 
et al., 2008; Higenbottam, 1980; Hoyte, 2013; Jamilla et al., 2000; 
Kenn & Balkissoon, 2011; Martin et al., 1987; O’Donnell, Sanii, 
Anthonisen, & Younes, 1987; Patterson & O’Connell, 1994). 
These laryngeal findings should not be present as long as the 
asthma or other obstructive pulmonary condition is controlled with 
corticosteroids or other inhalers (well-controlled obstructive 
disease categorized as FEV1 > 80% predicted).  
 
(7) Use of the following 
medications: (a) anti-
hypertensive, (b) 
cardiovascular, (c) 
psychotropic 
 
These classes of medications have all been shown to influence 
sympathetic nervous system response (Chernow, Zaloga, Lake, 
Coleman, & Ziegler, 1984; Del Colle et al., 2007; Iwamoto et al., 
2012).  
(8) Identifiable (organic) vocal 
fold pathology occluding more 
than a 1/3 of the airway (e.g., 
lesions, nodules), found on 
laryngeal examination 
 
Organic pathology occluding more than a third of the airway could 
influence configuration of the larynx or could increase laryngeal 
configuration measurement errors by raters (SA1[A]; SA2[A]).  
(9) Intolerance to flexible 
nasoendoscopy or history of 
adverse response to over the 
counter nasal decongestants  
 
All participants must tolerate the flexible laryngoscope and Afrin 
(or other nasal decongestant medication) to reduce discomfort of 
laryngoscopy in order to visualize the larynx for off-line laryngeal 
signs analysis (SA1[A]; SA2[A]).  Moreover, a history of adverse 
response to nasal decongestants would put the participant at risk for 
potentially serious health consequences. 
 
 
3.3.4 Recruitment and Informed Consent  
Plans for recruitment. Patients with suspected E-ELBD were recruited for the experimental 
group from the Voice and Speech Laboratory at the MEEI during routine clinical care. Potential 
participants presenting with symptoms of E-ELBD were approached by the PI or another Speech-
Language Pathologist at the initial consultation appointment. Control participants, recruited from 
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local sports teams and schools in the New England region, were consented by the PI at the time 
they presented to the clinic for possible participation. Advertisements (e.g., study brochures and 
flyers) were used to recruit participants, as needed. Prior to their initial visit to the clinic, all 
potential participants were asked to refrain from exercise or caffeine consumption within 2 hours 
prior to their appointment, and to wear comfortable clothing and closed toed shoes (e.g., sneakers). 
These instructions were provided by staff making the appointment.  
 Informed consent process. All patients presenting to the Voice and Speech Laboratory at the 
MEEI with report of atypical levels of dyspnea with exertion resulting in athletic performance 
decrements for more than 2 weeks were approached for informed consent by the PI prior to 
enrollment and the start of the initial formal clinical evaluation. Informed consent was completed 
by participants 18 yr old and by both participants and parent/guardian for those participants under 
the age of 18.  Information communicated during the informed consent process included the study 
purpose, description of the study and its procedures, potential risks and benefits, information about 
compensation, and procedures in the event of injury. Both the patient and the parent/guardian were 
given ample time to ask questions and received clarification or additional information regarding 
any aspect of the study as requested. Participants (age 18 yr) and participant plus parent/guardian 
(12-17 yr) affirmed willingness to participate by providing signatures on the Informed Consent 
form.  
3.4 DESCRIPTION OF MANUSCRIPT CHAPTERS 
The study’s procedures and study findings will be addressed in the following two chapters. These 
chapters consist of two manuscript-ready articles for future publication. The articles were broken 
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down into physiological responses (Chapter 4) and perceptual responses (Chapter 5) in E-ELBD, 
using exercise responses in athletic volunteers as normative references. Specifically, Chapter 4 
addresses glottic and supraglottic laryngeal response patterns at rest and to vigorous exercise with 
incremental resistance on a cycle trainer. The chapter also elucidates the role sympathovagal 
responses may play in E-ELBD. Chapter 5 clarifies symptoms that best represent the exercise-
induced ELBD variant from a previous list of commonly ascribed symptoms: chest tightness, 
cough, dysphagia, globus sensation, lightheadedness, limb paresthesia, dyspnea, stridor, syncope, 
systemic fatigue, throat clearing, throat tightness/constriction, and dysphonia/hoarseness. 
Common features were identified and quantified between athletes with and without E-ELBD, and 
clinical diagnostic benchmarks for E-ELBD were determined. The chapter also addresses findings 
on temperament (stress reactivity) between the two athletic cohorts, as compared to the general 
adolescent population, using the EATQ-R Fear subscale. As a reminder, the term “exercise-
induced paradoxical vocal fold motion disorder (E-PVFM)” was used in the two manuscripts 
instead of E-ELBD as this term is most familiar to medical providers and investigators studying 
ELBD. 
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4.0 MANUSCRIPT #1: PHYSIOLOGICAL FEATURES OF E-PVFM 
4.1 ABSTRACT 
Introduction: Exercise-induced paradoxical vocal fold motion disorder (E-PVFM) affects the 
lives of up to 1 million children and adolescents in the United States each year (De Guzman et al., 
2014). Unfortunately, these individuals are frequently misdiagnosed due to the lack of consensus 
surrounding key clinical features and severity benchmarks of pathology. Consequences included 
missed collegiate opportunities and psychosocial consequences such as adverse effects to self-
worth and personal identity, which are both crucial during the adolescent years. Therefore, the 
goals of this study were to (1) identify and quantify laryngeal responses indicative of E-PVFM 
using normative comparisons and (2) investigate the merit of the autonomic nervous system’s role 
in E-PVFM pathogenesis for future investigations, using proxy cardiovascular estimates (i.e., 
systolic blood pressure and heart rate recovery).  
Methods: 27 athletic teenagers were enrolled in the study. Participants with suspected E-PVFM 
were recruited from the Massachusetts Eye and Ear Infirmary Voice and Speech Laboratory, while 
healthy athletic volunteers were from the greater Boston region. Flexible laryngoscopy was 
conducted at rest and in conjunction with an exercise challenge. Systolic blood pressure was 
measured at baseline and during maximum exertion and magnitude of change for blood pressure 
between the two conditions was calculated. Heart rate was continuously monitored with a heart 
rate monitor and heart rate recovery was determined by taking the difference between heart rate 
(raw score) at the height of maximum exertion and two minutes post-maximum exertion. Seven 
naïve raters evaluated laryngeal responses using the previously recorded laryngoscopic 
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examinations for respective participants. Glottic responses were measured using anterior glottal 
angles on digital still images. The presence and severity of medial-lateral and antero-posterior 
supraglottic responses (arytenoid prolapse, epiglottic collapse, and ventricular compression) were 
determined on a 0-3 scale using previously recorded laryngoscopic videos.  
Results: Glottic and supraglottic configurations were virtually identical between groups at rest. 
Significantly smaller glottal angles were seen in response to exercise during the inspiratory 
respiratory cycle in the E-PVFM group (p = .02) as compared to the control group (p = .16) during 
the same condition. Significantly larger expiratory glottal responses to exercise were seen in the 
control group (p < .001) but not the E-PVFM group (p > .05). However, there were no group 
differences between the E-PVFM and control groups on expiratory glottal angles at baseline (p = 
.24) or exercise (p = .14). Significant differences were also seen in response to exercise, compared 
to baseline, with arytenoid prolapse (E-PVFM: p = .002; control: p = .01) with no significant group 
differences seen between the groups at either the baseline or exercise conditions (p > .05). There 
were also no group or condition differences with epiglottic collapse or ventricular compression 
outcome parameters. Systolic blood pressure (raw) was higher in the control group than the E-
PVFM group at rest and exercise. However, there were no significant differences seen between 
groups on magnitude of change in systolic blood pressures (ΔSBP) as a function of exercise (p > 
.05). Heart rate recovery was slightly faster in the E-ELBD group, compared to the control group. 
However, no significant differences in HRR were seen between the two groups.  
Discussion: Inspiratory glottal adduction responses to strenuous physical activity greater than 8° 
may be a good diagnostic benchmark for ELBD pathology. However, further studies are needed 
to improve sensitivity of severity benchmarks using glottal angles as an outcome parameter. 
Although expiratory glottal angles with decreases more than 32° may occur in ELBD, the high 
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variability in laryngeal responses during the expiratory phase amongst individuals in both groups 
may make the parameter less sensitive. Arytenoid prolapse may be more a feature of the adolescent 
age group—where cartilaginous structures are more pliable and susceptible to collapse with high 
negative inspiratory pressures—and not necessarily a diagnostic feature of E-PVFM. Trends in 
higher blood pressures seen in the control group at maximum exertion and larger heart rate 
recovery observed in the E-PVFM group after exertion suggests further studies into the role of the 
autonomic nervous system in E-PVFM is warranted.  
Conclusion: Study findings can increase accuracy of E-PVFM diagnosis. Results also highlight 
the importance of incorporating provocation challenge into the diagnosis of E-PVFM. Finally, 
trends in autonomic responses should be further studied to improve our understanding of 
underlying mechanisms driving clinical expression in E-PVFM. 
4.2 INTRODUCTION 
Paradoxical vocal fold motion disorder (PVFM) is an episodic breathing disorder, thought to 
originate from periodic paroxysmal laryngeal obstruction induced by environmental or systemic 
triggers (Christopher & Morris, 2010; Hoyte, 2013; Michael J. Morris & Christopher, 2010; 
Shembel et al., 2017). Diagnosis of PVFM has traditionally been based on patients’ symptoms and 
“atypical” laryngeal-respiratory dynamics seen on laryngoscopic visualization. Laryngeal 
kinematics thought to indicate PVFM have variously been described as prolapse, narrowing, 
constriction, or obstruction either medially, anteroposteriorly, or both (Shembel et al., 2017). The 
arytenoids, aryepiglottic folds, epiglottis, ventricular folds, and/or true vocal folds have all been 
implicated in these patterns. However, whether any of these laryngeal features are indicative of 
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PVFM or whether they are the result of normal responses to respiratory perturbations has largely 
remained unexplored. 
The lack of clarity in how we identify and interpret laryngeal movement in PVFM is the 
result of several clinical and methodological gaps. Traditionally, PVFM has been managed by 
healthcare providers who rarely encounter “normal” larynges in clinical settings. Without 
normative reference points, laryngeal configurations and kinematic patterns commonly seen in 
patient populations can be misinterpreted as clinical signs of pathology. For example, several 
studies have attributed brief bursts of partial laryngeal adduction (e.g., “twitchy larynx”) seen on 
endoscopy as characteristic of PVFM (Corey et al., 1998; Treole et al., 1999). However, these 
“twitchy” laryngeal patterns may be a normal response to something foreign (e.g., endoscope) in 
the laryngeal vestibule (Brancatisano, Collett, et al., 1983; England & Bartlett, 1982; Tervonen et 
al., 2009; Wood & Milgrom, 1996). Previous work has also suggested expiratory glottal narrowing 
to be a diagnostic indicator of PVFM (El-Kersh et al., 2014; Fowler et al., 2010). However, several 
studies have suggested glottal narrowing during expiration can occur anywhere between 10-40% 
in healthy individuals during the expiratory phase, depending on the larynx’s response to systemic 
ventilatory needs (Brancatisano, Collett, et al., 1983; Brancatisano, Dodd, et al., 1983). Finally, 
laryngeal dynamics evaluated in medical settings are typically assessed when the patient is 
asymptomatic, thus further increasing the probability of false positive findings.  
To summarize, clinical biases and methodological flaws challenge current utility of 
laryngeal observations as reliable diagnostic indicators of PVFM. This is concerning, considering 
qualitative assessment of laryngeal response, typically without provocation, is the current "gold 
standard" approach for diagnosing PVFM. It is therefore not surprising that up to 90% of 
individuals are misdiagnosed, resulting in prolonged medical mismanagement (average 7.5 years) 
 96 
(Bernstein, 2014; Newman et al., 1995; Traister et al., 2013). More systematic approaches, with 
better attention to methodology, are needed to improve diagnostic accuracy and streamline 
management of PVFM. Therefore, the first goal of this study was to quantify laryngeal kinematics 
at baseline and in response to vigorous exercise, and to compare findings between two groups: (1) 
patients with one type of PVFM trigger variant, exercise-induced PVFM (E-PVFM) and (2) 
healthy athletic adolescents without PVFM. 
In addition to gaps in our understanding of laryngeal-respiratory dynamics in PVFM, there 
is also a poor understanding of underlying mechanisms driving these clinical presentations. 
Previous literature has alluded to altered balance within the  autonomic nervous system (ANS) as 
a potential mechanism in PVFM (Ayres & Gabbott, 2002). Recent studies have also shown a 
positive correlation between increased intrinsic laryngeal muscle activity and heightened 
autonomic response with stressors in healthy subjects (Helou, 2014; Helou et al., 2013). Although 
currently speculative, findings suggest autonomic function could play a role in laryngeal control 
in the PVFM population. One way to measure autonomic response is through cardiovascular 
parameters. This is because the sympathetic (SNS) and parasympathetic nervous systems (PNS)—
the two subsystems of the ANS—work together to regulate heart rate (HR) and heart contractibility 
(blood pressure). The symbiotic relationship of these subsystems is especially critical during 
physiological stressors, like exercise (Coote, 2010; Mador & Acevedo, 1991; Younes & Burks, 
1985). During exercise, the PNS initially withdraws and the sympathetic system increases in 
activation, resulting in increased heart rate (Eryonucu et al., 2000). At the height of maximum 
exertion, the sympathetic nervous system becomes the primary responder. This response can be 
observed in high systolic blood pressures (SBP) and heart rates. When exercise is terminated, the 
right combination of sympathovagal balance is needed to return the system back to homeostatic 
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baseline. Parasympathetic reactivation post-maximum exertion occurs at about 44 (± 37) seconds, 
with sympathetic withdrawal occurring shortly after PNS reactivation (Pierpont & Voth, 2004). 
Systolic blood pressure (SBP) is thought to be primarily mediated by the SNS during 
vigorous exertion, whereas heart rate (HR) results from sympathovagal balance in both 
submaximal and maximal exertion conditions (Coote, 2010; Eryonucu et al., 2000). The difference 
between heart rate at peak exercise and 2-minutes post-exercise—referred to as heart rate 
recovery—is thought to be a robust indicator of efficient sympathovagal balance (Dishman et al., 
2000; Eryonucu et al., 2000; Langdeau et al., 2000; Tunnicliffe et al., 2001). HRR latency has been 
implicated in a variety of conditions including asthma, anxiety, and overtraining syndrome (Ayres 
& Gabbott, 2002; Dishman et al., 2000; Pierpont & Voth, 2004), conditions which have all been 
seen concomitantly with PVFM. Imbalance between the SNS and PNS (i.e., sympathovagal 
imbalance) could also result in aberrant exercise responses and atypical laryngeal patterns. 
However, whether sympathovagal balance actually plays a role in laryngeal breathing pathology 
has yet to be studied. Therefore, the second goal of the present study was to determine the merit 
of the autonomic dysfunction theory in PVFM etiology for further study. 
4.3 METHODS 
4.3.1 Participants 
Twenty-seven adolescent athletes (13 PVFM, 14 control) were recruited for the study. Participants 
in the PVFM group were recruited by advertisements and referred by pediatric pulmonary and ear, 
nose, and throat (ENT) physicians in the Boston region. Individuals in the control group were 
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recruited from New England sports communities. Participants all had similar training levels 
(exercised 5-7 times a week, 60-120 minutes per session) and were similar in age (range = 12-18 
yr). Participants were eligible for the E-PVFM group if they experienced levels of dyspnea that 
prevented optimal athletic performance at least once for at least 2 consecutive weeks; participants 
in the control group were eligible if they experienced no dyspneic symptoms detrimental to athletic 
performance (or exercise in general) within the past 6 months. The Dyspnea Index (DI) was 
administered to both groups to confirm the impact of dyspneic-related symptoms on quality of life. 
Patients with suspected E-PVFM were enrolled in the study if they scored more than a 10 out of 
40 on the DI; healthy athletic volunteers were enrolled if they scored less than a 7 out of 40 on the 
DI (see Appendix F: Dyspnea Index18). For participants’ safety, anyone with behavioral or 
cognitive deficits precluding them from following directions was excluded from the study. 
Participants were also excluded if they had any neurological, cardiovascular, or pulmonological 
disorders that could affect cardiovascular biomarker measurements or make the exercise bike 
challenge unsafe. Participants with asthma were excluded only if their asthma was not well 
controlled (not well-controlled asthma characterized as < 80% FEV1 predicted). Last, participants 
with intolerance to flexible endoscopy and obstructive organic lesions occluding more than a third 
of the upper airways were also excluded from the study. 
4.3.2 Procedures 
Once consented, participants were fitted with a heart rate monitor (Polar H7 Bluetooth Heart Rate 
Sensor & Fitness Tracker). The electrodes on the chest strap (WearLink®) were moistened with 
                                                 
18 For dissertation document only.  
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water and the strap was placed on the chest, firmly against the skin, just below the pectoral muscles. 
The H7 connector was then snapped onto the strap in the center of the chest. The signal was 
detected using the Polar Beat app on an Android 7.1.2 cell phone. Continuous heart rate readings 
were automatically calculated every second throughout the entirety of the protocol. Systolic blood 
pressure readings and heart rate with a blood pressure cuff (Welch Allyn Spot Vital Signs LXi, 
Skaneateles Falls, NY) were then recorded three times consecutively while participants were 
trained to use a 1-8 physical exertion effort scale. A score of 1 represented no feelings of exertion, 
while a score of 8 represented maximum exertion that could not be sustained for longer than a 
minute. Participants were informed they would be encouraged to pedal until they reached an 8 on 
the exertion scale. A stationary trainer (SF-B1203 Indoor Cycle Trainer) was used for the exercise 
challenge. The height and seat of the bike was adjusted to prevent participants from gripping the 
handlebars, which could cause peripheral constriction and confound cardiovascular outcomes. The 
investigators also ensured adjustments afforded a natural flexion of the knee at maximum leg 
extension (10-15 degrees) while the participant was on the bike.  
Once participants were seated on the trainer, oxymetazoline (Afrin®) was sprayed into the 
nostrils bilaterally to decongest the nasal passages. The flexible nasoendoscope (KayPENTAX 
EPK-1000, Kay Elemetrics Corp., Lincoln Park, NJ) was passed through the nares with the larger 
meatus and the laryngeal vestibule was visualized with halogen light. Structural and organic 
laryngeal pathology was ruled out and laryngeal movement at rest was videorecorded (nStream 
G3, Image Stream Medical). Three consecutive blood pressure and heart rate readings were taken 
for the second time while participants sat still on the trainer. Laryngeal patterns at rest were 
observed with flexible endoscopy and simultaneously video recorded for later analysis. Two 
investigators monitored ribcage movement in conjunction with laryngeal response patterns 
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visualized on the computer monitor in real-time. Airflow from the participants’ nose and mouth 
were also used as tactile feedback on the index finger and thumb used to stabilize the endoscope 
to monitor respiratory cycle bounderies. Asynchrony between laryngeal patterns and respiratory 
movement was addressed by verbally calling the start of each breath cycle (“I” for inspiration and 
“E” for expiration), as needed.  
Participants were asked to pedal continuously on the trainer between 50-110 rpms while 
the resistance on the trainer was incrementally increased one lever rotation every 30 seconds, 
determined by a stopwatch. The goal was to ramp up resistance on the bike while participants 
pedaled as hard as they could without so much resistance as to prevent participants from being 
able to pedal. Laryngeal-pulmonary synchronization was monitored simultaneously with the 
exercise challenge using the same methods as for the baseline laryngoscopy condition. 
Additionally, a lapel microphone (KayPENTAX EPK-1000, Kay Elemetrics Corp., Lincoln Park, 
NJ), placed in front of the participants to capture audible breaths and calling of the breath cycles 
when needed, was used to later confirm respiratory cycle boundaries for data extraction. 
Participants in the control group pedaled on the trainer until they reported an 8 on the exertion 
scale, at which point an additional 30 seconds of videoendoscopy was recorded prior to the exercise 
protocol being terminated. Participants in the experimental group cycled with 30-second 
incremental resistance loads until an 8 was reported on the exertion scale or a PVFM dyspneic 
episode was provoked, at which point 30 additional seconds of laryngeal movement was recorded 
before the exercise challenge was terminated. Participants were also asked to stop pedaling at the 
3-minute mark if symptoms were not elicited at an exertion level of 8 in the experimental group. 
At the point of maximum exertion (8 on the scale), or in the case of a PVFM attack, three 
consecutive readings of systolic blood pressure and heart rate were taken for the third and final 
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time. The heart rate monitor was kept on the chest until the heart rate reached baseline readings, 
before being removed, to capture heart rate recovery readings and to ensure safety of participants. 
Raw heart rate readings were also compared between groups (see Table 4-1 for summary of 
experimental protocol stages and Figure 4-1 for example of exercise laryngoscopy setup, 
respectively). 
 
Table 4-1. Experimental Protocol Stages 
Stage I: 
Screening 
Stage II: 
Pre-Baseline 
Stage III: 
Baseline 
Laryngoscopy  
Stage IV: 
Exercise 
Laryngoscopy  
IA. Case History 
IIA. Heart rate 
monitor fitted and 
app started 
IIIA. Laryngoscopy 
(at rest) 
IVA. Continuous 
Exercise 
Laryngoscopy 
w/ cycle trainer) 
IB. Dyspnea Index 
IIB. SBP and HRR 
Recordings - 1 
IIIB. SBP 
Recordings - 2 
IVB. SBP 
Recordings - 3 
 
IIC. 1-8 Physical 
Effort Scale 
Training 
 
 
 
 
IID. Trainer 
adjustment 
  
 
IIE. Oxymetazoline 
administration 
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4.3.2.1 Glottal angle and supraglottic response patterns 
For each participant, two 30-second videos of previously recorded laryngeal breathing patterns, 
sans phonation or swallow response, were created, first for the baseline (rest) laryngoscopy 
condition and second for the maximum exertion (exercise) condition. Videos were extracted into 
two distinct MP4 files for the two respective conditions for a total of 54 videos. These videos were 
later used to rate supraglottic responses. Eight digital still images of laryngeal configuration from 
each participant’s laryngeal examination (216 total) were also extracted, with two sets taken during 
each of the following conditions: (1) height of inspiration at baseline rest, (2) height of expiration 
at baseline rest, (3) height of inspiration during maximum exertion (or PVFM attack), and (4) 
height of expiration during maximum exertion (or PVFM attack). Boundaries of respiratory cycles 
were determined by investigator verbal feedback (“I” and “E”) or audible breaths with the 
Figure 4-1. Cycle trainer exercise challenge setup 
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microphone simultaneously recorded previously on the laryngoscopy videos. Thirty percent (30%) 
of the 54 videos and 30% of the 216 digital stills were each randomized separately for each of the 
seven independent raters so that each of the videos and images were analyzed at least twice. 
To analyze the digital stills, the seven raters (range: 3-20 years of laryngoscopic assessment 
experience) blinded to group and condition, were asked to manually identify anterior glottal angles 
of their respective analyzed images using a computer mouse and customized MATLAB program 
(see McKenna, Murray, Lien, & Stepp, 2016 for details). Raters were fellowship trained 
laryngologists or clinically certified voice-specialized speech-language pathologists who all had 
at least three years of experience with laryngoscopic examinations. In short, raters were asked to 
first identify the medial edge of each vocal fold. Raters then placed a coordinate at the medial tip 
of the right vocal process with a single click of the mouse, followed by double clicking the mouse 
at the vertex of the anterior commissure on the ipsilateral side (or slightly past the commissure) to 
create a line that followed the medial edge of the superior vocal fold. The same patterns were 
conducted on the left vocal fold, creating crosshairs at the anterior commissure (Figure 4-2). 
Anterior glottal angles were calculated from the crosshairs and automatically populated into an 
Excel spreadsheet using the customized MATLAB program.  
 
 
Figure 4-2. Anterior glottal angle measurements. 
3
1° 
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For images where the glottis could not be visualized due to arytenoid obstruction, raters 
were instructed to place coordinates anterior of the vocal process and follow the marginal edges 
of the superior vocal fold to (or slightly past) the anterior commissure. Raters were then asked to 
mark the image with the letters “PO” (for posterior obstruction)19 (Figure 4-3(A)).  If the anterior 
commissure was occluded (e.g., epiglottic collapse), raters were asked to start at the vocal process 
posteriorly and follow the marginal edges of the superior true vocal folds until crosshairs were 
created anteriorly. Raters were then asked to mark the image with the letters “AO” (for anterior 
obstruction)20 (Figure 4-3(B)). Raters then commented whether they thought the obstruction was 
due to camera angle or as a result of supraglottic movement. Once all raters had analyzed the 
images, intraclass correlation coefficients (ICC) for each respective image were calculated, and 
once robust ICCs were confirmed (see Section 4.4.2 for details), the angles for each image were 
averaged across the seven raters. 
 
Figure 4-3. (A) Example of anterior glottal angle acquisition for images with posterior glottal 
obstruction (e.g., arytenoids). (B) Example of anterior angle acquisition for images with 
anterior obstruction (e.g., epiglottis). 
                                                 
19 Reported in 8% of images 
20 Reported in 11% of images 
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The same raters then rated the severity of supraglottic obstruction (arytenoid prolapse, 
epiglottic collapse, and ventricular compression) on pre-recorded laryngoscopy videos for both 
baseline and exercise conditions, using a 0-3 severity scale (Table 4-2). The audio track for all the 
videos was muted so as not to bias raters to the condition (rest versus exercise) which could affect 
their rating responses. Ratings were documented on an Excel spreadsheet. Raters were also asked 
to document any other atypical laryngeal presentations they saw (e.g., edema, quivering 
arytenoids) and to indicate poor images that could affect accuracy of laryngeal analysis, using the 
same spreadsheet. Once ratings had been conducted for all seven raters. severity ratings for each 
video were averaged to the nearest integer across the seven raters for each video.  
 
Table 4-2. Rating System for Supraglottic Laryngeal Responses 
Obstruction 
Type 
0 1 2 3 
Arytenoid 
prolapse1 
Expected 
maximal 
abduction of the 
aryepiglottic folds 
with no visible 
medial rotation 
(top of cuneiform 
tubercles pointed 
vertical or slightly 
lateral) 
Visual medial 
rotation of the 
cranial edge of 
the aryepiglottic 
folds and tops of 
the cuneiform 
tubercles 
Further medial 
rotation of the 
cuneiform 
tubercles with 
exposure of the 
mucosa on the 
lateral sides of the 
tubercles 
Medial rotation 
until near 
horizontal 
position of the 
cuneiform 
tubercles and 
tops of the 
cuneiform 
tubercles move 
towards the 
midline 
Epiglottic 
Collapse2 
Epiglottis hugs 
the tongue 
Epiglottis 
between 0-45° 
Epiglottis 
between 45-90° 
Epiglottis over 
90° 
Ventricular 
(False) Fold 
compression3 
Absent 
1/3 of the true 
vocal folds 
covered 
2/3 of the true 
vocal folds 
covered 
True vocal folds 
completely 
hidden 
1Validated by Maat (2011); 2validated by Catalfumo et al., (1998); 3validated by Schonweile et al (1998) 
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4.3.2.2 Autonomic biomarkers  
Systolic blood pressure readings acquired at pre-baseline and baseline laryngoscopy were each 
averaged across the three readings for each respective condition. Readings across the three 
timepoints, pre-baseline (ave. x3), baseline laryngoscopy (ave. x3), and maximum exercise 
laryngoscopy (x1) were compared between groups. The magnitude of change in systolic blood 
pressure from pre-baseline (rest) to maximum exertion (exercise challenge) was then calculated 
for each participant. Heart rate raw scores acquired from the blood pressure cuff and heart rate 
monitor were compared to confirm robust reliability. Scores were also used to determine whether 
there were differences between groups across the conditions. Heart rate recovery was then 
calculated using the raw heart rate scores. The highest heart rate reading acquired at maximum 
exertion was subtracted from the heart rate reading acquired two minutes after the maximum 
exertion timepoint.  
4.3.2.3 Statistical analysis 
Intraclass correlation coefficients (two-way mixed model, absolute agreement) were run for glottal 
angles (inspiration and expiration) across the seven raters to determine absolute interrater 
reliability. A series of nonparametric statistical tests (Kruskal Wallis H test, Mann-Whitney U test, 
Wilcoxon Sign-Rank test) were conducted to determine group (E-PVFM, control) and condition 
(rest, exercise challenge) differences for glottal angles and supraglottic responses. For the 
autonomic parameters, factorial Analysis of variances (ANOVAs) were conducted on raw systolic 
blood pressure and heart rate readings. Independent samples t tests were performed between 
groups as a function of condition, with magnitude of systolic blood pressure response and heart 
rate recovery as the dependent variables, respectively. All parametric and nonparametric statistical 
analyses were corrected with Bonferroni adjustment to account for Type 1 errors. 
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4.4 RESULTS 
4.4.1 Demographics 
There were 9 females and 4 males in the E-PVFM group and 9 females and 5 males in the control 
group. One participant (male) of the 13 total participants in the E-PVFM group was not induced 
with provocation challenge and the laryngeal data for that participant were removed from analysis. 
Mean age of participants analyzed was 14.33 years (SD = 1.97) for the PVFM group and 16.87 
(SD = 1.19) for the control group. Participants were all competitive athletes and engaged in at least 
one organized, aerobic sport/athletic activity per year. The average length of time it took to reach 
maximum perceived exertion during the exercise challenge protocol in the present study was 
around 5 minutes in both E-PVFM and control groups (277.00 ±85.87 sec. and 265.71 ±48.48 sec., 
respectively).  
4.4.2 Reliability Measures: Glottal Angles 
Interrater reliability for glottal angle (inspiration and expiration) was statistically robust across the 
seven raters for both baseline and exercise laryngoscopy conditions (Table 4-3). The average 
intraclass correlation coefficient (ICC) was 0.95 (SD = 0.05), with a range of 0.75-0.995. These 
findings corresponded with previous work by McKenna and colleagues (2016) that showed 
intraclass correlation coefficients to be 0.91 for laryngeal kinematic calculations using the same 
laryngeal landmark identification protocol. Strong correlations across raters, despite the varying 
levels of clinician experience, confirm the utility of glottal angle measurements in both clinical 
and academic settings. 
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Table 4-3. Interrater Reliability for Glottal Angle 
 
4.4.3 Glottal Angle (inspiration) 
Descriptively, anterior glottal angles at the height of inspiration were highly similar at baseline 
laryngoscopy (rest) between the E-PVFM (M = 53.33°, SD = 10.36°) and control (M = 52.69°, 
SD = 8.17°) groups (d = 0.07). However, inspiratory glottal angles during exercise were smaller 
in the E-PVFM group (M = 44.75°, SD = 17.81°), compared to the control group (M = 54.31°, SD 
= 7.57°) (d = 0.70) (Figure 4-4). Statistically, data for inspiratory glottal angle violated 
assumptions of normality and variance. Therefore, a series of nonparametric tests were conducted. 
Kruskal-Wallis H tests showed group differences between glottal angles (raw) with inspiration 
were not significant at baseline (p = .24) or exercise (p = .19), likely due to variable glottal angle 
differences across participants. However, results did show magnitude of change, from baseline to 
exercise, was significantly smaller in the E-PVFM group (p = .04) than the control group, as 
assessed by a Mann-Whitney U test. Wilcoxon Signed-Rank tests also revealed a significant effect 
of exertion in the E-PVFM group (p = .02) but not in the control group (p = .16). 
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4.4.4 Glottal Angle (expiration) 
On average, glottal angles measured at the height of expiration were also highly similar between 
the E-PVFM and control groups at rest (M = 36.33°, SD = 11.08°; M = 36.35°, SD = 9.20°, 
respectively; d = 0.002). However, during the exercise challenge, expiratory glottal angles were 
slightly larger in the control group (M = 49.20°, SD = 9.95°) as compared to the E-PVFM group 
(M = 40.25°, SD = 16.66°) (d = 0.65) (Figure 4-4). Statistically, the data violated assumptions of 
normality and variances and a series of nonparametric tests were therefore conducted. The 
Kruskal-Wallis H test showed no statistically significant differences in glottal angle (raw) between 
groups at baseline (p = .85) or exercise (p = .14). The Mann-Whitney U test also showed no 
statistically significant differences in magnitude of change in glottal angle at the height of 
expiration from baseline to exercise laryngoscopy conditions across the two groups (p = 0.06). 
However, Wilcoxon Signed-Rank tests did show a significant increase in glottal angles with 
expiration during maximum exertion from rest in the control group (p < .001), but not the E-PVFM 
group (p > .05).  
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4.4.5 Supraglottic Laryngeal Responses  
4.4.5.1 Arytenoid movement 
Descriptively, 25% of participants in the PFVM group and 21% in the control group were rated by 
the raters as having mild medial arytenoid movement (1 on 0-3 scale) at rest (baseline 
laryngoscopy). During exercise, 92% of participants in the E-PVFM group and 79% in the control 
group showed some level of medial arytenoid activity (rating of 1 or more on 0-3 scale), with 50% 
in the E-PVFM group and 25% in the control group exhibiting moderate medial arytenoid prolapse 
(2 on 0-3 scale). No participants in either group were rated as having severe arytenoid prolapse (3 
on 0-3 scale) (Table 4-4). Statistically, there were no significant differences between groups on 
amount of arytenoid activity at baseline (p = 0.83) or exercise (p = 0.22) laryngoscopy, as assessed 
by a Kruskal-Wallis H Test. Wilcoxon Signed-Rank tests showed exercise had a significant effect 
Baseline Inhale Baseline Exhale Exercise Inhale Exercise Exhale
E-PVFM 53.33 36.33 44.75 40.25
CONTROL 52.69 36.35 54.31 49.20
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Figure 4-4. glottal angle (inspire and expire) configuration 
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on arytenoid response in both the E-PVFM group (p = .002) and control group (p = .01) (Figure 
4-5Figure 4-5. Supraglottic Laryngeal Responses). 
4.4.5.2 Epiglottic collapse 
Descriptively, 33% of participants in the E-PVFM group and 14% in the control group were rated 
as having mild epiglottic movement (between 0-45 degrees towards the level of the glottis) at rest 
(1 on 0-3 scale). One individual in the control group was rated as having moderate epiglottic 
movement (2 on 0-3 scale). During exercise, 17% of participants in the E-PVFM and 21% in the 
control group were rated as having mild collapse towards the level of the glottis, with no 
participants exhibiting moderate (2 out of 3) or severe (3 out of 3) epiglottic movement during 
exercise (Table 4-4). There were no statistically significant differences between groups on amount 
of epiglottic activity at baseline (p = 0.33) or exercise (p = 0.76) laryngoscopy, as assessed by a 
Kruskal-Wallis H Test. Wilcoxon Signed-Rank tests also showed there were no significant 
epiglottic responses to exercise in either the E-PVFM group (p = .32) or control group (p = 1.00) 
(Figure 4-5). 
4.4.5.3 Ventricular (false fold) compression 
Ventricular compression was not seen at rest in either the E-PVFM or control groups. During 
maximum exertion, raters identified mild ventricular compression in 17% of participants in the E-
PVFM group and 21% in the control group (Table 4-4). There were no statistically significant 
differences between groups on amount of false fold activity at baseline (p = 1.00) or exercise (p = 
0.76) laryngoscopy, as assessed by a Kruskal-Wallis H Test. Exercise did not have a significant 
effect on ventricular medial response in either the E-PVFM group (p = .56) or control group (p = 
.05), as assessed by Wilcoxon Signed-Rank tests (Figure 4-5). 
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Figure 4-5. Supraglottic Laryngeal Responses 
 
Table 4-4. Descriptive Findings for Supraglottic Patterns at Baseline (Rest) and Maximum 
Exertion (Exercise Challenge) in participants with E-PVFM and Controls. Prevalence is 
based the 0-3 severity rating scale 
Supraglottic Patterns E-PVFM Control 
Arytenoid 
Prolapse 
Baseline 0: 75% 1: 25% 2: 0% 0: 79% 1: 21% 2: 0% 
Exercise 0: 8% >1: 92% 2: 50% 0: 21% >1: 79% 2: 25% 
Epiglottis 
Collapse 
Baseline 0: 67% 1: 33% 2: 0% 0: 78% 1: 14% 2: 7% 
Exercise 0: 83% 1: 17% 2: 0% 0: 79% 1: 21% 2: 0% 
Ventric. 
Compres. 
Baseline 0: 100% 1: 0% 2: 0% 0: 100% 1: 0% 2: 0% 
Exercise 0: 83% 1: 17% 2: 0% 0: 79% 1: 21% 2: 0% 
 
4.4.6 Sympathovagal Balance Biomarkers 
4.4.6.1 Systolic blood pressure 
Descriptively, systolic blood pressure readings at rest and during rigorous exercise were higher in 
the control group than the E-PVFM group (Figure 4-6). A mixed-design factorial ANOVA was 
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Epiglottis
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conducted to determine whether there were statistically significant differences in systolic blood 
pressure readings over the three conditions: pre-baseline, baseline laryngoscopy, and exercise 
laryngoscopy between the E-PVFM and control groups. There were no outliers in the data, 
characterized as studentized residual values greater than +/-3. The assumption for normality was 
met, as assessed by Shapiro-Wilk's test of normality (p > .05). Homogeneity of variance was met 
for all three conditions (pre-baseline, baseline, and exercise) (p > .05), as assessed by Levene's test 
of homogeneity of variances. Homogeneity of covariances was met (p > .05), as assessed by Box's 
M test. Mauchly's test of sphericity indicated that the assumption of sphericity was violated for the 
two-way interaction, χ2(2) = 14.430, p < .001. Epsilon (ε) was .661, as calculated according to 
Greenhouse & Geisser (1959), and was used to correct the mixed-design factorial ANOVA. There 
was no statistically significant interaction between group and condition on systolic blood pressure, 
F(1.321, 27.742) = .215, p = .714, partial η2 = .010. The main effect of condition showed a 
statistically significant difference in mean systolic blood pressure measures at the three different 
time points, F(1.321, 27.742) = 77.465, p < .001, partial η2 = .787. The main effect of group 
showed significantly higher systolic blood pressure measurements in the control group (M = 
130.03 mmHg, SE = 2.62 mmHg) as compared to the E-PVFM group (M = 118.40 mmHg, SE = 
2.85 mmHg) F(1, 21) = 7.726, p = .011, partial η2 = .269. Post hoc analysis with a Bonferroni 
adjustment revealed that systolic blood pressure measurements were statistically higher in the 
exercise condition (M = 143.98, SE = 3.06) than the pre-baseline (M = 113.50 mmHg, SE = 1.78 
mmHg) and baseline (M = 115.16 mmHg, SE = 2.44 mmHg) conditions, respectively (p < .001). 
There were no significant differences between the pre-baseline and baseline conditions (p = .635) 
(see Table 4-5 for SBP descriptive statistics and Figure 4-6 for visual representation of SBP for 
the two groups across the three conditions and post-maximum exertion. Raw systolic blood 
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pressure readings at the 2- and 3-minute post-maximum exertion time points have also been 
included for comparison). 
 
Table 4-5. Descriptive Statistics for Raw Systolic Blood Pressure Readings Across Conditions 
 
 
Descriptive Statistics for Systolic Blood Pressure Readings 
 
Group 
Mean 
(mmHg) 
Std. Dev. 
(mmHg) 
N 
Cohen’s 
d 
Pre-Baseline 
E-PVFM 108.17 7.39 11 
1.24 Control 118.83 9.60 13 
Total 113.94 10.07 24 
Baseline 
Laryngoscopy 
E-PVFM 109.76 13.16 11 
0.90 Control 120.56 10.73 13 
Total 115.61 12.87 24 
Exercise 
Laryngoscopy 
E-PVFM 137.27 17.16 11 
0.89 Control 150.69 12.78 13 
Total 144.54 16.12 24 
2 Minutes Post-
Max Exertion 
E-PVFM 130.70 17.77 10 
1.02 Control 147.76 15.54 13 
Total 140.35 18.32 23 
3 Minutes Post-
Max Exertion 
E-PVFM 128.00 21.30 5 
0.57 Control 137.83 11.81 6 
Total 133.36 16.66 11 
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Figure 4-6. Means and standard deviations for systolic blood pressure across conditions. 
 
 
An independent samples t test was conducted to determine whether there were group 
differences in magnitude of sympathetic response to exercise—as measured via systolic blood 
pressure changes from baseline to exercise (ΔSBP)—between E-PVFM and control groups. There 
were no outliers in the data, as assessed by boxplot. Systolic blood pressure readings were normally 
distributed, as assessed by Shapiro-Wilk’s test (p > .05) and assumption of homogeneity was met, 
as assessed by Levene’s test for equality of variances (p = .47). ΔSBP (measured in mm Hg) was 
greater in the control group (M = 31.86 mmHg, SD = 11.12 mmHg) than the E-PVFM group (M = 
29.11 mmHg, SD = 16.00 mmHg). However, there was no statistically significant difference 
between the two groups, t(22) = -0.50, p = .63, d = 0.20.  
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4.4.6.2 Heart rate recovery 
Descriptively, heart rate (bpm) at rest (pre-baseline and baseline laryngoscopy) and maximum 
vigorous exercise were highly similar between groups (Figure 4-7). A mixed-design factorial 
ANOVA was conducted to determine whether there were statistically significant differences in 
raw heart rate readings across the three conditions: pre-baseline, baseline laryngoscopy, and 
exercise laryngoscopy between the E-PVFM and control groups. There were no outliers in the 
data, characterized as studentized residual values greater than +/-3. The assumption for normality 
was met, as assessed by Shapiro-Wilk's test of normality (p > .05). Homogeneity of variance was 
met for pre-baseline and exercise conditions (p > .05), but not for baseline laryngoscopy condition 
(p = .004), as assessed by Levene's test of homogeneity of variances. Homogeneity of covariances 
was violated (p = .003), as assessed by Box's M test. Mauchly's test of sphericity indicated that the 
assumption of sphericity was met for the two-way interaction, χ2(2) = 1.07, p = .59. There was no 
statistically significant interaction between group and condition on heart rate, F(2, 50) = 1.48, p = 
.24, partial η2 = .056. The main effect of condition showed a statistically significant difference in 
mean heart rate measures at the different time points, F(2, 50) = 558.20, p < .001, partial η2 = .957. 
There were no significant differences in group for heart rate measures F(1, 25) = 0.003, p = .96, 
partial η2 = .000. Post hoc analysis with a Bonferroni adjustment revealed that heart rate measures 
were statistically higher in the exercise condition (M = 167.06 bpm, SE = 2.08 bpm) than the pre-
baseline (M = 79.34 bpm, SE = 2.80 bpm) and baseline (M = 85.20 bpm, SE = 3.20 bpm) 
conditions, respectively (p < .001). There were no significant differences between the pre-baseline 
and baseline conditions (p = .11). (see Table 4-6 for HR descriptive statistics and Figure 4-7 for 
visual representation of raw HR readings for the two groups across the three conditions and post-
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maximum exertion. Raw heart rate readings at the 1-, 3-, and 20-minute minute post-maximum 
exertion time points have also been included for comparison). 
 
Table 4-6. Descriptive Statistics for Raw Heart Rate Readings (in bpm) Across Conditions 
Descriptive Statistics for Heart Rate (Raw Readings) 
 
Group 
Mean 
(bpm) 
Std. Dev. 
(bpm) 
N 
Cohen’s 
d 
Pre-Baseline 
E-PVFM 76.54 14.84 13 
0.38 Control 82.13 14.29 14 
Total 79.44 14.56 27 
Baseline 
Laryngoscopy 
E-PVFM 86.64 21.41 13 
0.17 Control 83.76 10.42 14 
Total 85.15 16.37 27 
Exercise 
Laryngoscopy 
(Max Exertion) 
E-PVFM 168.77 8.58 13 
0.32 Control 165.36 12.52 14 
Total 167.00 10.75 27 
1min Post-max 
Exertion 
E-PVFM 132.38 21.60 13 
0.05 Control 131.31 20.93 14 
Total 132.37 20.84 27 
2min Post-max 
Exertion 
E-PVFM 114.69 19.61 13 
0.05 Control 115.69 18.24 14 
Total 115.89 18.58 27 
3min Post-max 
Exertion 
E-PVFM 113.85 20.83 13 
0.11 Control 111.69 17.06 14 
Total 112.93 18.62 27 
20min Post-max 
Exertion 
E-PVFM 95.00 19.42 13 
0.33 Control 101.23 17.37 14 
Total 98.41 18.34 27 
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Figure 4-7. Means and standard deviations for heart rate (raw readings) across conditions 
(pre-baseline, baseline, and exercise) 
 
 
An independent samples t test was also conducted on 2-minute post-exertion heart rate 
recovery (2-min HRR) to determine whether there were group differences in parasympathetic 
reactivation after maximum exertion between the two groups. There were no outliers in the data, 
as assessed by boxplot. The assumption of normality was met, as assessed by Shapiro-Wilk's test 
of normality (p > .05). Homogeneity of variance was also met (p > .05), as assessed by Levene's 
test of homogeneity of variances. Two-minute HRR was greater in the E-PVFM group (M = 54.08, 
SD = 15.10) than the control group (M = 49.15, SD = 15.91). However, differences between the 
two groups were not statistically significant, t(24) = 0.81, p = .43, d = 0.32. 
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4.5 DISCUSSION 
During quiet respiration, glottal configurations between the groups were almost identical. Both 
groups showed phasic glottal widening during inspiration and glottal narrowing during expiration. 
On average, glottal angles decreased from inspiration to expiration by 32%. Findings of laryngeal 
patterns at rest (without provocation) in both E-PVFM and control groups are consistent with those 
from previous literature which show the glottis decreases from inspiration to expiration during 
vegetative breathing in healthy controls anywhere between 10-40% (Brancatisano, Collett, et al., 
1983). Laryngeal response patterns to exercise in the control group were also similar to those 
reported in previous studies. From baseline (rest) to maximum exertion (exercise challenge), the 
control group’s glottal angles increased with both inspiration (average increase: 2%) and 
expiration (average increase: 36%). These laryngeal patterns are thought to augment airway 
patency in order to meet greater ventilatory demands with exercise (Brancatisano, Dodd, et al., 
1983), especially during expiration.   
Conversely, in the E-PVFM group, glottal angles decreased with exercise (from rest) 
during inspiration (average decrease: 15%), with statistically significant differences between 
groups observed during the same condition. Nine out of 13 participants had more than an 8° 
decrease in anterior glottal angle with exercise during inspiration. These patterns align with 
previously documented inspiratory "paradoxical" findings described in the literature (e.g., Beaty, 
Wilson, & Smith, 1999), and are thought to be counterproductive for meeting high ventilatory 
demands during strenuous exercise.  
With expiratory glottal angles in the E-PVFM group, the angles also increased in response 
to exercise (from rest). However, unlike in the control group, laryngeal responses were not 
significantly different between rest and exercise. In fact, these responses showed to be more 
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blunted in the E-PVFM group (average increase: 11%) during exercise as compared to the control 
group (average increase: 36%) in the same condition. Expiratory findings could point to a 
reduction in respiratory efficiency in patients with E-PVFM, as opposed to frank “paradox” (seen 
with inspiration). Interestingly, while the majority of participants in the E-PVFM group had 
abducted vocal fold responses to exercise (albeit blunted), two out of the thirteen participants in 
the same group did have adductory responses to exertion with expiration (3-4° and 15-20° 
expiratory glottal angle decreases with exercise from baseline, respectively). These findings show 
that there may be some variability in response patterns with the expiratory cycle in patients with 
E-PVFM and point to potential differences in mechanisms underlying these glottal response 
patterns. Findings may also point to a disordered respiratory and laryngeal system that may 
manifest in disturbed or discoordinated physiological patterns that differ from patient to patient 
with potentially similar underlying mechanism(s). 
Overall, results showed decreased inspiratory glottal configurations, characterized by 
paradoxical vocal fold adduction, is a good diagnostic indicator of E-PVFM. Blunted abducted 
(and in some cases paradoxical adducted) expiratory laryngeal patterns may also be observed in 
response to exercise in patients with E-PVFM. However, because these patterns were not 
significantly different from athletic controls they may not be as robust a clinical indicator of E-
PVFM. Additionally, the fact that these pattern differences were only present during exercise 
highlights the need to implement provocation challenges into clinical practice to prevent over- or 
under-diagnosis of PVFM.  
Supraglottic patterns showed higher prevalence of medial arytenoid movement patterns 
during exercise (compared to rest) in both groups. Although the prevalence of arytenoid prolapse 
was slightly higher in the E-PVFM group (compared to control) during exercise, there were no 
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significant differences between the two groups (p > 0.05) at rest or exercise. These results suggest 
arytenoid response patterns may occur variably in young athletes in general, and the presence of 
these patterns may not necessarily be indicative of E-PVFM, although future investigation with 
larger cohorts are needed to be sure. Prolapsed arytenoids are thought to occur with substantial 
negative inspiratory pressures (i.e., Bernoulli effect, Venturi effect) or alterations in muscle tone, 
causing laryngeal tissues to draw together (Bent et al., 1996; Christopher & Morris, 2010). These 
significant pressure changes may occur during maximum exertion or strenuous physical activity, 
which could explain why supraglottic obstruction might be more prevalent in athletes (Christopher 
& Morris, 2010; Nagai et al., 1992; Pinho, Tsuji, Sennes, & Menezes, 1997). The smaller diameter 
of the airways in younger individuals, which can create more negative pressure, combined with 
increased pliability of the larynx in the pediatric population (Hudgins, Siegel, Jacobs, & 
Abramowsky, 1997), could explain the higher prevalence of medial movement of the arytenoids 
seen in young athletes during high physical demands. 
Additionally, the lower prevalence of epiglottic and ventricular responses in both groups 
across conditions may suggest these patterns could be more representative of other PVFM variants 
(e.g., Irritable Larynx Syndrome) than of the exercise PVFM variant. The supraglottic patterns 
found in this study align with previous work. In a study by Christensen and colleagues, paradoxical 
glottal movement of the true vocal folds, as well as supraglottic prolapse of the arytenoids, were 
noted during a continuous laryngoscopy exercise (CLE) test in the majority of 97 adolescent 
athletes diagnosed with E-PVFM (Christensen et al., 2010). Abu-Hasan and colleagues (2005) also 
found paradoxical glottal movement, as well as arytenoid and epiglottal prolapse, but the latter 
presentation only occurred in 13 out of 142 participants with exercise-induced dyspnea during a 
similar exercise task. 
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Interestingly, when raters were asked to freely note any additional laryngeal features they 
thought indicated E-PVFM, five out of the seven raters reported presence of “twitchy” larynges 
and edema/erythema. When blinded to group and condition, prevalence of “twitchiness” identified 
by the raters was slightly higher in the control group (29% [4/14]) than the E-PVFM group (17% 
[2/12]). The presence of edema/erythema was similar between the E-PVFM group (17% [2/12]) 
and control group (14% [2/14]). These findings point to the need for caution when extrapolating 
laryngeal findings to PVFM pathology in absence of normative reference points. However, further 
investigation is needed to determine the role of these physiological responses in PVFM across 
larger sample sizes, different trigger variants (e.g., irritant-induced), and different pathological 
cohorts with similar signs and symptoms to E-PVFM (e.g., exercise-induced asthma, anxiety 
disorders). 
There were no statistically significant differences between groups on sympathovagal 
responses to exercise. However, lower SNS trends seen in the E-PVFM group, in spite of 
seemingly alarming PVFM subjective “attacks,” when combined with slightly faster PNS 
reactivation post-exertion, may point to autonomic dysfunction as a potential mechanism in some 
individuals with E-PVFM. These findings align with previous studies showing PNS hyperfunction 
and SNS hypofunction in patients with asthma, reflux disorders, and chronic vasomotor rhinitis 
(Ishman et al., 2007; Jaradeh et al., 2000; Loehrl et al., 2002). Interestingly, these conditions have 
high comorbidities with PVFM. Studies by Helou and colleagues also showed increased 
parasympathetic responses to high physiological (cold pressor task) and psychological (public 
speaking task) demands placed on the body—with simultaneous increases in intrinsic laryngeal 
muscle activity—in two cohorts of healthy individuals, compared to biomarker parameters at 
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homeostatic baseline (Helou, 2014; Helou et al., 2013). Findings of the present study warrant 
future investigations into the role(s) sympathovagal balance plays in PVFM.  
Interestingly, exercise—a different type of physiological stressor than the one used by 
Helou and colleagues—perturbs respiratory patterns (volume, flow, and timing), causing changes 
in ventilatory responses. The ANS typically alters these perturbed respiratory patterns to 
accommodate increased respiratory demands placed on the system with exercise. However, with 
chronic demands placed on the system, the sympathetic and parasympathetic systems can become 
imbalanced (Brame & Singer, 2010). Too much parasympathetic activity could result in vagally-
mediated tension within the intrinsic laryngeal muscle adductors or reduced laryngeal tone in the 
abductor muscles, reducing airway patency (Streeter, Gerbarg, Saper, Ciraulo, & Brown, 2012). 
Although the theory is at this point speculative, it could help explain laryngeal patterns found 
within the E-PVFM cohort, and can facilitate direction of future investigations. 
It is important to note that it is not suggested that the ANS does play a role in E-PVFM but 
that it could play a role. Due to the high variability in autonomic responses amongst participants, 
combined with the small sample size in the present study, caution should be taken so as not to 
over-attribute ANS dysfunction to PVFM. Further investigations with larger, appropriately 
powered sample sizes are needed to further confirm or refute this theory. Specifically, an interim 
power analysis suggests that 788 participants (394 E-PVFM and 394 healthy controls) would need 
to be recruited to provide 80% statistical power to detect a clinically significant difference between 
magnitude of change in systolic blood pressures using independent t tests with an alpha level of 
0.05 (Cohen’s d = 0.2). For the 2-minute heart rate recovery parameter, 352 total participants (176 
E-PVFM and 176 healthy controls) would need to be recruited to provide 80% statistical power to 
detect a clinically significant difference between magnitude of change in systolic blood pressures 
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using independent t tests with an alpha level of 0.05 (Cohen’s d = 0.3). However, preliminary 
findings showing trends in lower systolic blood pressure responses to exercise, combined with 
faster heart rate recovery post-exercise in the E-PVFM group in many of the participants is curious 
and should be further explored. 
There were several limitations to the study surrounding the blood pressure readings that 
should be noted. First, average systolic blood pressures were higher in the control group than the 
E-PVFM group across conditions. Findings were primarily attributed to trends in autonomic 
dysregulation in the experimental group. However, the lower blood pressures seen in the E-PVFM 
group at rest and with laryngoscopy (baseline and exercise) could instead have been attributed to 
the extra 15-20 minutes participants in the E-PVFM group remained seated after they were 
consented and completed the screening form but prior to the start of the protocol. During this time 
patients with suspected E-PVFM were given brief psychoeducational counseling on PVFM 
principles. However, both groups remained seated for at least half an hour after they arrived at the 
Voice and Speech Laboratory at the Massachusetts Eye and Ear Infirmary while they underwent 
the consent process, screening, and completed the Dyspnea Index. Previous studies suggest the 
amount of time the participants sat prior to starting the protocol (~30 minutes) was sufficient for 
cardiovascular parameters to reach homeostatic baseline (Al Haddad, Laursen, Chollet, Ahmaidi, 
& Buchheit, 2011; Becker, Silva, Moreira, & Victor, 2007; Buchheit et al., 2008; Muntner P, He 
J, Cutler JA, Wildman, & Whelton, 2004; Singh, Rhodes, & Gauvreau, 2008). Regardless, future 
studies should incorporate psychoeducational counseling for both groups into the study’s protocol 
to keep the design of the study as consistent as possible.  
Second, blood pressure readings during maximum exertion needed to be initiated 
immediately at the point of exercise cessation due to the sensitivity of the blood pressure cuff to 
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physical movement. Therefore, acquisition of SBP for the maximum exertion readings took an 
additional 10-20 seconds after the participant stopped pedaling on the trainer to account for 
inflation and deflation of the blood pressure cuff. As a result, the SBP readings acquired for max 
exertion could have been slightly lower than actual arterial pressures at the maximum exertion 
timepoint. However, it is unlikely the timing of SBP readings confounded differences seen 
between the two groups. First, measurements were collected at exactly the same time for both 
groups. Second, previous studies have shown pressure readings to be relatively constant within the 
first minute of exercise termination (Al Haddad, Laursen, Chollet, Ahmaidi, & Buchheit, 2011; 
Becker, Silva, Moreira, & Victor, 2007; Buchheit et al., 2008; Muntner P, He J, Cutler JA, 
Wildman, & Whelton, 2004; Singh, Rhodes, & Gauvreau, 2008). Third, SBP readings taken for 
the maximum exertion time point were also lower in the E-PVFM group across the other 
timepoints as well. Therefore, the method of acquisition for the maximum exertion time point 
should not have confounded study results. 
The second limitation associated with the maximum exertion SBP readings was that only 
one reading was used to compare group differences, while the average of three readings was used 
for the pre-baseline and baseline laryngoscopy SBP measurements. However, the averaged 
readings taken during the two rest conditions were all well within 5-10 mmHg of each other, 
showing good reliability with the blood pressure cuff and instilling confidence in the maximum 
exertion SBP readings. The final limitation was the high prevalence of failed SBP readings at the 
3-minute post-maximum exertion time point across groups (n = 5 E-PVFM, n = 6 control, 
respectively). Participants remained on the cycle trainer until their heart rates and blood pressure 
readings had decreased in order to reduce the risk of dizziness and injury during trainer dismount. 
However, by the three-minute mark participants became restless on the trainer, thus increasing the 
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rate of cuff reading failures. Fortunately, since these readings were solely used to monitor safety 
of the participants and not as outcome parameters, cuff failure at this point was less of a concern. 
In cases where the cuff readings did fail, the heart rate monitor was used to assess cardiovascular 
recovery to make sure participants were safe to dismount and leave the hospital premises after 
completing the study protocol. 
4.6 CONCLUSION  
Results of this prospective experimental study suggest the best physiological correlates of E-
PVFM are anterior glottal angles observed during the inspiratory phase of the respiratory cycle 
during provocation challenge. The role of expiratory glottal angles and arytenoid pattern responses 
during provocation for E-PVFM diagnostics require future investigation with larger sample sizes, 
other PVFM trigger variants, and pathological comparison groups to determine their merit. 
Overall, study findings highlight the importance of provocation challenge and use of comparative 
studies involving healthy normal cohorts to identify key laryngeal features indicative of E-PVFM. 
Finally, trends in sympathovagal response differences between the two groups suggest there is 
merit to studying the role of the autonomic nervous system in future investigations. The results of 
this study will likely improve the sensitivity of diagnostic paradigms and overall management of 
E-PVFM; the study can also be used to drive future investigations into PVFM identification, both 
from a clinical and etiological perspective.  
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5.0 MANUSCRIPT #2: PERCEPTUAL FEATURES OF E-PVFM 
5.1 ABSTRACT 
Introduction: Exercise-induced paradoxical vocal fold motion disorder (E-PVFM) is a condition 
typically seen in adolescent athletes. Acute E-PVFM episodes are triggered by increased physical 
demands such as high intensity or extended periods of aerobic activity (e.g., running, swimming). 
The hallmark clinical features of these acute episodes—paradoxical adduction of the true vocal 
folds and dyspnea—cause detriments to athletic performance. However, various other features, 
such as paradoxical supraglottic response (e.g., arytenoid prolapse, epiglottic collapse) and a host 
of associated symptoms (e.g., cough, dysphonia, throat tightness), have been attributed to E-PVFM 
presentation as well (Shembel et al., 2017). Unfortunately, the majority of individuals with E-
PVFM are initially misdiagnosed with another medical condition, such as exercise-induced 
asthma, resulting in prolonged mismanagement of the condition (Bernstein, 2014; Traister et al., 
2016). The high prevalence of initially unsuccessful identification of E-PVFM is largely due to a 
lack of consensus in key clinical features that indicate a diagnosis. The dearth of validated 
quantifiable methods to improve specificity of diagnosis and lack of severity benchmarks also 
complicate matters. Finally, there is a significant gap in prospective experiments using participants 
with normal systemic responses to exercise as comparisons to distinguish the “typical” from the 
“atypical.” Mechanisms underlying E-PVFM clinical presentation are also poorly understood, 
further complicating identification and management of the condition. However, certain 
temperament qualities such as perfectionism, neuroticism and high stress reactivity have been 
implicated as the underlying cause (Forrest et al., 2012; Husein et al., 2008).  
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The objectives of this study were twofold. The first goal was to identify and quantify key 
symptom presentations in E-PVFM, using normative and atypical perceptual responses to exercise 
as diagnostic benchmarks. The second goal was to investigate whether stress reactivity plays a role 
in E-PVFM pathology by comparing temperament differences between participants with and 
without E-PVFM.  
Methods: 27 adolescent athletes (13 E-PVFM, 14 control) were recruited from the Massachusetts 
Eye and Ear Voice and Speech Laboratory and the greater Boston region. All participants 
underwent a graded exercise test on a cycle trainer during continuous laryngoscopy; cardiovascular 
biomarkers were also acquired during the protocol. Prior to the exercise test, participants were 
asked to rate the severity of their current symptoms experienced at rest using a 0-100 continuous 
visual analog scale (VAS) and completed the Fear subscale on the Early Adolescent Temperament 
Questionnaire – Revised (EATQ-R). Participants then rated the same symptoms experienced with 
rigorous exertion using the 0-100 VAS immediately after the exercise test protocol had been 
completed. 
Results: There were significant group differences in exercise response between patients with E-
PVFM and athletic volunteers (control) for inspiratory and expiratory dyspnea (p = .01, 
respectively). Both groups had significant responses to exercise, compared to baseline, for 
symptoms of stridor (E-PVFM: p = .01; control: p = .001) and throat tightness (p = .01, 
respectively). However, there were no significant group differences found between the two cohorts 
for the latter two symptom parameters. The following symptoms features were not as prevalent 
amongst the patients with E-PVFM: chest tightness, cough, dysphagia, globus, lightheadedness, 
limb paresthesia, syncope, systemic fatigue, throat clearing, and dysphonia. Measurements of 
stress reactivity (suggestive of proclivity towards anxiety) using the EATQ-R Fear subscale were 
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remarkably similar between the two athletic groups. However, EATQ-R Fear Subscale scores for 
both groups were significantly higher compared to normative data across typical adolescents in the 
US population.  
Discussion: Participants in both groups got short of breath with exercise, which is to be expected 
during strenuous physical activity. However, severity ratings on shortness of breath were 
significantly higher in the E-PVFM group than the control group during these physically 
demanding tasks. Severity benchmarks indicate that a visual analog scale of 30 out of 100 or higher 
is a good diagnostic marker for E-PVFM pathology using dyspnea as a biomarker. However, 
further study is needed with larger sample sizes to confirm this statement. Furthermore, both 
groups experienced noisy breathing and throat tightness in response to exercise. However, the 
latter two parameters did not significantly distinguish participants with E-PVFM from those 
without the condition; these same two parameters were also highly variably in how they were 
perceived across both groups. Furthermore, the following features: chest tightness, cough, 
dysphagia, globus, lightheadedness, limb paresthesia, syncope, systemic fatigue, throat clearing, 
and dysphonia may better reflect other comorbidities common in the E-PVFM population (e.g., 
asthma, muscle tension dysphonia, anxiety disorders) or may better represent other PVFM variants 
(e.g., irritable larynx syndrome, psychosomatic-associated PVFM). Finally, similarities on 
responses to stress reactivity between athletic groups insinuates certain temperaments typically 
attributed to patients with E-PVFM may instead better reflect temperaments in competitive young 
athletes, in general.   
Conclusion: Study findings highlight the importance of normative comparisons when studying E-
PVFM as well as the clinical utility of provocation challenge to improve sensitivity of E-PVFM 
 130 
diagnosis. Findings also suggest caution when attributing temperament and personality traits to E-
PVFM pathogenesis.  
5.2 INTRODUCTION 
 
Paradoxical vocal fold motion (PVFM) disorder is a condition that is thought to present primarily 
as shortness of breath (dyspnea) and has been attributed to airflow obstruction at the level of the 
larynx (Heimdal et al., 2006). Symptoms are provoked suddenly and acutely by systemic or 
environmental stimuli. Many other symptoms, including hoarseness, cough, throat clearing, 
dysphagia, and globus sensation, have all been associated with PVFM as well (Morrison & 
Rammage, 2010b; Vertigan et al., 2006; Vertigan, Theodoros, Winkworth, & Gibson, 2008; 
Vertigan, Theodoros, Gibson, & Winkworth, 2007). However, whether these symptoms are 
indicative of PVFM or whether they reflect concomitant pathologies that often co-occur in the 
PVFM population (e.g., muscle tension dysphonia, chronic cough, asthma) is unknown. Gaps in 
systematic, prospective study of PVFM, and the dearth of normative studies to compare to and 
better identify pathology specific to PVFM, has resulted in differential diagnosis based on 
exclusion. As a result, features axiomatic to PVFM, and severity benchmarks of pathology, are left 
open to interpretation. 
It is therefore not surprising that as many as 90% of individuals with PVFM are initially 
misdiagnosed (Bernstein, 2014; Newman, Mason, & Schmaling, 1995; Traister, Fajt, Whitman-
Purves, Anderson, & Petrov, 2013; Koufman & Block, 2008; MacConnell & Danielsen, 20103.; 
Mikita & Mikita, 2006; Morris et al., 2006; Nascimento et al., 2013; Tilles & Inglis, 2009). 
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Unfortunately, these concerns are non-trivial. A delay in correct diagnosis means individuals are 
mismanaged, on average, for 7.5 years (Bernstein, 2014; Newman et al., 1995; Traister et al., 
2013). For example, individuals with an exertional- or exercise-induced PVFM variant (herein 
referred to as E-PVFM) are often misdiagnosed with exercise-induced asthma (EIA). The first line 
approach is inhaled corticosteroids to manage symptoms. As symptoms persist, the course of 
treatment becomes longer and medication dosing becomes higher. Unfortunately, prolonged 
pharmacological mismanagement can lead to iatrogenic consequences such as osteoporosis, 
obesity, stunted growth, Cushing’s disease, and hypertension in otherwise healthy, young 
individuals (Christopher et al., 1983; Heinle et al., 2003; Newman et al., 1995; Noyes & Kemp, 
2007).  
For adolescent athletes with E-PVFM—the cohort most commonly seen in the clinical 
setting with an exertional trigger variant (Ahrens, Seibt, & Kitz, 2001; Gavin et al., 1998; 
Landwehr et al., 1996; Sandage & Zelazny, 2004; S. A Tilles, 2003)—protracted mismanagement 
can also mean missed collegiate scholarship opportunities and can result in withdrawal from sports 
and the sports community, leading to feelings of isolation and impairment to self-concept (De 
Guzman et al., 2014; Røksund et al., 2009; Weinberger & Abu-Hasan, 2009; Weinberg & Gould, 
2011). Therefore, to help prevent frequent misdiagnosis and mismanagement of the condition, the 
primary goal of this study was to quantify inspiratory dyspnea and compare severity ratings 
between athletic adolescents with and without E-PVFM as means to improve diagnostic 
benchmarks for pathology. The second goal was to identify other perceptual features relevant to 
the E-PVFM cohort. These additional clinical features representing the E-PVFM cohort were also 
compared to typical sensations individuals without E-PVFM experience during exercise to 
improve diagnostic specificity.  
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In addition to the gap in identifiable features indicative of PVFM, creating diagnostic 
challenges, the underlying mechanisms involved in PVFM etiology are also largely unknown. 
Although previous literature has frequently alluded to temperament and mental/mood disorders as 
the cause (Brown M., Merritt, & Evans, 1988; Earles, Kerr, & Kellar, 2003; Guglani, Atkinson, 
Hosanagar, & Guglani, 2014; Husein et al., 2008; Leo & Konakanchi, 1999; Mobeireek, Alhamad, 
Al-Subaei, & Alzeer, 1995; Weinberger & Doshi, 2017)—especially in young adolescent female 
athletes—the theory is largely unsubstantiated due to lack of empirical evidence. PVFM induced 
by exertional activity has been deemed a form of somatization due to the high-achieving, 
competitive, and anxious nature characterizing individuals with the exercise-induced variant (Leo 
& Konakanchi, 1999; Maschka et al., 1997). However, it could just as easily be that these traits 
are characteristic of any athlete with a competitive drive and proclivity towards perfectionism (trait 
anxiety) (Bartulovic et al., 2017; Hill & Madigan, 2017; Weinberg & Gould, 2011). Conversely, 
perceptions of uneasiness and inadequacy could be a consequence of PVFM symptoms that are 
causing detriments to athletic performance (state anxiety) (Hicks et al., 2008; Mathers-Schmidt, 
2001; Nascimento et al., 2013). If there is, in fact, a relationship between PVFM and 
psychopathology, determining whether the relationship is causal, consequential, or correlational is 
a worthwhile pursuit to improve management of the condition. Therefore, to determine the merit 
of psychopathology as a mechanism in PVFM for future pathoetiological studies, the third goal of 
this study was to compare temperament (stress reactivity) in competitive young athletes, with and 
without E-PVFM. 
 To accomplish these study objectives, participants in the E-PVFM group were asked to 
identify which clinical symptoms they experienced during athletic activity from a list of symptoms 
associated with PVFM across the condition spectrum found in the current literature (see Table 5-1 
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for complete list of symptoms; also see Shembel et al., 2017, for details on working comprehensive 
taxonomy framework). Two groups of competitive adolescent athletes, with and without E-PVFM, 
were then both asked to quantify self-perceived severity of clinical features using the most frequent 
symptoms reported by the E-PVFM group on a 0-100 continuous visual analog scale (VAS) during 
rest (baseline) and exercise challenge. Participants were also asked to complete the Fear subscale 
of the Early Adolescent Temperament Questionnaire- Revised (EATQ-R) to target anxiety-related 
temperament (i.e., stress reactivity) (Ellis & Rothbart, 1999).  
5.3 METHODS 
5.3.1 Participants 
Twenty-seven adolescent athletes (n = 13 E-PVFM; n = 14 control) were recruited for the study. 
Participants were all physically active, competitive athletes who participated in organized sports. 
Individuals with suspected E-PVFM were recruited from the Voice and Speech Laboratory at 
Massachusetts Eye and Ear Infirmary (MEEI) at the time of their initial consultation visit with the 
Speech-Language Pathology team. Participants in the control group were recruited from local 
schools and sports teams in the New England region. Participants in both groups were eligible for 
the study if they were between the ages of 12-18 years and played competitive sports at least three 
times a week for a minimum of 40 minutes per athletic session. Potential recruits from the patient 
population at MEEI were included in the experimental group if they scored at least a 10 out of 40 
on the Dyspnea Index (Gartner-Schmidt et al., 2014) and if laryngeal patterns on laryngoscopy 
involved “atypical” responses (e.g., paradoxical adduction of the vocal folds; prolapse or quivering 
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of the arytenoids) either at rest or during exercise (see Shembel et al., 2017 for specifics on PVFM 
laryngeal categorization). Potential participants had all undergone extensive medical workups with 
specialists (e.g., ENT, GI) prior to their initial consultation at the Voice and Speech Laboratory to 
rule out other pathology that could account for their dyspneic-related symptoms (e.g., asthma, 
allergies). Participants were included if they had no asthma (defined as FEV1 >80% predicted), or 
well-managed asthma (defined as FEV1 >80% predicted with their inhaler during methacholine 
challenge). The decision to include participants with well-controlled exercise-induced asthma into 
the experimental group was driven by the higher prevalence of co-occurring asthma in the E-
PVFM population (30-40% comorbidity). Since bronchodilators (inhalers) temporarily open the 
airways, any symptoms related to dyspnea with FEV1 >80% will be reflective of E-PVFM and not 
exercise-induced asthma (Balkissoon & Kenn, 2012; Collett et al., 1983; England et al., 1985; 
Higenbottam, 1980; Martin et al., 1987; O’Donnell et al., 1987; Patterson & O’Connell, 1994). 
Athletic volunteers were eligible for the control group if they had not previously 
experienced dyspnea detrimental to athletic performance within the past 6 months, and if they 
scored less than 7 out of 40 on the Dyspnea Index. Participants were excluded if they had a history 
of previously diagnosed obstructive pulmonary diseases (e.g., asthma). 
Participants in both groups were excluded if they had any of the following in their medical 
history: (1) developmental, behavioral, or cognitive disorders that would make following 
directions for the cycling challenge difficult, (2) neuromuscular disorders that could affect exercise 
response, (3) cardiovascular conditions that would make the exercise challenge unsafe, (4) 
intolerance to flexible nasoendoscopy, and (5) structural or anatomical abnormalities that occluded 
more than a third of the upper airways at rest. All eligible participants were asked to refrain from 
exercise or caffeine consumption within 2 hours prior to their appointment, and to wear 
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comfortable clothing and closed toed shoes (e.g., sneakers) that would allow them freedom of 
movement for exercise. Participants with well-managed asthma in the E-PVFM group were also 
asked to bring their inhaler with them to the appointment. 
5.3.2 Procedures 
Once consented, participants rated severity of symptoms they experienced at the present moment 
using a 0-100 continuous visual analog scale (VAS), first at baseline (x2; pre-baseline and baseline 
laryngoscopy) and then once at maximum exertion (bike challenge) (see Table 5-1 for complete 
list of symptoms). In addition to the symptoms in Table 5-1, participants were also asked to rate 
the severity of their leg fatigue at rest and maximum exertion. This parameter was used as a 
positive control foil to confirm consistency in responses between the two groups. The list of 
symptoms and positive control foil were randomly presented to participants to prevent order effect.  
 
Table 5-1. List of PVFM-related symptoms, based on a comprehensive literature review by 
Shembel et al., 2017 
Perceptual Symptom Parameters 
Chest tightness 
Cough 
Dysphagia (swallowing complaints) 
Globus sensation 
Lightheadedness/dizziness 
Limb paresthesia 
Shortness of breath with expiration 
Shortness of breath with inspiration 
Stridor (noisy breathing) 
Syncope 
Systemic fatigue 
Throat clearing 
Throat tightness/constriction 
Voice complaints (dysphonia/hoarseness) 
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Each symptom had a corresponding 0-100 continuous horizontal line below it. Participants 
were asked to place a tick mark representing respective levels of severity for each parameter, using 
a Fire HD-10 touch-screen tablet (Amazon Ltd.) and customized VAS, created at 
www.surveygizmo.com (see representative example in Figure 5-1). The most common symptoms 
reported in the E-PVFM group were then statistically analyzed between groups and conditions to 
determine perceptual differences between individuals with and without PVFM, specific to the 
exertion PVFM variant.   
 
Figure 5-1. Example of VAS symptom severity rating tablet interface. Figure not to scale. 
 
After each participant completed baseline severity ratings, but prior to completing severity 
ratings with exertion, participants were asked to respond to questions on the Fear Subscale of the 
Early Adolescent Temperament Questionnaire – Revised (EATQ-R) (Ellis & Rothbart, 1999) 
using the same digital touch-screen tablet. The EATQ-R, overall, measures different temperament 
Exercise 
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constructs such as self-regulation and emotionality. The Fear subscale on the EATQ-R, 
specifically, measures perceived levels of unpleasantness and negative affect associated with 
anticipation of stressful events (i.e., stress reactivity) (Ellis & Rothbart, 1999). This subscale is 
thought to correlate with high levels of anxiety and neuroticism in adolescents (Muris & Meesters, 
2009; Snyder et al., 2015).  
Once baseline ratings and responses on the Fear EATQ-R subscale were completed, a heart 
rate monitor (Polar H7 Bluetooth Heart Rate Sensor & Fitness Tracker) and blood pressure cuff 
(Welch Allyn Spot Vital Signs LXi) were each placed on the participant’s chest and right arm, 
respectively, to monitor vitals. Oxymetazoline (nasal decongestant) was then administered into the 
nostrils bilaterally in accordance with standard of care procedures at Massachusetts Eye and Ear 
Voice and Speech Laboratory. Participants were trained to quantify levels of physical effort using 
a perceived exertion scale (1-8) while vigorously riding a stationary bike (trainer) (1 = no exertion, 
8 = anaerobic activity that cannot be sustained for longer than a minute) and were told they would 
be encouraged to continue pedaling until maximum, vigorous exercise had been reached (8 on the 
exertion scale). Patients with suspected E-PVFM were instructed to give a “thumbs up” sign when 
they experienced symptoms representative of complaints they typically experienced during their 
respective sport(s) or other competitive athletic activities. Once participants communicated 
understanding, the height and seat of the stationary bike (SF-B1203 Indoor Cycle Trainer) was 
adjusted to each participant’s configuration. Target ergonomics was a slight bend at the knee joint 
(10-15° angle) and comfortable extension of the arms on the handlebars for stability (Paridon et 
al., 2006; Pollock, Wilmore, & Fox, 1984).  
Participants sat on the bike once it had been adjusted to meet their specifications. Surgical 
lubricant jelly (E-Z Jelly, Medline Industries, Inc., Mundelein, IL) was placed on the tip of the 
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flexible endoscope (KayPENTAX EPK-1000, Kay Elemetrics Corp., Lincoln Park, NJ) and the 
endoscope was then passed through the naso- and oro-pharynx into the laryngeal vestibule. Once 
the camera was in place, the larynx was briefly visualized with halogen light to rule out structural 
or organic anomalies that could explain dyspneic symptoms experienced with exertion. 
Participants again rated symptoms on the VAS for later pre-baseline comparisons and to 
preemptively account for potential differences in symptom presentation with introduction of the 
endoscope into the laryngeal vestibule. Videorecordings of laryngeal movement (nStream G3, 
Image Stream Medical) were then initiated with cycle challenge (Continuous Exercise 
Laryngoscopy test [CLE-test]; refer to Heimdal et al., 2006 and Olin et al., 2016 for details). The 
protocol involved progressive resistance increments (one 360° rotation with lever) every 30 
seconds at 50-110 rpms on a stationary bike with concurrent flexible laryngoscopy. For the control 
group, resistance increased until participants perceived an 8 on the exertion scale, at which point 
30 additional seconds of laryngeal movement was visualized to confirm no paradoxical movement 
was seen on the laryngoscopy video and to parallel the protocol with the E-PVFM group. Once 
participants in the control group had reached maximum exertion, the exercise protocol was 
terminated and the endoscope was removed. For participants with suspected E-PVFM, resistance 
increased incrementally every 30 seconds until an E-PVFM episode was induced. At the point of 
induction, 30 additional seconds of the provoked episode was recorded before participants in the 
E-PVFM were asked to cease pedaling. Rescue breathing techniques were then implemented, as 
needed, to mitigate symptoms of the attack after the cycle protocol had been terminated (see 
CliftonSmith & Rowley, 2011; Mathers-Schmidt, 2001; Sandage & Zelazny, 2004 for details). 
Presence of E-PVFM in the experimental group was confirmed based on (1) patient report 
(“thumbs up” to indicate E-PVFM symptoms) and (2) concurrent glottic and/or supraglottic 
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responses seen on videoendoscopy during cycling challenge. An E-PVFM episode was considered 
present if both patient perceptions of symptoms and medial laryngeal responses/glottic obstruction 
with exercise challenge occurred. Presence of atypical laryngeal response patterns were 
determined by two licensed speech-language pathologists at the Voice and Speech Laboratory at 
Massachusetts Eye and Ear. As soon as participants (in both groups) had stopped pedaling on the 
trainer, they were immediately asked to rate the severity of symptoms they experienced during 
maximum exertion on the tablet for the third and final time. Finally, using a 1-10 scale (1 = no 
symptoms, 10 = most severe episode experienced), participants in the E-PVFM group were asked 
to rate the severity of the episode they experienced with the exercise challenge, as compared to 
symptoms typically experienced with their respective sports/athletic activities. Participants were 
also asked to indicate (yes/no) whether the symptoms they experienced with the exercise challenge 
were representative of symptoms they typically experienced on the court or field. 
Symptom severity scores (1-100 continuous VAS) acquired during rest conditions (pre-
baseline and baseline laryngoscopy) and exercise challenge, as well as EATQ-R Fear subscale 
scores, were extracted from the tablet and raw data were placed into an Excel spreadsheet for later 
data reduction and analysis. Kruskal Wallis H tests, Mann-Whitney U tests, and Wilcoxon Sign-
Rank tests with Bonferroni corrections were conducted on the common symptoms reported in the 
E-PVFM group (inspiratory dyspnea, expiratory dyspnea, stridor, and throat tightness) to 
determine group (E-PVFM, control) and condition (rest, exercise) differences on these parameters. 
An independent samples t test was also conducted for the EATQ-R Fear Subscale. Statistical 
analysis used for each outcome parameter will be discussed in detail in the Results section. 
 140 
5.4 RESULTS 
5.4.1 Demographics 
The mean age of participants was 14.46 years (SD = 1.94) for the E-PVFM group and 16.87 (SD 
= 1.19) for the control group. There were 9 females and 4 males in the E-PVFM group, and 9 
females and 5 males in the control group. The 2:1 prevalence in female-to-male ratio in the E-
PVFM group is consistent with previous literature showing E-PVFM affects twice as many 
females as males (as compared to the 3-5 times greater female prevalence in other types of PVFM) 
(Olin et al., 2015). All participants played competitive organized sports and were heavily involved 
in other athletic extracurricular activities (see Table 5-2 for details). Participants in the E-PVFM 
group participated in sports an average of 5.57 times per week (SD = 1.14); participants in the 
control group played sports an average of 5.83 times per week (SD = 0.96). Average length of time 
per athletic session was 103.46 minutes (SD = 31.32) for the E-PVFM group and 95.67 minute 
(SD = 42.80) for the control group. Average level of self-reported physical effort exerted during 
regularly scheduled athletic activities was 8.08 for the E-PVFM group (SD = 1.04) and 7.47 for 
the control group (SD = 1.25) (1-10 scale, 1 = no effort and 10 = maximum effort). Mean Dyspnea 
Index scores for the E-PVFM group was 25.15 (SD = 5.16) and 2.60 (SD = 2.90) for the control 
group. The mean length of time to maximum exertion during the study’s exercise challenge was 
277.00 seconds (SD = 85.87 sec.) in the E-PVFM group and 265.71 seconds (SD = 48.48 sec.) in 
the control group. See Table 5-2 for a summary of demographic findings. 
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Table 5-2. Demographics of E-PVFM and Control Groups 
Group Age Gender Aerobics/Sports 
Times/ 
Week 
 
Session 
Length 
(min.) 
Effort 
Level 
(1-10) 
Dyspnea 
Index 
Time to 
max 
exertion 
(sec.) 
E-
PVFM 
14.46 
±1.94 
9 F 
4 M 
1 Basketball 
1 Crew 
3 Cross 
country/Track & 
Field 
1 Frisbee 
1 Ice hockey 
2 Lacrosse 
1 Skiing 
5 Soccer 
3 Softball/Baseball 
2 Squash 
1 Swimming 
5.75  
±1.14 
103.46 
±31.32 
8.08 
±1.04 
25.15 
±5.16 
277.00 
±85.87 
Control 
16.87 
±1.19 
9 F 
5 M 
2 Crew 
9 Cross country/ 
Track & field 
1 Cycling 
1 Field hockey 
1 Ice hockey 
1 Dancing (aerobic) 
2 Skiing 
3 Soccer 
1 Softball/Baseball 
1 Swimming 
3 Tennis 
5.83 
±0.96 
95.67 
±42.80 
7.47 
±1.25 
2.60 
±2.90 
265.71 
±48.48 
 
The screening protocol revealed that within the E-PVFM group, the average reported 
length of time to onset of E-PVFM episodes experienced when playing sports outside of the 
clinical setting (e.g., on field or court) was 5.78 minutes (range 30 seconds – 15 minutes) and 
average resolution of symptoms was 16.38 minutes (range 2 minutes – 2 hours). All 13 participants 
had been prescribed a trial course of inhalers prior to their initial consultation at the Mass Eye and 
Ear Voice and Speech Laboratory. The average improvement in E-PVFM-related symptoms with 
inhalers was 29.58% (range 0-85%). Of the 13 participants, 9 of the participants reported less than 
50% improvement with inhalers.  
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The prevalence of concomitant asthma found in 38% [5/13] of participant in the E-PVFM 
group (confirmed with pulmonary function testing) is consistent with previous literature showing 
asthma co-occurs with E-PVFM 30-40% of the time (Christopher & Morris, 2010; Hicks et al., 
2008; Hoyte, 2013). Diagnosed environmental allergies were also prevalent in 38% (5/13) of 
patients with E-PVFM in the present study. Gastroesophageal reflux disease (GERD) was 
prevalent in 15% (2/13) of E-PVFM participants. Clinically diagnosed generalized anxiety 
disorder was found in 8% of E-PVFM participants (1/13). Three out of 13 participants (31%) in 
the E-PVFM group reported extreme temperatures and environment (e.g., heat, cold, dry air, 
humidity) further amplified E-PVFM symptoms they typically experienced with exertion. E-
PVFM episodes were induced with cycle challenge in ninety-two percent (92%) of participants 
(12/13) using the continuous laryngoscopy exercise (CLE) test protocol. Positive provocation, 
defined by patient-reported symptoms and concurrent laryngeal response pattern changes, was not 
evoked in one of the thirteen participants in the E-PVFM group. Mean severity of E-PVFM 
symptoms experienced with cycle challenge (compared to temporal parameters of typical sports-
induced episodes, previously noted) was 7.30 (range: 5-9; scale: 1 = no symptoms, 10 = most 
severe episode experienced). Qualitatively, all participants reported symptoms during the cycle 
challenge were representative of symptoms they typically experienced during athletic practices or 
competition.  
Twelve out of 13 participants reported inspiration was typically more challenging then 
expiration during their typical athletic activities (e.g., out on the field or court), although all 
participants in the E-PVFM group experienced some levels of shortness of breath during both 
inspiratory and expiratory cycles. The 13th participant reported expiration and inspiration were 
equally challenging. The four bolded symptoms in Table 5-3—inspiratory dyspnea, expiratory 
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dyspnea, stridor, and throat tightness—were the most prevalent features reported in the E-PVFM 
cohort. Therefore, the severity of these symptoms was compared between groups with and without 
E-PVFM and statistically analyzed to determine group and condition differences. Severity of leg 
fatigue was also statistically analyzed to confirm perceptual consistency between groups and 
ensure that groups reached equivalent exertion levels. The other (non-bolded) symptoms in Table 
5-3—chest tightness, cough, dysphagia, globus pharyngeus, dizziness, paresthesia of the limbs, 
systemic fatigue, throat clearing, and voice complaints—were less prevalent in the E-PVFM 
cohort. Therefore, severities of these features were not rated or statistically analyzed between the 
two groups.  
 
Table 5-3. List of Symptoms Associated with PVFM Across the Symptom Complex and 
Prevalence of Reported Symptoms in E-PVFM Group 
Perceptual Symptom Parameters 
# (%) of E-PVFM 
Participants 
Chest tightness 3 (23%) 
Cough 1 (8%) 
Dysphagia (swallowing complaints) 1 (8%) 
Globus sensation 1 (8%) 
Lightheadedness/dizziness 2 (15%) 
Limb paresthesia 1 (8%) 
shortness of breath with expiration 8 (60%) 
shortness of breath with inspiration 13 (100%) 
Stridor (noisy breathing) 6 (46%) 
Syncope 0 (0%) 
Systemic fatigue 1 (8%) 
Throat clearing 2 (15%) 
Throat tightness/constriction 6 (46%) 
Voice complaints (dysphonia/hoarseness) 2 (15%) 
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5.4.2 Symptom Severity Ratings 
5.4.2.1 Inspiratory Dyspnea 
On average, participants in the E-PVFM group reported greater dyspnea with inspiration on the 0-
100 continuous VAS at both pre-baseline21 (M = 7.46, SD = 17.78) and exercise (M = 62.92, SD = 
33.08) conditions, compared to control participants (M = 0.57, SD = 1.09; M = 33.50, SD = 23.74, 
respectively) (baseline Cohen’s d = 0.55; exercise Cohen’s d = 1.02) (Figure 5-2). Statistically, the 
data violated assumptions of normality and variance, requiring nonparametric statistical analysis. 
Therefore, the Kruskal-Wallis H Test was performed to determine whether there were significant 
group differences in raw VAS scores at rest and exercise. Wilcoxon signed-rank tests were also 
performed to determine whether there were significant differences on raw VAS scores between 
rest and exercise conditions across the groups. Mann-Whitney U Tests were performed to 
determine whether there were significant differences in magnitude of change from rest to exercise 
conditions between the two groups. Results showed significantly higher ratings of inspiratory 
dyspnea (raw scores) during exercise as compared to baseline in both the E-PVFM (p = .002) and 
control groups (p = .001), per the Wilcoxon signed-rank test. There were also significant raw score 
differences between groups on inspiratory dyspnea with the exercise challenge (p = .01) but not 
baseline rest (p = .09), as determined by Kruskal-Wallis H tests. However, no significant 
differences were seen in magnitude of change between groups (p = .07). 
                                                 
21 Pre-baseline and baseline laryngoscopy severity ratings were highly similar between the two conditions on all 
symptom parameters and were therefore not statistically analyzed. The baseline (rest) condition severity ratings were 
analyzed using the pre-baseline ratings. 
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Figure 5-2. Inspiratory dyspnea (raw scores) group differences at rest and exercise 
 
5.4.2.2 Expiratory Dyspnea 
On average, participants in the E-PVFM group had higher perceptions of dyspnea (raw scores) 
with expiration both at baseline (M = 7.15, SD = 17.83) and during exercise (M = 48.62, SD = 
34.61), as compared to control participants (M = 0.21, SD = 0.65; M = 34.61, SD = 26.78, 
respectively) on the VAS (baseline Cohen’s d = 0.55; exercise Cohen’s d = 0.45) (Figure 5-3). 
Statistically, the data violated assumptions of normality and variance, requiring the same 
nonparametric analyses as for inspiratory dyspnea. Results showed significantly higher ratings of 
expiratory dyspnea (raw scores) during exercise as compared to baseline in both the E-PVFM and 
control groups (p = .003, respectively), per the Wilcoxon signed-rank test. There were significant 
raw score differences between groups on expiratory dyspnea with the exercise challenge (p = .01) 
and baseline rest (p = .02), as determined by Kruskal-Wallis H tests. However, no significant 
differences were seen in magnitude of change between groups (p = .15). 
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Figure 5-3. Expiratory dyspnea (raw scores) group differences at rest and exercise 
  
5.4.2.3 Stridor 
On average, severity levels of self-reported stridor (noisy breathing during inspiration) were 
similar between groups (Figure 5-4) (baseline Cohen’s d = 0.12; exercise Cohen’s d = 0.002). 
Statistical analysis showed no statistically significant differences between groups for the rest and 
exercise conditions (raw scores) or magnitude of change across conditions (p > .05), as assessed 
by Kriskal-Wallis H test and Mann-Whitney U tests, respectively. However, significant 
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differences were seen between baseline rest and exercise conditions in both the E-PVFM (p = .01) 
and control groups (p = .001), as assessed by Wilcoxon signed-ranks tests. 
 
5.4.2.4 Throat Tightness 
On average, participants in the E-PVFM group had higher perceptions of throat tightness both 
during baseline (M = 9.31, SD = 15.05) and during exercise (M = 41.08, SD = 37.57) conditions, 
as compared to control participants (M = 0.21, SD = 0.58; M = 20.14, SD = 21.64, respectively) 
on the VAS ratings (baseline Cohen’s d = 0.85; exercise Cohen’s d = 0.68) (Figure 5-5). However, 
it is important to note substantial variation in responses within each group (as shown by large 
standard deviations). A series of nonparametric tests were performed to determine whether there 
were statistically significant differences in raw scores and magnitude of change across conditions 
between the two groups, due to violations of normality and variance assumptions. There were no 
statistically significant differences on throat tightness raw scores between groups in either baseline 
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Figure 5-4. Stridor (raw scores) group differences at rest and exercise 
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or exercise conditions (p > .05) or differences in magnitude of change across conditions (p > .05), 
as assessed by Kriskal-Wallis H test and Mann-Whitney U tests, respectively. Significant 
differences were seen, however, between baseline rest and exercise conditions in both the E-PVFM 
and control groups (p = .01, respectively), as assessed by Wilcoxon signed-ranks tests. 
 
5.4.2.5 Leg Fatigue 
Results on self-reported VAS ratings of leg fatigue between groups and across conditions showed 
that the groups were equivalent in physical fitness and experienced similar perceived exertion 
levels. Specifically, participants in the E-PVFM group had similar perceptions of leg fatigue (M = 
5.54, SD = 11.19) to control participants (M = 4.79, SD = 9.83) at baseline. Groups were also 
similar during maximum exertion (E-PVFM: M = 57.54, SD = 33.14; control: M = 63.43, SD = 
26.83) (baseline Cohen’s d = 0.07; exercise Cohen’s d = 0.20) (Figure 5-6). Statistical analysis 
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Figure 5-5. Throat tightness (raw scores) group differences at rest and exercise 
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showed no significant differences between groups for either rest or exercise (raw scores) (p > .05), 
as assessed by Kruskal-Wallis H tests. Magnitude of change across conditions was also similar 
between groups (p > .05), as assessed by Mann-Whitney U test. Results showed both groups 
experienced significantly more leg fatigue during maximum exertion, as compared to baseline rest 
(E-PVFM: p = .002; control: p = .001), as assessed by Wilcoxon Signed-Rank Test. 
 
Figure 5-6. Leg fatigue (raw scores) group differences at rest and exercise 
5.4.3 Temperament and Stress Reactivity (EATQ-R Fear Subscale) 
An independent samples t test was conducted to determine if there were significant differences in 
the EATQ-R Fear subscale between E-PVFM and control groups. There was one outlier in the 
data, as assessed by boxplot. EATQ-R Fear subscale responses were normally distributed, as 
assessed by Shapiro-Wilk’s test (p > .05) and assumption of homogeneity was met, as assessed by 
Levene’s test for equality of variances (p = 0.97). EATQ-R Fear subscale scores were slightly 
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higher in the E-PVFM group (M = 14.23, SD = 4.69) than the control group (M = 12.64, SD = 
4.48). However, these group differences were not statistically significant, mean difference = 1.59, 
95% CI [-2.05, 5.22], t(25) = 0.90, p = 0.37, d = 0.35. Interestingly, group differences between 
competitive athletes in the present study and the general adolescent population (M = 2.65, SD = 
0.77)—based on previously normed epidemiological studies on the EATQ-R—did show 
statistically significant differences amongst the E-PVFM, athletic control, and general population 
cohorts, respectively (p < 0.001) (E-PVFM group versus general population: d = 3.45; control 
group versus general population: d = 3.11) (Muris & Meesters, 2009). 
 
  
Figure 5-7. Study group and general population EATQ-R Fear Subscale Scores 
  
PVFM CONTROL POPULATION
Series1 14.23076923 12.69230769 2.65
0
2
4
6
8
10
12
14
16
18
20
E
A
T
Q
-R
 F
ea
r 
Su
m
 S
co
re
s
Group
EATQ-R Fear Subscale
E-PVFM
14.23 12.69
 151 
5.5 DISCUSSION 
Dyspnea (inspiratory and expiratory) was the most commonly reported symptom in the E-PVFM 
group, with the greatest group differences. Qualitatively, all patients in the E-PVFM group 
reported they experienced dyspnea severe enough to cause detriments to athletic performance. 
Quantitatively, there were significant group differences on dyspnea severity scores in response to 
exercise challenge between participants with and without E-PVFM, where patients with E-PVFM 
reported significantly higher dyspnea. From the list of symptoms thought to indicate PVFM, 
dyspnea appears to best correlate with the exertion-induced PVFM cohort. Interestingly, 
participants with E-PVFM also reported sensations of dyspnea at rest before the exercise 
provocation challenge was initiated. These findings were significantly higher at baseline rest for 
expiratory dyspnea but not inspiratory dyspnea. The higher sensations with dyspnea patients with 
E-PVFM experience already experience at rest may be amplified during exercise (see Figure 5-8 
for schematic representation of magnitude change differences from rest to exercise between 
groups), Higher dyspnea experienced at rest could point to another mechanism in additional to, or 
instead of the larynx, that could be contributing to E-PVFM symptoms (e.g., accessory respiratory 
muscle tension). Or the findings could indicate different thresholds to laryngeal pattern responses 
represented in Figure 5-8 (e.g., somatosensory threshold dysfunction). To summarize, the 
following diagnostic benchmarks can be used to increase confidence in inclusion criteria and 
improve accuracy of E-PVFM diagnosis: greater than (a) 30/100 on the VAS with strenuous 
exercise, (b) 20/40 or more on the Dyspnea Index, and (c) presence of stridor and throat tightness 
during exercise. 
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It is important to note that the mere presence of dyspnea should not be used as a diagnostic 
indicator, since both groups experienced dyspnea with exercise. Rigorous physical activity causes 
shortness of breath, regardless of aberrant laryngeal breathing patterns or athletic abilities (who 
amongst us has not been winded running up a hill or booking it after a bus?). Furthermore, many 
other disease processes (e.g., asthma, heart disease) cause dyspnea. Therefore, future studies with 
larger cohorts are needed (n > 30) to better identify benchmarks for pathology, using perceptions 
of dyspnea during provocation challenges as an outcome parameter. These severity cutoff scores 
can more accurately identify patients with PVFM, appraise treatment outcomes, and identify 
appropriate cohorts for future studies.  
The second most common set of symptoms reported in the E-PVFM group (from the list 
of PVFM-related symptoms) were stridor and throat tightness. Qualitatively, findings showed 
Figure 5-8. Magnitude of response differences between groups on dyspnea severity at rest 
and exercise. Patterns suggest other mechanisms may contribute to symptoms experienced 
during asymptomatic periods, such as respiratory musculoskeletal inefficiencies outside the 
larynx or somatosensory integration dysfunction within the larynx. 
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stridor and throat tightness occurred variably across individuals in both groups during rigorous 
physical activity. Quantitatively, severity of responses on these two parameters increased with 
exercise in both groups, with no significant differences seen between groups. Results suggest 
perceptions of stridor and throat tightness may have more to do with the physiological demands 
athletes place on their bodies, in general, and less to do with a PVFM diagnosis, specifically. 
However, further study with larger sample sizes are needed to better identify the utilization of 
these two parameters. High prevalence of dyspnea, throat tightness, and stridor symptoms suggest 
these features may be more common to the E-PVFM variant. The other, less common features 
(e.g., cough, dysphonia), may better reflect other PVFM trigger variants (e.g., irritants), other types 
of PVFM (e.g., irritable larynx syndrome), or other concomitant pathologies (e.g., chronic cough, 
muscle tension dysphonia, asthma).  
Finally, results on the EATQ-R Fear subscale suggest athletes with E-PVFM may have 
analogous temperaments to other competitive athletes. Extra caution should be taken in the future 
so as not to assume psychopathology to be the cause of E-PVFM. Fortunately, the study of 
perceptual patterns across different presentations of laryngeal breathing disorders could help guide 
future etiological investigation. Objective, empirical study using such a holistic approach can help 
us better identify underlying systems that could be responsible for PVFM symptomology. For 
example, increased levels of dyspnea and throat tightness in E-PVFM, especially during 
asymptomatic, non-provoked periods, could point to a disrupted somatosensory system. Or, 
because the respiratory system involves numerous skeletal muscles in the head and neck that help 
us breathe, the issue could be musculoskeletal. Just as leg muscles can become tight and tethered 
with repetitive use (e.g., endurance running) causing decrements to athletic performance, so can 
accessory muscles of the upper airways with chronic heavy exertion.  
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It is easy to reduce the respiratory system to a series of tubes for gas exchange. However, 
we often forget about all the tiny, intricate neck/throat muscles that facilitate respiration. The 
palatoglossus and palatopharyngeus muscles, for example, regulate respiratory rate and airway 
resistance via changes to oropharyngeal configuration. The pharyngeal constrictors (superior, 
middle, and inferior) regulate expiratory flow (de Carlos et al., 2013; Dempsey & Pack, 1995; 
Mathew & Sant’Ambrogio, 1988). Within the larynx itself, the intrinsic laryngeal adductors 
(thyroarytenoid, intrarytenoids, and lateral cricoarytenoids) and abductor (posterior cricoarytenoid 
muscle) work in tandem for each inspiratory and expiratory phase of the respiratory cycle. During 
rigorous exercise, these laryngeal muscles must also coordinate more closely with extrinsic 
laryngeal muscle elevators (styloglossus, genioglossus, and stylopharyngeas) to increase airway 
patency (Hillel, 2001; Mathew & Sant’Ambrogio, 1988). In general, all of these head and neck 
muscles must work together for optimal respiratory coordination and support. Tethered/tight 
muscles—potentially perceived as throat constriction—from repetitive, high caliber physical 
activity, can cause imbalance within the system and result in discoordinated breathing (dyspnea). 
In other words, higher perceptions of throat tightness and dyspnea at rest in the E-PVFM group 
could point to muscle inadequacies at rest (especially outside of the larynx), amplifying aberrant 
muscle responses to strenuous activities.   
5.6 CONCLUSION  
This prospective mixed-design study was the first step in a programmatic line of work to help 
improve diagnostic accuracy of PVFM. Results show inspiratory and expiratory dyspnea are good 
perceptual correlates to E-PVFM. However, further investigation is needed to improve severity 
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benchmarks for pathology and to differentiate symptoms in E-PVFM from normal levels of 
dyspnea found with exertion. Validated severity benchmarks and cutoff scores can then be used to 
determine level of disability and appraise treatment outcomes. Future studies are also needed to 
determine perceptual differences between PVFM and other disorders with overlapping 
symptomology (e.g., asthma, COPD, panic disorders). These findings should be studied in relation 
to normal variation in exercise intolerance as a result of normal physiological limitations (e.g., 
deconditioning). Findings can guide diagnostic paradigms and reduce prevalence of misdiagnosis 
and mismanagement in the PVFM population. In addition to studying normative benchmarks for 
pathology using perceptual features that correlate with PVFM, physiological studies are also 
needed to better elucidate etiology underlying symptoms. Outcomes of this study and can help 
guide clinical diagnostic approaches and future academic investigations into physiological and 
etiological factors causing PVFM.  
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6.0 SYNTHESIS & FUTURE DIRECTIONS 
Exercise-induced episodic laryngeal breathing disorders (E-ELBD) are thought to originate from 
laryngeal impedance acutely triggered by exertion (Shembel et al., 2017). Numerous symptoms 
and laryngeal patterns have been implicated in E-ELBD. However, whether any of these clinical 
presentations are indicative of E-ELBD up until this point have been largely unknown due to 
sparsity in prospective study, normative comparisons, and validated metrics. As a result, clinicians 
have been forced to rely heavily on expert opinion. Considering laryngeal signs and patient-
reported symptoms are currently the "gold standard" to diagnose E-ELBD, the ambiguity 
surrounding the clinical utility of these features is concerning. Therefore, to address these 
knowledge gaps, the goal of the present study, described in full in the previous two manuscript 
chapters, was to characterize physiological and perceptual features characteristic of E-ELBD. 
Stress reactivity (temperament) and autonomic regulation as two potential mechanisms underlying 
these presentations were also explored to help identify directions for future programmatic study. 
The findings will be summarized and synthesized in the following section. How these findings fit 
into the broader picture of ELBD pathoetiology, and their implications for future investigation, 
will then follow.   
6.1 SUMMARY & SYNTHESIS OF MANUSCRIPT CHAPTERS 
Results of the study showed statistically significant group (E-ELBD, control) and condition (rest, 
exercise) differences with glottal configuration and dyspnea. Specifically, subjects with E-ELBD 
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reported significantly higher inspiratory and expiratory dyspnea severity levels with exercise than 
participants in the athletic control group. Symptoms of stridor and throat tightness in response to 
exercise were the other two most prevalent features reported in the E-ELBD group, which could 
mean these symptoms are more common in the exercise variant as compared to symptoms related 
to voice complaints (dysphonia) and airway protection (cough, dysphagia). However, severity of 
stridor and throat tightness varied greatly across individuals with and without E-ELBD, and group 
differences were not observed on these two parameters. These findings suggest these latter two 
features as less sensitive diagnostic indicators of ELBD and may be more common in athletes, in 
general.  
Participants in the E-ELBD group also presented with paradoxical inspiratory adduction 
and blunted expiratory abduction (and at times paradoxical expiratory adduction) in response to 
strenuous exercise. These laryngeal patterns directly contrasted with increased vocal fold angles 
(glottal widening) in response to exercise seen in healthy athletic volunteers, during both 
inspiratory and expiratory cycles. Arytenoid prolapse was seen variably in both athletic groups, 
while epiglottic collapse and ventricular compression were rarely seen in either group, suggesting 
the former two features are more prevalent in athletes in general. Finally, trends in autonomic 
parameters showed smaller sympathetic responses or sluggish parasympathetic deactivation 
during strenuous exercise (in the context of seemingly alarming E-ELBD attacks thought to trigger 
“fight or flight” sympathetic responses) and slightly greater parasympathetic reactivation after 
exercise in the E-ELBD group, compared to the control group. However, no significant differences 
were found in sympathovagal biomarkers. Trends in group differences was in contrast to 
similarities between groups on the EATQ-R Fear subscale, suggesting similar stress reactivity 
between the two athletic groups. 
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In summary, the following features appear to be good diagnostic indicators of the exercise-
induced variant of E-ELBD, and especially when seen in combination, will improve diagnostic 
specificity:  
(1) Paradoxical inspiratory glottal movement with exertion  
(2) Inspiratory and expiratory dyspnea under exertion 
The following thresholds can be used to increase confidence in the diagnosis of E-ELBD: greater 
than (a) an 8° decrease in anterior glottal angle indicative of inspiratory vocal fold adduction during 
strenuous exercise, compared to at rest baseline laryngoscopy, (b) less than 32° true vocal fold 
adduction during expiration with exercise, compared to rest, suggesting a blunted expiratory vocal 
fold response, (c) 30/100 or greater on the VAS with strenuous exercise, and (d) 20/40 or more on 
the Dyspnea Index. Additional investigations comparing the presence and severity of these clinical 
features with other breathing disorders (e.g., asthma, panic disorders) should also be conducted. 
These comparative studies will further define ELBD characteristics and distinguish features of 
ELBD from other conditions with similar signs and symptoms. Replication studies with larger 
sample sizes are also needed to determine how the following clinical presentations, present in the 
E-ELBD group, but shown to vary with athletes of comparable athletic abilities and age, fit into 
the ELBD spectrum: 
(1) Laryngeal patterns consisting of blunted expiratory glottal abduction (or at times 
paradoxical adduction) with exertion  
(2) Arytenoid prolapse with exertion 
(3) Throat tightness with exertion  
(4) Stridor with exertion  
(5) Systolic blood pressure at maximum exertion 
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(5) Heart rate recovery post-maximum exertion.  
A few key points should be emphasized. First, laryngeal pattern differences between the two 
athletic groups were only appreciated during the exercise challenge, demonstrating the need to 
observe laryngeal kinematic patterns concurrently with provocation. The indistinguishable group 
differences in glottal patterns seen during quiet, vegetative breathing at baseline (rest), stark 
contrasts in laryngeal patterns between groups with exercise, and the quick resolution of aberrant 
responses post-exercise in the experimental group, all point to the clinical utility and even 
imperative of incorporating provocation challenge into standard of care assessment protocols for 
patients with suspected E-ELBD. 
Along the same lines, similarities in arytenoid response to rigorous exercise between the 
two groups of adolescent athletes not only demonstrates the relevance of provocation challenge, 
but also illustrates the importance of normative comparisons. Previous literature has suggested the 
presence of arytenoid prolapse points to E-ELBD, citing reduced muscle tone, tissue redundancy, 
and smaller airway diameters as potential underlying causes (Bent et al., 1996; Christopher & 
Morris, 2010; Nagai et al., 1992; Pinho, Tsuji, Sennes, & Menezes, 1997; Hudgins, Siegel, Jacobs, 
& Abramowsky, 1997). However, these laryngeal characteristics outside the ELBD literature have 
also been reported to be features of normal laryngeal development and may not be unique to 
patients with E-ELBD (Fitch & Giedd, 1999; Sapienza, Ruddy, & Baker, 2004; Hirano 1983). 
When floppy laryngeal tissue or cartilages are present in combination with high negative 
inspiratory pressures (e.g., during physical exertion), the laryngeal tissue can get “sucked in” to 
the glottal lumen, resulting in airway obstruction (Christopher & Morris, 2010). Because typical 
adolescent athletes in the context of ELBD typically do not undergo continuous laryngoscopy 
exercise challenges, it is not surprising these same supraglottic responses have not been previously 
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acknowledged in the ELBD literature. These findings highlight the importance of normative 
references when attributing clinical features to pathology. 
The take home point may be that arytenoid prolapse can occur variably in young athletes, 
in general, and may not necessarily indicate E-ELBD. However, additional investigation is needed 
to confirm or refute this assertion. Similarly, the prevalence and severity of "twitchy" laryngeal 
responses and laryngeal edema/erythema, both features that have been attributed to ELBD, were 
equally prevalent in the two athletic groups. Again, these findings emphasize the need for caution 
when attributing laryngeal findings to ELBD in absence of normative reference points.  
 In a similar vein, stress reactivity (temperament) may not have as prominent a role in 
ELBD pathogenesis as previously alleged (at least not in the exercise-induced variant). Results on 
the Fear subscale of the EATQ-R showed athletic groups were similar in their self-perceived 
reactions to anticipated stressful events. These similarities contrasted with significantly lower 
normative scores across the general adolescent population on the same subscale in a previous study 
(Muris & Meesters, 2009). Because this is the first study on ELBD and temperament that included 
a typical athletic group of comparable age, gender, and athleticism, it is not surprising that stress 
reactivity could likely have been previously overgeneralized to athletes with ELBD. This is not to 
say psychological stressors have no influence in E-ELBD pathogenesis. However, what may differ 
between athletic groups with and without E-ELBD is not their temperament, but their physical 
responses to stressors. Potential future directions addressing the study of physical stressor 
responses will be discussed in greater details in Section 6.3.  
Trends in autonomic responses between the two groups could also point to differences in 
how the system responds to physical stressors in athletes with and without E-ELBD. Trends in 
decreased sympathetic output (i.e., decreased parasympathetic withdrawal) during heavy exertion 
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and faster parasympathetic reactivity after exercise seen in the E-ELBD group compared to the 
athletic control group align with previous studies showing robust correlations between increased 
parasympathetic and laryngeal muscle responses to acute stressors in healthy individuals (Helou 
et al., 2013, 2014). The difference between the present study and previous studies may lie in the 
ability to adapt to physical stressors, including exercise training. Typically, when a novel stressor 
is presented to the system, sympathovagal response is high and may persist even after the stressor 
is withdrawn (McEwen, 1998, 2000). With repeated exposures, however, the body adapts and 
sympathovagal responses become less robust and not as prolonged. However, with autonomic 
dysregulation, the system may not be able to acclimate to repeated athletic exposure. As a result, 
sympathetic “fight or flight” response may continue to be too high or prolonged. Conversely, the 
inability of the system to adapt may result in blunted sympatho-excitation to exercise (McEwen, 
2000, 2007).  The latter response may point to the lower blood pressures and slightly faster heart 
rate recovery outcomes seen in the E-ELBD group. These patterns have been demonstrated with 
physical stressors (e.g., muscle overload and fatigue) and certain types of overtraining syndromes 
(e.g., Addison-type) (Lehmann et al., 1998). Implications are described in more detail in Section 
6.3. 
6.2 STUDY LIMITATIONS 
The following study limitations can provide springboards for future investigations. The first 
limitation was that the EATQ-R assessed the perception of anticipated stressful events in athletes, 
but did not measure direct physical responses to psychological stressors. Previous studies have 
shown psychological stressors can have negative physical effects on the body (e.g., hormonal, 
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musculoskeletal), resulting in decrements to athletic performance (Kreher & Schwartz, 2012). 
Therefore, future investigation should address physiological stress responses to provocation 
challenge, as well as psychological appraisal of the event, to more fully appreciate the role (or lack 
thereof) of psychological factors in E-ELBD and the pathways through which they might mediate 
physical responses. For example, the type of event (e.g., important competition), appraisal of the 
stressor (e.g., benefit or harm), and coping mechanisms used to mitigate stress responses (e.g., 
problem- versus emotion-focused) could all play roles in physical stress responses in E-ELBD 
(Baker, Côté, & Hawes, 2000). 
The second limitation of the study was the omission of tidal volume measurements. As a 
result, influences of respiratory physiology on laryngeal muscle responses could not be directly 
assessed. The decision to forgo assessment of this parameter was twofold. From a theoretical 
perspective, the primary goal was to identify symptoms and laryngeal patterns that represent E-
ELBD to more accurately diagnose patients in clinical settings as well as to better identify 
inclusionary criteria for future studies. Having a better appreciation for the composition of E-
ELBD presentation with the present study’s findings, the next step is to assess the role of the 
pulmonary system in laryngeal-respiratory system coupling in future studies. From a 
methodological perspective, inductance plethysmography, used to estimate tidal volume and other 
pulmonary parameters, would have interfered with the placement of the heart rate monitor to obtain 
HRR calculations in the present study. 
The third limitation was the use of the exertion scale to determine levels of physical 
exertion. Although previous studies have shown exertion scales, such as the Borg Scale, to be a 
good indicator of exertion, it can be influenced by mood and other psychological factors affecting 
appraisal of the event. More objective measures, such as cycle trainer RPM or resistance (watts), 
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would have addressed these concerns. Fortunately, both groups reported similar severities in leg 
fatigue with the exercise challenge, and duration to maximum exertion was comparable between 
groups. These findings suggest physical efforts during exercise challenge, as well as the appraisal 
of physical effort, were similar across the two groups, and places confidence in the physical 
exertion scale as a good indicator of exertion for present purposes.  
A fourth limitation surrounds alternate theories for autonomic parameter (HRR, SBP) 
differences found between the two athletic groups. Slightly faster HRR seen in the experimental 
group post-maximum exertion could be attributed to the rescue breathing techniques (e.g., pursed 
lip breathing) the majority of participants needed to implement to alleviate ELBD attacks induced 
by provocation challenge. Previous studies found that increased airway resistance during 
pranayama yoga breathing increases parasympathetic response as a way to “soothe” the body 
(Streeter et al., 2012). However, there is a limitation to extrapolating these previous findings to the 
present study as the ujjayi breath or “ocean sound” in yoga involves pharyngeal constriction 
configurations that differ from oropharyngeal configurations in traditional respiratory retraining 
techniques (e.g., pursed lip breathing) (Blager, 2000) (see Appendix G: Respiratory Retraining 
Therapy (Conceptual) and Appendix H: Respiratory retraining (Mass Eye and ear Protocol)). 
Therefore, whether parasympathetic responses with respiratory retraining are similar to 
parasympathetic responses in yoga breathing is unknown and requires further investigation. It 
would obviously be unethical to withhold rescue breathing techniques to mitigate ELBD attacks. 
One way to address both ethical and methodological concerns for future studies would be to have 
both groups with and without ELBD implement rescue breathing immediately after the height of 
maximum exertion. If differences in HRR are still seen between groups, these findings can increase 
confidence that parasympathetic reactivation plays a role in the autonomic balance hypothesis. 
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The final limitation is that asthma was not formally ruled out in participants enrolled in the 
athletic control group. Control participants were recruited based on their having no symptoms of 
dyspnea, low scores on the Dyspnea Index, and the assumption lung volumes and capacities were 
highly functional at such competitive levels of athletic capabilities. However, there could be a 
possibility, although highly unlikely, that the healthy individuals in the control group could have 
had lower predicted long volumes (FEV1 < 80% predicted) without any symptoms of asthma. 
However, if this were to be the case, it is also highly unlikely these subclinical findings would 
have significantly influenced participant symptom ratings or laryngeal response patterns in the 
present study. Previous studies have shown that the amount of laryngeal responses to lower airway 
pathology directly correlates with the severity of pulmonary pathology (Jamilla et al., 2000), 
although the exact amount of laryngeal adduction has yet to be quantified. 
6.3 FUTURE DIRECTIONS 
Study findings provide insight into approaches to diagnostic assessment of ELBD; specifically, 
what features can be used to diagnose E-ELBD and the importance of provocation challenges to 
improve diagnostic specificity. Study findings also provide insight into how we think about other 
clinical features of E-ELBD that occur variably within a broader context, how E-ELBD and other 
ELBD variants (e.g., irritant-inducing) fit into the overall comprehensive taxonomy framework, 
and the consideration of other mechanisms that can drive clinical expression in E-ELBD (and 
ELBD in general). Results indicate abnormal true vocal fold dynamics and sensations of dyspnea 
with provocation challenge to be the features that best differentiate typical from pathological 
clinical presentations in athletes with ELBD. However, the heterogeneity and variable presence of 
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other clinical features (e.g., throat tightness, arytenoid prolapse), even within a seemingly 
homogenous group of athletes with and without E-ELBD, points to the multifactorial nature of 
ELBD. Findings reaffirm that ELBD is likely not one entity, and therefore it might be wise to 
consider ELBD a symptom complex and not a sole diagnosis. The first section (Section 6.3.1) 
provides a proposed change in how we think about and diagnose ELBD. The second section 
(Section 6.3.2) is a summary of other potential mechanisms that could also play a role in ELBD 
presentation to set the tone for future studies. The third section (Section 6.3.3) is a summary of 
potential mechanisms involved in other trigger variants in ELBD within the comprehensive 
taxonomy framework (c.f., Section 2.2.3) to guide future investigations.   
6.3.1 Proposed (updated) approaches to ELBD diagnostics 
Descriptions of how practitioners approach and diagnose ELBD (e.g., “how I do it” papers) are 
abundant in the ELBD literature. However, without objective assessment and normative references 
to assess the validity or effectiveness of these methods, clinicians are left to rely on expert opinions 
and unsubstantiated claims to make clinical decisions. Unfortunately, the lack of consensus in key 
features of ELBD and dearth of validity in quantitative methods to diagnose the spectrum of 
conditions results in misrepresentations of key features and inherent cognitive biases (e.g., 
anchoring effect22).  
In fact, these shortcomings even presented themselves in the dissertation study.  One of the 
participant in the E-ELBD met all inclusionary criteria for suspected ELBD a priori. He had 
                                                 
22 The tendency to rely on one trait or piece of information when making decisions. Usually influenced by order 
effect. 
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dyspneic symptoms that were detrimental to his athletic performance, scored higher than a 10/40 
on the Dyspnea Index, and presented with “abnormal” laryngeal patterns: oscillatory motion of the 
corniculate cartilages and true vocal folds during the baseline laryngoscopy and exercise 
laryngoscopy examination, respectively. Therefore, he was enrolled in the study. However, an 
ELBD episode could not be provoked during the exercise challenge despite vigorous pedaling on 
the bike with extreme resistive loads for three consecutive minutes. Consequently, per the study’s 
protocol, his laryngoscopic examinations were removed from analysis. The decision was made to 
analyze the other parameters based on (at that time) current knowledge of ELBD presentation 
informed by a comprehensive framework from previous literature (Shembel et al., 2017).  
Retrospectively, knowing that individuals with and without ELBD can present variably 
with “twitchy” larynges, the individual would not have been included into the study’s experimental 
group (of note, post-hoc analysis without these data points showed greater differences between 
groups on dyspnea severity during exercise, but did not change the story surrounding high 
variability across the other common auxiliary features or in cardiovascular and temperament 
findings). There is a chance this individual may have had another condition (e.g., mitochondrial 
dysfunction) but was instead given a diagnosis of ELBD, based on informed knowledge of ELBD 
features at point in time. Regrettably, the participant was lost to clinical follow up, as is often the 
case with individuals who find little relief with traditional respiratory retraining methods for 
ELBD. Results of the dissertation study suggest we might be misattributing laryngeal patterns, 
especially at rest, to ELBD, resulting in the over-diagnosis of the condition. Ironically, this is the 
very frustration healthcare professionals have had with the high rate of misdiagnosis of other 
conditions in the ELBD population. Unfortunately, where ELBD was once the “zebra among 
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horses” in specialty voice clinics, we could very likely now see any horse with black and white 
coloring as zebras.23 
In general, how we approach ELBD diagnostics needs to be reconsidered. One way to 
restructure diagnostic paradigms can be extrapolated from clinical approaches to the diagnosis and 
management of dysphagia, another symptom complex with many potential underlying 
mechanisms driving clinical expression. Specifically, it is not enough to affirm the presence of 
dysphagia. Clinicians must also consider where the dysfunction is occurring within the head and 
neck and what is causing the dysfunctional deglutition. That is because mechanisms underlying 
difficulty swallowing will drive how we provide clinical care. For example, the management of 
someone with dysphagia caused by Amyotrophic Lateral Sclerosis (ALS, also known as Lou 
Gehrig’s disease) will be different from that of someone with dysphagia due to a Zenker’s 
diverticulum, general deconditioning, or esophageal cancer. The same should hold true for ELBD. 
Unfortunately, typical assessment methods in ELBD involve confirmation of ELBD through 
symptom reporting without asking what causes these presentations or why these presentations 
occur in the first place. Diagnostic approaches commonly rely on self-reported patient symptom 
history and forgo direct visualization or provocation of laryngeal responses, making it further 
challenging to determine the cause or locus of dysfunction. As a result, we are left with 
management using blanket approaches irrespective of etiology (e.g., pursed lip breathing, see 
                                                 
23 Interestingly, the clinical utility of provocation continues to be debated amongst experts, the most recent of which 
occurred during the Fall Voice Conference webinar on September 26, 2017: “Paradoxical Voce Fold Dysfunction: 
Philosophy and Management” (panelists: Mary Sandage, PhD CCC-SLP; Adrianna Shembel, M.A. CCC-SLP; Laura 
Matrka, MD; Albert Merati, MD; and Milan Amin, MD). During this webinar, the need for provocation was 
challenged on the notion the diagnosis and course of treatment would not differ (c.f., Section 2.1.2 for pros and cons 
of provocation challenge) 
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Appendix G: Respiratory Retraining Therapy (Conceptual)). It is therefore not shocking that only 
two-thirds of the ELBD population report resolution of their symptoms (De Guzman et al., 2014).  
Just as the penetration-aspiration scale24 in the domain of dysphagia can be used to evaluate 
loci and severity of dysphagia (Rosenbek, Robbins, Roecker, Coyle, & Wood, 1996), identifying 
and quantifying glottal angles and supraglottic configuration can be used to determine the location 
of obstruction and the severity of ELBD. Different anatomical, physiological, and symptom-based 
patterns can not only provide insight into the cause but can also be used to guide how we treat 
patients. Along the same lines, without direct visualization using swallow function tests (e.g., 
modified barium swallow examinations [MBS], fiberoptic endoscopic evaluation of swallowing 
[FEES]), in conjunction with functional assessment (e.g., bolus trials with different food and liquid 
consistencies), there is no way to determine why or where within the system the dysfunction is 
occurring. A bedside swallow, although a great screening tool, should not be used to diagnose 
dysphagia any more than a case history and patient-reported symptoms should be used to diagnose 
ELBD, especially when better diagnostic approaches exist and have good clinical utility. 
Furthermore, functional assessment using typical provocations that elicit the ELBD episode serve 
the same purpose as in the evaluation of swallowing with consistencies that closely represent foods 
consumed during regular mealtimes. The more clinicians can provide functional assessments 
mimicking natural settings and situations, the better the specificity of the diagnostic approach. 
Table 6-1 compares proposed gold standard assessment methods in ELBD diagnostics with current 
gold standard methods for diagnosing dysphagia. 
 
                                                 
24 The penetration-aspiration scale is an 8-point interval scale describing how far material enters the airway with 
deglutition during a Modified Barium Swallow (MBS); the scale also addresses whether material is expelled out of 
the airway if it does, in fact, enter the airway (i.e., if the individual is sensate).  
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Table 6-1. Similarities Between ELBD and Dysphagia Diagnostic Methods 
Assessment Method ELBD Dysphagia 
Screening tool 
Case history, Dyspnea 
Index, Symptom-reporting 
Case history, Bedside 
swallow examination 
Diagnostic test Continuous laryngoscopy 
Modified barium swallow, 
videofluoroscopy 
Functional component 
Provocation challenge 
(exercise, irritants) 
Barium trials with different 
consistencies (nectar, thin) 
Quantifiable severity 
benchmarks 
Dyspnea severity (VAS), 
Anterior glottal angle 
measures, Supraglottic 0-3 
rating scale 
Penetration-Aspiration 
Scale, Quantitative measures 
of pharyngeal transit time, 
hyoid displacement, and 
timing of laryngeal vestibule 
closure relative to bolus 
arrival 
Examples of anatomical 
deficits (obstruction) 
attributing to disorder’s 
symptom complex  
Vocal fold lesions, 
laryngomalacia 
Zenker’s diverticulum, 
esophageal web 
Examples of associated 
pathology contributing to 
disorder’s symptom complex 
Asthma, gastroesophageal 
reflux disease 
Parkinson’s Disease, 
Amyotrophic Lateral 
Sclerosis (ALS), 
Cerebrovascular accident 
(CVA) 
 
6.3.2 Other potential E-ELBD mechanisms  
As mentioned previously, there are likely different mechanisms that can underlie signs and 
symptoms in ELBD. The differences in laryngeal patterns, symptom presentations, and wide range 
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of symptom onset and resolution of symptoms25 speaks to these likely differences in mechanisms 
(or differences in discoordinated patterns for laryngeal-pulmonary coupling) driving clinical 
expression. Several of these mechanisms—musculoskeletal dysfunction, somatosensory 
integration issues, and abnormal respiratory physiology—will be addressed in the following 
sections.  
6.3.2.1 Musculoskeletal Dysfunction 
One alternative mechanism may involve fatigue or discoordination of muscles within the 
respiratory system. Although primary respiratory muscles are typically fatigue resistant, how 
energy is supplied and stored within the muscles and how muscles respond to activities involving 
increased loads of excessive strength or endurance (tension and contractibility) can influence the 
fatigability of respiratory muscles. Fatigue and discoordination can also be influenced by central 
respiratory drive or neuromuscular transmission (Aldrich, 1988; Macklem & Roussos, 1977). 
Studies have shown that respiratory muscle efficiency and proclivity towards inspiratory muscle 
fatigue has more to do with the relationship between energy demands and supplies than the 
percentage of fatigue-resistant fibers in the inspiratory muscles. Respiratory muscle efficiency can 
be further reduced by lung hyperinflation or how the intercostals and accessory muscles are 
recruited in respiration. Lower cardiac output may also decrease the rate at which energy is 
supplied to the respiratory muscles (Macklem, Cohen, Zagelbaum, & Roussos, 1981). This latter 
point is especially interesting considering trends in lower systolic blood pressures were found in 
the ELBD group in the dissertation study.26 Finally, layering muscle contractions for high intensity 
                                                 
25 Range of reported symptom resolution in dissertation study: 15 minutes – 2 hours  
26Although SBP readings were, on average, lower in the E-ELBD group, average diastolic blood pressures (DBP) rose 
slightly with exercise in the E-ELBD group. Typically, DBP will remain the same or become lower in athletes with 
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exercise, especially when other muscle groups are involved in muscle contraction for throwing or 
kicking a ball may lead to earlier blood lactate accumulation, increased ventilation, and faster 
fatigue (McArdle et al., 2010).27  
With such a seemingly simple task as breathing, it is easy to forget that the muscles of 
respiration play a vital role in respiratory modulation, especially in the context of ELBD. For 
instance, the primary muscles of inspiration—the diaphragm and the posterior cricoarytenoid 
(PCA) intrinsic laryngeal muscle—facilitate lung inflation and increase airway patency, 
respectively, during both rest and exercise (Hillel, 2001; Hlastala & Berger, 2001; Jones, Harvey, 
Marston, & O’Connell, 2013). With certain aerobic activities such as distance running, the 
abdominal muscles and external intercostals may also activate to optimize oxygen-carbon dioxide 
exchange by preventing the lungs from recoiling too quickly during expiration (Zemlin, 1998) or 
in sprinting to maximize airflow for high ventilatory demands.  
Because breathing is constant for metabolic respiration, the respiratory muscles cannot ever 
fully deactivate or the system goes into respiratory distress. This is especially true for inspiratory 
muscles because inspiration is always active (except with mechanical ventilation). Fatigued 
muscles have more trouble firing within their (typically) invariant patterns of timing for 
appropriate patterns of muscle activation. These atypical patterns result in detriments to respiratory 
muscle coordination needed to maintain the body’s internal milieu. Additionally, the use of inhaled 
corticosteroids has been shown to inhibit protein synthesis necessary for muscle recovery, further 
amplifying muscle wasting and fatigue (Dekhuijzen et al., 1996; Reid & MacGowan, 1998; 
                                                 
efficient cardiovascular systems during intense exercise. These findings, although not significant, should be 
considered further in future studies. 
27 Interestingly, women have been shown to have 5-10% less hemoglobin than men, which can play a role in reducing 
aerobic capabilities. These patterns could explain the higher prevalence of ELBD found in females (McArdle et al., 
2010). 
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Weiner, Azgad, & Weiner, 1993). Pharmacological consequences are especially problematic in 
young athletes growing rapidly and undergoing frequent developmental and pubertal changes. 
Unfortunately, corticosteroid use is common in the E-ELBD population because many athletes are 
initially treated for exercise-induced asthma. Even after a correct diagnosis of E-ELBD has been 
made, there is typically some hesitation to completely wean from corticosteroids in fear of 
detriments to athletic performance from the weaning process. The high prevalence of 
corticosteroid use in adolescent athletes with ELBD could help explain why the condition can 
perpetuate in this population. 
Respiratory muscle fatigue or discoordination can become amplified with additional 
physical demands, especially when these muscle groups are already pre-fatigued from previous 
physical loads or when there has not been enough time to recover. In fact, prolonged periods of 
chronic musculoskeletal overload to the system without rest can result in overtraining syndrome28 
(Zając, Chalimoniuk, Maszczyk, Gołaś, & Lngfort, 2015). Overtraining syndrome comes in two 
variants, sympathetic and parasympathetic, both of which can occur when the system is unable to 
maintain responses to allostatic loads (McEwen, 2000). Studies have shown that parasympathetic 
overtraining syndrome, more common in aerobic sports, can lead to lower resting heart rates, lower 
baseline blood pressures, and blunted cardiovascular response to exercise, as the body places itself 
into persistent “rest and digest” mode in an attempt to repair itself (Kreher & Schwartz, 2012). 
Trends in smaller blood pressure responses to exercise and higher parasympathetic responses post-
maximum exertion seen in the experimental group with HRR could point to overtraining syndrome 
as an alternative underlying mechanism in E-ELBD.  
                                                 
28Also known as burnout, staleness, failure adaptation, under-recovery, training stress syndrome, chronic fatigue, 
and unexplained underperformance syndrome (Kreher & Schwartz, 2012).  
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To prevent respiratory muscle fatigue or discoordination caused by high intensity or 
prolonged aerobic activity (e.g., sprinting, long distance running, respectively), small, stepwise 
increases in training intensity and frequency are required. These adaptive increases have been 
termed “functional overreaching” (Kreher & Schwartz, 2012). Conversely, increases in workload 
that are too fast or too long can cause prolonged muscle fatigue (referred to as “nonfunctional 
overreaching”), making the muscles susceptible to further discoordination and even injury. 
Muscles also need appropriate intervals of rest interspersed across these workload increases to be 
able to recover from the physical stress that comes with training. Numerous increases in training 
loads without adequate recovery lead to accelerated time to fatigue, more chronic fatigue, and 
decrements to athletic performance, requiring even longer periods of rest to recover (Kreher & 
Schwartz, 2012; Romer & Polkey, 2008; Zając et al., 2015).  
Both groups in the dissertation study reported being equally active (5-7 days a week; 
average 1.5-hour sessions) and the average intensity within sessions was comparable between 
groups (7.5-8 on 1-10 scale). If there is validity in the parasympathetic overtraining hypothesis, 
the differences in autonomic outcomes between groups may lie in the stepwise intensity from one 
training session to the next, especially in how patients ramp-up their athletic abilities at the start 
of the athletic season.  Conversely, these differences could be due to an inability to recover between 
sessions, either as a result of autonomic dysregulation, muscle weakness (e.g., inadequate energy 
supply or neurotransmission signals to the muscle) in certain respiratory muscle groups, or 
genetics. If these hypotheses hold true, future treatment paradigms for patients with E-ELBD may 
need to focus on the intensity of load increments from one session to the next. For example, 
mileage may need to be ramped up more slowly for runners with ELBD. Or the patient may need 
to implement more active rest days in between training sessions (i.e., anaerobic cross-training 
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using different muscle groups) to give certain respiratory muscle groups a rest without losing too 
much in the way of athletic abilities.  
A third hypothesis could point to inadequacies in muscle pattern recruitment of the primary 
respiratory muscles, resulting in faster activation of fatigue-prone secondary respiratory muscles 
or discoordination between muscle groups. Previous studies have shown accessory muscles of the 
head and neck are recruited when lower respiratory system muscles are weakened or fatigued. For 
example, the scalenes and sternocleidomastoid (SCM) elevate the ribcage to keep the lungs from 
deflating when the diaphragm is tired/weak; the genioglossus and geniohyoid prevent upper airway 
collapse with intercostal muscle inadequacy (Brouillette & Thach, 1979, 1980). However, because 
the accessory muscles are better suited for quick-burst activities, such as cough and deglutition, 
when they are recruited for activities requiring intense or prolonged training, they fatigue more 
quickly than other muscles of respiration.  
Already pre-fatigued respiratory muscles may also explain abnormal laryngeal patterns in 
the context of athletic activity. With greater number of muscles recruited comes higher ventilatory 
demands and much more coordination required across muscle groups for optimal respiration. 
Specifically, with vigorous exertion, the serratus posterior superior raises the upper ribs, while the 
serratus posterior inferior pulls down on the lower ribs. The levatores costarum raises the rib below 
each costarum muscle, often in conjunction with contraction of the iliocostalis (thoracis and 
cervicis) to elevate the rib cage. Finally, the quadratus lumborum increases the vertical height of 
the thorax by lowering the twelfth rib (Gray, 2009; Spiro, Silvestri, & Agusti, 2012). With forced 
expiration during anaerobic workloads (e.g., sprinting), the internal intercostals, transverse 
thoracis, transervse abdominus, rectus abdominus, external obliques, and internal obliques activate 
to push the diaphragm upwards and pull the ribcage downwards to maximum ventilatory effort in 
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the lungs (Hlastala & Berger, 2001). These muscle groups also need to coordinate with each other 
as well as with the other primary muscles of respiration, mentioned previously. The athletic 
synchronous “dance” required of these various muscles during high physical demands is in stark 
contrast to the number of muscles involved in quiet, vegetative breathing that need to synchronize 
with each other. 
Unfortunately, overuse of these respiratory muscle groups from heavy athletic demands 
can result in muscle fatigue (e.g., low energy reserves) and discoordination, leading to decreases 
in airway patency and stability. The larynx has been shown to compensate for inadequacies in 
expiratory abdominal muscle recruitment in a phenomenon known as positive end-expiratory 
pressure, or auto-PEEP. The larynx in auto-PEEP reduces upper airway diameter by adducting the 
vocal folds on expiration, “braking” air flow to slow lung emptying, thereby reducing tachypnea 
(fast and shallow breathing) and breath stacking (successive inspiration prior to full expiration of 
the previous breath). Auto-PEEP patterns have been shown to minimize respiratory muscle load 
to prevent further muscle fatigue and decrease hyperventilation (Brancatisano, Dodd, & Engel, 
1984; Jamilla et al., 2000).29  
The laryngeal patterns characteristic in auto-PEEP could explain the blunted expiratory 
vocal fold abduction responses seen in patients with E-ELBD, compared to controls, during 
strenuous exertion. If these patterns are representative of auto-PEEP, the abductory vocal fold 
responses seen with expiration in the experimental group could actually be a compensatory attempt 
to reduce the effects of lower respiratory muscle dysfunction. If this is the case, treatment 
                                                 
29Interestingly, individuals who exhibit these auto-PEEP patterns can also have changes to lung volume and 
intrathoracic pressures which can decrease cardiac output (systolic blood pressure) without changing heart rate 
(Luecke & Pelosi, 2005). The role of laryngeal patterns involved in auto-PEEP should be considered further in the 
context of the lower systolic blood pressures readings and relatively unchanged raw heart rate readings seen during 
intense exercise in the E-ELBD group, compared to the athletic control group, in the present study. 
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paradigms should focus on increasing the strength or endurance of the instigating muscles of 
respiration causing the discoordination or dysfunction and not directly on laryngeal responses (the 
traditional approach to ELBD).  
In addition to expiratory laryngeal compensation, the larynx may also compensate during 
inspiration. The thyroarytenoid (TA) and cricothyroid (CT) intrinsic laryngeal muscles can stiffen 
and elongate the vocal folds, respectively, to reduce airway collapse and prevent the vocal folds 
tissue from “fluttering” and getting “sucked” into the glottal lumen (Christopher & Morris, 2010). 
In the present study, vocal fold stiffening and elongation were seen in 6/13 (46%) of individuals 
with E-ELBD and in 6/14 (43%) of individuals in the control group during vigorous exercise. The 
larynx’s inability to prevent tissue collapse may be due to difficulties compensating for lower 
respiratory tract muscle insufficiency. Further investigation is needed to not only determine the 
merit of this theory but to also evaluate whether TA/CT compensation plays a role in perceived 
severity of symptoms (dyspnea, stridor, throat tightness) in patients with E-ELBD. 
Interestingly, the traditional approach to ELBD management—respiratory retraining 
therapy—is thought to compensate for reduced airway patency when laryngeal obstruction occurs. 
Decreasing the configuration of the oropharynx in pursed lip rescue breathing, for example, may 
work similarly to auto-PEEP, resulting in elongation of the expiratory phase and maintenance of 
ventilation at appropriate lung volumes (Fallon, 2004). However, these traditional breathing 
strategies have been shown to work in only two-thirds of individuals with E-ELBD (De Guzman 
et al., 2014). More recent studies showing improvements in athletic performance after inspiratory 
and expiratory muscle strength training in both healthy and disordered athletic populations points 
to respiratory system muscle weakness as another potential underlying mechanism in some 
patients with E-ELBD (McConnell & Romer, 2004; Romer, McConnell, & Jones, 2002; Romer & 
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Polkey, 2008; Witt, Guenette, Rupert, McKenzie, & Sheel, 2007). However, more empirical 
evidence is needed to determine the role the musculoskeletal system and strength training plays in 
E-ELBD.  
To summarize, the larynx is typically implicated in the symptoms patients with ELBD 
experience. However, these sensations could also stem from other accessory muscles of the neck, 
base of tongue, or oropharynx used in respiration. If the accessory muscles are being 
inappropriately recruited for respiration during high physical demands, they can become fatigued. 
This mechanism could explain the (on average) higher perceptual levels of dyspnea and throat 
tightness reported in the ELBD group at rest, even with seemingly normal laryngeal kinematics 
during the same period. Anecdotally, the majority of individuals with E-ELBD exhibited some 
form of tension in the head neck musculature on digital palpation. Common muscle groups 
included the base of tongue and sternocleidomastoid muscle. Future study is needed to determine 
the role accessory muscle tension and respiratory discoordination/fatigue has on ELBD. 
6.3.2.2 Somatosensory Dysfunction  
Previous studies have shown that muscle fatigue and tension can distort somatosensory 
information coming from muscles. Typically, sensory information coming from 
mechanoreceptors—types of afferent receptors that detect stretch, pressure, and temperature 
within the muscle—trigger reflexive responses within the airways. Two types of afferent 
pulmonary stretch receptors, slowly adapting (SARs) and rapidly adapting (RARs) work closely 
with the vagus nerve to regulate sensory inputs. The SARs sense changes in lung volume and 
respond to changes in muscle tone and mechanical distortion in the airways to prevent excessive 
stretching of the lungs during inspiration. When SARs are activated, they send signals through the 
vagus nerve to the inspiratory area of the medulla and pneumotaxic area in the pons, initiating the 
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Hering-Breuer reflex to terminate inspiration and initiate expiration as to not over-inflate the lungs. 
The Hering-Breuer reflex may also play a role in the initiation of inspiration with sensation of lung 
under-inflation (Barnes, 1996; Dempsey & Pack, 1995; Hlastala & Berger, 2001; Karlsson, 1994; 
Middlekauff, Park, & Moheimani, 2014).  
Conversely, the pre-Bötzinger complex, which initiates inspiration through bulbospinal 
pathways to motoneurons of the inspiratory muscles, activates the diaphragm (Butler, 2007; 
Levitzky, 1995). Another area in the medullary respiratory center, rostral to the pre-Bötzinger 
complex, is active in expiration involving increased respiratory drive. The two areas, the pre-
Bötzinger complex and the area rostral to the pre-Bötzinger complex, are collectively known as 
the ventral respiratory group, and work together to maintain rhythmic respiration (Butler, 2007). 
Medullary activity involving the vagal and diaphragmatic afferents appear to be more active with 
expiratory load changes, playing a role in ribcage and ventilatory response coordination (Barrière, 
Delpierre, Del Volgo, & Jammes, 1993; Gozal et al., 1996). The brainstem also controls a variety 
of other laryngeal sensorimotor processes vital for regulating and protecting the respiratory system 
(e.g., cough, swallowing, expiratory, apneic, and diving reflexes) (Arteaga-Solis et al., 2013; 
Dempsey & Pack, 1995; Mukhopadhyay et al., 2007).  
Sensory signals from the larynx have also been traced from the vagus nerve to the 
mesocortex, an area of the brain thought to be responsible for hypercapnic sensations, via the 
medullary ventral and dorsal respiratory nuclei. Additionally, limbic system activity in the 
amygdala has been shown to activate in conjunction with the vagus during resistive inspiratory 
load and to decrease during resistive expiratory load (Gozal et al., 1996; Macey et al., 2003; Von 
Leupoldt, Mertz, Kegat, Burmester, & Dahme, 2006). These findings support the notion that the 
vagus is involved in both sensory and affective processing of dyspnea (Thach & Bradley, 1997).  
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Chronic or prolonged mechanical stimuli within the larynx has been shown alter receptor 
responses and can even cause neuroplastic changes in the brainstem and limbic system. Changes 
in laryngeal vagal reflex response thresholds can cause a cascade effect of increased sensitivity to 
additional stimuli over time, resulting in muscle tension or spasms upon exposure even to typical 
sensory stimulation (Morrison et al., 1999). A defective inspiratory termination threshold or 
neoplastic changes within these areas of the brain could explain some of the clinical presentations 
seen in E-ELBD. Signals to and from the vagus nerve and bulbar regions may be affected in this 
population, resulting in early inspiratory termination before metabolic needs of the system are met. 
Specifically, these mechanisms may help explain the atypical adductory responses of the vocal 
folds seen during the inspiratory phase in conjunction with increased physical demands; it may 
also help explain the sensation of dyspnea patients with E-ELBD experience.  
A study by Hammer and Krueger showed mechanical sensory receptor thresholds in the 
larynx were lower in female compared to male subjects. The investigators attributed these findings 
to increased sensory laryngeal nerve firing in women and indicated results may explain the higher 
prevalence of functional30 voice disorders and other sensorimotor laryngeal conditions seen in 
women (Hammer & Krueger, 2013). If this theory holds true, it might also help explain the 2:1 
female-to-male ratio seen in the E-ELBD group in the present study. However, this theory does 
not explain why some female athletes develop ELBD while other female athletes do not. 
Comparative studies involving mechano-sensory manipulation in participants with and without 
ELBD as well as between the sexes are needed to better identify the role these response patterns 
play in ELBD pathogenesis.  
                                                 
30 Physiologically-based, not psychologically-based (as the latter is often eluded). 
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Previous studies have also shown there are more sensory receptors in the accessory muscles 
than in other respiratory muscles, which can heighten sensations of dyspnea and throat tightness 
when these muscles are prematurely recruited, such as could be the case with ELBD, described 
previously in the musculoskeletal section (Harms, Wetter, Croix, Pegelow, & Dempsey, 2000). 
Additionally, the vagus nerve (CN X) innervating the larynx is in close proximity to, and overlaps 
with, other sensory nerves including the glosopharyngeas nerve (CN IX)—which innervates the 
mucosa of the pharynx, and the trigeminal nerve (CN V) and facial nerve (CN VII)—both which 
innervate the nasopharynx (Wilson-Pauwels, Akesson, & Stewart, 2002). This overlap explains 
why sensations within the pharynx are hard to define and why individuals with nasopharyngeal 
inflammation may complain of a sore throat (Eccles, 2003). It can also explain sensations of throat 
tightness and dyspnea at rest experienced in the E-ELBD group, even in the presence of normal 
laryngeal dynamics. 
Future studies involving manipulation of various mechanical sensitivity response 
thresholds with simultaneous brain imaging in participants with and without ELBD are needed to 
determine the merit of somatosensory integration as a potential mechanism underlying ELBD. 
Additionally, why these patterns are more prevalent in women, if they do in fact play a role in 
ELBD pathogenesis, also need to be illuminated. Brain imaging and sensory threshold testing can 
also be studied in the irritant-induced ELBD population, compared to normal populations, using 
chemo-sensitive agents such as capsaicin to identify threshold response differences (see Section 
6.3.3.1 for further details on irritant-induced ELBD). 
6.3.2.3 Respiratory physiology dysfunction 
Respiratory physiology plays an essential role in meeting the system’s respiratory demands and 
should therefore be considered in dysfunctional breathing, especially in the context of ELBD. With 
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high ventilatory demands, the pulmonary system acutely responds by increasing the movement of 
air in and out of the body. This response causes an increase in gas exchange between the 
environment and the body and plays a role in regulation of acid-base balance. Specifically, when 
exercise is initiated, minute ventilation increases rapidly via increased breathing frequency and 
tidal volume (i.e., hyperpnea). Central feedforward commands and muscle receptor feedback 
commands provide information to determine the right amount of ventilation required to meet the 
system’s needs for the given task (McArdle et al., 2010). With sustained physical demands, 
ventilation steadily rises in an attempt to continue to meet the system’s metabolic needs 
before ventilatory responses eventually plateau. This shift is referred to as the ventilatory 
threshold and is believed to result from lactic acid accumulation from increased hydrogen ion 
concentrations in the blood stream. During this period, the body needs to continue to 
maintain arterial gas partial pressures and pH levels to maintain homeostasis in the context of 
allostatic loads to the system. Increased ventilation helps eliminate carbon dioxide buildup and 
restores acid-base balance. The maintenance of this acid-base balance is accomplished via 
the transport of carbon dioxide molecules to the lungs as plasma bicarbonate (HCO3) 
(McArdle et al., 2010). 
Various mechanisms related to aberrant respiratory physiology have been implicated in a 
variety of dysfunctional breathing pattern conditions including hyperventilation from heightened 
sympathetic responses, inadequate inspiratory-expiratory ratios, and poor body 
alignment (Chaitow, Gilbert & Morrison 2014; Strauss-Blasche 2000). Breathing that is too fast 
and shallow (tachypnea) can cause a shift from aerobic to anaerobic respiration during high 
physical demands. This shift can lead to hypocapnia (i.e., reduced carbon dioxide levels in 
the blood) and blood alkalinity resulting in increased muscle contraction, muscle tetany and 
tension, chest pain, and dizziness (Chaitow, Gilbert & Morrison 2014).  
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Blood gas imbalances could be one underlying mechanism in ELBD. However, this 
potential mechanism does not explain why patients with ELBD would exhibit these patterns in the 
first place. Specifically, hyperventilation from heightened sympathetic nervous system responses 
is the most commonly cited reason (Chaitow, Gilbert & Morrison 2014). However, this is in direct 
contrast to the lower SBP responses seen within the ELBD group in the dissertation study. Patterns 
of hypocapnia and oxygen-carbon dioxide imbalances, if they are observed in ELBD, may instead 
be a byproduct of the musculoskeletal or somatosensory mechanisms mentioned in the previous 
two sections.  
6.3.3 Potential mechanisms underlying other ELBD trigger variants 
The final section is a review of two other ELBD trigger variants described in the comprehensive 
taxonomy framework (c.f., Section 2.2.3): irritant-induced and psychosomatically-associated 
ELBD. Some potential future directions will also be addressed in these sections. 
6.3.3.1 Potential underlying mechanisms in irritant-induced ELBD 
Laryngeal hyperresponsiveness is thought to be the primary mechanism underlying irritant-
induced ELBD (I-ELBD). The laryngeal hyperresponsiveness model assumes an abnormal glottal 
reflex response caused by inflammatory, viral, mechanical or chemical receptor influences. 
Morrison and colleagues hypothesize that chronic stimulation of sensory fibers within the larynx 
alters brainstem control of laryngeal sensory-motor processes (i.e., neuroplasticity), resulting in 
muscle tension or spasms upon exposure even to typical sensory stimulation (Morrison et al., 
1999). However, the exact influences and their role in neuroplastic changes are largely unknown.  
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Laryngeal hyperresponsiveness is thought to begin with a primer, which decreases the 
laryngeal vagal reflex response threshold, and causes a cascade effect of sensitivity to additional 
sensory stimuli over time (i.e., a faulty alarm system) (CliftonSmith & Rowley, 2011; Hoyte, 2013; 
Jamilla et al., 2000; Kalk, Nutt, & Lingford-Hughes, 2011). There are many primer/faulty alarm 
system variables, as well as factors that can influence the primer-faulty alarm system relationship. 
For example, viral etiologies, specific receptors, or a combination of both, in the airways may be 
responsible for precipitating (priming) this hyperresponsive laryngeal reflex. Taramarcaz and 
colleagues showed epithelial inflammatory damage suggestive of neural changes with 
picornavirus, a variant of the “common cold,” in patients with ELBD, which may predispose these 
patients to a hypersensitive response in the larynx (Taramarcaz, Grissell, Borgas, & Gibson, 2004).  
Additionally, studies by Couto and colleagues, and Chandra and colleagues, demonstrated 
increased activity of TRPV1 in airway tissue with exposure to capsaicin (the active ingredient in 
hot peppers). TRPV1 are receptors that cause inflammatory reactions to the airways when exposed 
to noxious stimuli. They have also been shown to increase vascular permeability for calcium and 
sodium ions responsible for neural conduction, which may explain the increased vagal motor 
laryngeal reflex response to irritants (e.g., capsaicin) in the airway (Chandra, Gerber, & Holinger, 
2001; Couto, de Diego, Perpiñi, Delgado, & Moreira, 2013; Morris et al., 1999, p. 199).  
Efferent vagal motor response has also been associated with increased muscle contraction, 
increased breathing rate, and decreased breathing depth, which may explain why individuals with 
I-ELBD experience episodic dyspnea even with mild laryngeal obstruction (Fontana & Lavorini, 
2006; Gimenez & Zafra, 2011; Ibrahim et al., 2007; Reidenbach, 1998; Taramarcaz et al., 2004). 
Chemoreceptors and mechanoreceptor expression within the larynx are also thought to change 
their response threshold over time with consistent stimulation, resulting in laryngeal sensitivity to 
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non-specific irritants (e.g., smoke, fumes, post nasal drip (PND), and acid reflux) even in the 
absence of the initial insult or inflammation in the airways (Couto et al., 2013; Thach & Bradley, 
1997; Undem & Potenzieri, 2012; Vertigan et al., 2013). Neuroplastic changes resulting in vagally-
mediated laryngospasms and apneas secondary to overstimulation of chemoreceptors in the 
airways have been demonstrated in canine models and infants with exposure to gastric secretions 
of pH levels less than 2.5 (Orenstein, 2001; Thach & Bradley, 1997). 
Afferent nerves in the respiratory system have been shown to not only stimulate an efferent 
response to chronic irritation, but can also stimulate a local immune response by recruiting local 
proinflammatory factors (e.g., cytokines). This immune response—referred to as neurogenic 
inflammation—causes inflammation and can result in airway remodeling at the peripheral level 
over time (Barnes, 2001; Weigand & Undem, 2012). Studies have shown increases in subepithelial 
edema and antigens in laryngeal tissue of infants with arytenoid prolapse and laryngomalacia, but 
the exact correlation between these aberrant laryngeal patterns and immune responses is unclear 
(Ayres & Mansur, 2011; Chandra et al., 2001). Neurogenic inflammation has also been implicated 
in chronic bronchoconstriction and increased mucus production in patients with asthma (Michoud, 
2005; Middlekauff et al., 2014; Taramarcaz et al., 2004; Weigand & Undem, 2012). 
The laryngeal hyperresponsiveness model has its merits for I-ELBD, as evidenced by the 
multiple studies within various bodies of literature suggesting a neurogenic reflex and 
inflammatory response to irritants and various direct laryngeal stimuli. However, the model falls 
short in several aspects. First, the laryngeal vagal reflex response has not been directly studied in 
patients with I-ELBD, and should not be considered causal until directly examined. Second, 
inflammation of the larynx is not always appreciated on laryngeal examination in patients with the 
I-ELBD variant. Third, neurogenic vagal reflexes from the brainstem are not the only central 
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nervous system mediators that act on the larynx in respiration. The larynx also receives input from 
higher brain centers, where maladaptive or inappropriate laryngeal activity may be the result of 
the individual’s perception of a hyper-excitable larynx.  
Van den Bergh and colleagues proposed I-ELBD may have more to do with a Pavlovian-
like conditioned response or affective-motivational influences than with direct neuroplastic 
reflexive changes in the central or peripheral nervous system (Van den Bergh, Van Diest, Dupont, 
& Davenport, 2012). Put differently, neural connections do much more than “sense” respiratory 
sensation and irritation. Behavioral control and information processing mechanisms (e.g., 
associative experiences, perception, attention, emotional processing, and social context) are 
integrated with peripheral sensations. It may not be the threshold of laryngeal responsiveness itself 
that is to blame, but the interaction of sensations and brain-behavior mechanisms that result in 
increased laryngeal response (Van den Bergh et al., 2012). 
Studies comparing actual threshold responses (using laryngoscopy air puff tests and 
brainstem reflux responses [ABR]) and the effect of emotional influences on laryngeal 
hyperresponsiveness (using questionnaires/batteries and neuroimaging) are needed to determine 
the neurological, immunological, and psychological factors that influence episodic laryngeal 
obstruction and resultant dyspnea in I-ELBD.31 
6.3.3.2 Potential underlying mechanisms in psychosomatically-associated ELBD 
The primary model in psychosomatically-associated ELBD (P-ELBD) is based on the assumption 
that psychological factors are a direct cause of P-ELBD, or that P-ELBD, in and of itself, is a 
psychological disorder (somatization, conversion). For example, P-ELBD have been proposed as 
                                                 
31 These topics will likely be addressed in the candidate’s postdoctoral work within the next couple of years. 
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a need for the body to protect itself, to avoid confrontation (primary gain), or to elicit sympathy or 
attention (secondary gain) (Bernstein, 2014; Downing, Braman, Fox, & Corrao, 1982; Lacy & 
McManis, 1994; Patterson, Schatz, & Horton, 1974; Rodenstein, Francis, & Stuanescu, 1983; 
Selner et al., 1987). One example of how psychosomatic influences are thought to affect P-ELBD 
can be found in a published case report of an adolescent female who used her larynx as a 
“nonverbal communication tool to express her discontent of imposed exercise” her family had 
apparently placed on her. Once the patient was “called out” on her behavior, paradoxical 
movement of the vocal folds, respiratory distress, and stridor were no longer present (Liistro, 
Stǎnescu, Dejonckere, Rodenstein, & Veriter, 1990).  
Dunglison was the first to suggest P-ELBD are psychogenic in origin, when he described 
“hysteric croup” in a cohort of female patients (Dunglison, 1842). Since Dunglison’s time, many 
other investigators have followed suit, using nomenclature with Freudian-underpinnings, such as 
“emotional laryngeal wheezing” or “factitious asthma” (Christopher et al., 1983; Gavin et al., 
1998; Lacy & McManis, 1994; Mrazek, 1992; Newman et al., 1995; Wamboldt, Balkissoon, & 
Amerigo, 2001; Yellowlees & Kalucy, 1990). Copious examples of psychological symptoms and 
disorders in patients with P-ELBD can be found in case reports across various disciplines (e.g., 
depression, somatization, conversion, obsessive compulsiveness, adjustment issues, panic, 
anxiety, PTSD, social stressors, body dysmorphia, hypochondriasis, chronic pain, reflex 
sympathetic dystrophy, and childhood abuse, to name a few) (Freedman, Rosenberg, & Schmaling, 
1991; Fritz, Fritsch, & Hagino, 1997; Gavin et al., 1998; Leo & Konakanchi, 1999; Powell et al., 
2000; Selner et al., 1987). However, the causal relationship between these psychological factors 
and P-ELBD is currently unknown. 
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Investigators who consider P-ELBD a psychosomatic disorder advocate this concept based 
on the high prevalence of co-occurring psychiatric disorders, the dearth of organic/physiological 
mechanisms explaining symptoms, the common symptoms seen between P-ELBD and 
psychological disorders, and the noted decreases in dyspneic symptoms with cognitive/behavioral-
based interventions.  In a case review by Leo and Konaknachi, the authors proposed P-ELBD as a 
psychosomatic disorder because of the “high” rate of psychological disorders independently 
identified in their study cohort (conversion disorder (12%), anxiety disorder (11%), histrionic and 
other personality disorders (6%), family/school conflicts (4%), depression (4%), psychosomatic 
disorders (2%), factitious disorders (2%), and somatization disorders (1%)) (Leo & Konakanchi, 
1999). However, causation does not imply correlation, and the above observations do not 
necessarily equate a causal relationship between P-ELBD and a psychosomatic disorder. 
Furthermore, prevalence of many of these psychogenic disorders appears to be the same if not 
higher among the general population as compared to the P-ELBD population (conversion disorder 
was the only disorder lower in prevalence in the general population) (c.f., Table 2-4. Prevalence 
of Psychological Disturbances in The General Population Compared to The ELBD Population. 
(Carter, Briggs-Gowan, & Davis, 2004; deGruy, Columbia, & Dickinson, 1987; Gordon, 1987; 
Grant et al., 2004; Lichstein, 1986; Somers, Goldner, Waraich, & Hsu, 2006). 
Husein and colleagues have attributed P-ELBD to “psychological conversion reaction[s]” 
citing no abnormal neurologic testing had been reported across the P-ELBD literature, and because 
P-ELBD could not be explained by “medical conditions or effects of a substance” (Husein et al., 
2008). However, absence of evidence is not evidence of absence. Lack of etiological evidence due 
to the dearth of empirical study of P-ELBD should not equate to the lack of identifiable 
pathophysiological mechanisms in and of themselves.  
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Various studies have cited P-ELBD as psychosomatic owing to the overlap in symptoms 
with anxiety or panic disorders (e.g., hyperventilation). However, this concept should be 
considered with caution. Many disorders have similar symptoms, but that does not necessarily 
mean that these disorders come from the same etiological entity. For example, cardiac ischemia, 
pleural disease, and reflux disorders can all present with chest pain; however, the underlying 
mechanisms relating to the heart, lungs, and GI system, respectively, are all quite different. 
Assuming chest pain to be the same entity could result in administration of proton pump inhibitors 
to someone having a heart attack, which could obviously result in serious consequences. Finally, 
various studies reported symptoms of P-ELBD improved with behavioral interventions (e.g., 
cognitive behavioral therapy, psycho-educational counseling, hypnosis, positive placebos, and 
sedation). Unfortunately, it is unclear whether these behavioral interventions treat the underlying 
pathology or just the perception of symptoms and their severity, and the effectiveness of 
psychotherapy for P-ELBD is unknown due to experimental design constraints (Guglani et al., 
2014). 
Psychological factors as consequential to dyspneic-symptoms in P-ELBD have also been 
considered. Dyspnea may elicit the body’s internal “alarm system”, resulting in activation of the 
sympathetic “fight or flight” response (Hicks et al., 2008; Mathers-Schmidt, 2001). For example, 
a study by Ley (1985) demonstrated agoraphobics experience feelings of fear and panic as a result 
of episodes of physiological symptoms of hyperventilation. Additionally, Nascimento and 
colleagues (2013) found increased burnout, perceptions of inadequate accomplishment, reduced 
confidence, feelings of isolation, and issues with athletic identity in elite athletes with P-ELBD. 
The authors hypothesized these symptoms were what led to the P-ELBD. However, any individual 
who feels s/he is unable to meet personal goals or standards due to a physiological limitation (i.e., 
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reduced athletic performance due to ELBD), or where self-identity comes into question, would 
undeniably exhibit the above symptoms. Furthermore, chronic stress as a consequence of fear of a 
dyspneic event (and resultant poor performance) has been shown to result in physical factors (e.g., 
expiration, muscle fatigue), perpetuating a vicious cycle, where exhaustion/fatigue from stress 
causes proliferation of poor performance, which then causes additional stress, propagating 
dyspneic events (Weinberg & Gould, 2011).  
To clarify, it is not to say psychological factors do not influence P-ELBD, do not co-occur 
with P-ELBD, or there is no correlation to P-ELBD. It is just that P-ELBD as a primary 
psychosomatic disorder is currently an unsubstantiated claim and should not be assumed to be the 
underlying mechanism until a causal relationship can be appreciated. Recent literature suggests 
individuals with P-ELBD are not wishfully or willingly dyspneic, and symptoms of dyspnea most 
likely do not represent symbolic needs that are not being met, such as attention or protection 
(Bernstein, 2014; Martínez-Lavín & Hermosillo, 2000). Even if maladaptive brain activity is 
determined to be the underlying cause of P-ELBD, focus on the neurophysiological and 
neuromechanical functions and pathways in relation to the larynx-pulmonary system is a far more 
fruitful venture.  
Additionally, erroneously labeling a patient “somatic” or “malingering” merely because 
(1) they have similar symptoms to patients with hyperventilation, (2) because their symptoms 
improve with cognitive-behavioral therapy, or (3) because they have anxious personalities, can 
have negative consequences on the efficacy of management in P-ELBD, and will most likely result 
in the individual seeking treatment elsewhere. This section ends with a cautionary tale to illustrate 
the importance of using restraint as not to assume the etiology of a pathological process without 
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direct causal research. Interestingly, the history of asthma32 and its approaches to understanding 
its underlying mechanisms was historically addressed in the same manner as P-ELBD traditionally 
has been addressed. Although asthma is now known to be a physiological disorder involving 
chronic inflammation of the lower respiratory system (most likely due to a combination of genetic 
and environmental factors), between the 1930-1950s, asthma was considered one of the “seven 
holy psychosomatic illnesses,” and was managed as such (Dunbar, 1948). A child’s wheeze was 
thought to be a suppressed cry for his mother, and the standard of care was psychoanalysis and 
“talk therapy” (Opolski & Wilson, 2005). Unfortunately, the prevalent psychological assumption 
undermined years of medical and pharmacological research in this area (Brown, 2003). Luckily, 
in the 1970s, an appreciation for inflammatory processes involved in various diseases paved the 
way to studying pathophysiological mechanisms specific to asthma. Just as the concept of the 
asthmatic wheeze as a “suppressed cry” is viewed in today’s times as archaic, laryngeal obstruction 
as the “body’s need to protect itself,” or to elicit primary or secondary gain, may be perceived in 
the same fashion with better appreciation of underlying pathophysiological mechanisms of P-
ELBD. It is not to say psychological factors have no influence on asthma. In fact, stress and anxiety 
are known phenotypic triggers in asthma, and play a role in asthma exacerbation. However, the 
underlying etiology of asthma is patently physiological (i.e., inflammatory mechanisms), not 
psychosomatic and extrapolation into its pathogenesis should be treated with caution. 
Physiological responses to acute and prolonged stressors using cardiovascular parameters, 
electromyography (EMG), and brain imaging can all improve our understanding of P-ELBD. As 
                                                 
32 and various other disease processes, such as rheumatologic and autoimmune diseases, as well as spasmodic 
dysphonia (a focal dystonia treated successfully with Botox injection) (Moran, 1996). 
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mentioned in Section 6.2 (Study Limitations), physiological responses to psychological stressors 
should be addressed in future studies. 
6.4 CONCLUSION 
Episodic laryngeal breathing disorders have been acknowledged for more than 140 years, yet they 
are still not well understood. A large part of this has to do with the larynx and its multitasking 
abilities. What the larynx lacks in size, it makes up for in functional versatility. It is at the helm of 
vital biological function, protecting the lower respiratory system and mediating respiration for life-
sustaining purposes. Humans can communicate, sing, laugh, swallow, dive into a pool without 
drowning, give birth, and win heavy-weight championships, all with the help of the larynx. With 
the larynx’s ability to take on so many roles, it is no wonder any number of mechanisms can result 
in its pathology. Even within the same laryngeal role (i.e., respiratory modulation), a broad range 
of endogenous and exogenous influences can affect the larynx, causing perplexing clinical 
presentation variants. As a result, elaborate and comprehensive frameworks, coupled with 
multidisciplinary collaboration and systematic interdisciplinary approaches, are needed to 
elucidate the multidimensional and multifactorial spectrum of ELBD. 
To the dissertation candidate’s knowledge, this is the first study to compare laryngeal signs 
and self-reported symptom differences between rest and exercise in participants with and without 
one ELBD variant—exercise-induced ELBD—in the same prospective study design. The study’s 
broad inclusion of various potential characteristics attributed to ELBD afforded a Gestalt 
appreciation for features specific to the E-ELBD variant. The comparison group provided a 
normative comparison to differentiate typical responses to exercise challenge from pathological 
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responses. Study results highlight the clinical utility of laryngoscopy with concurrent provocation 
to accurately identify patients with E-ELBD. Improved quantitative methods and benchmarks to 
identify E-ELBD will reduce misdiagnosis and mismanagement. Studies addressing autonomic 
function, respiratory muscle responses, somatosensory integration, gas exchange, and laryngeal 
patterns are all reasonable next steps to help elucidate mechanisms underlying clinical 
characteristics in E-ELBD, as well as irritant-induced and psychosomatically-associated ELBD. 
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APPENDICES 
APPENDIX A: EPISODIC LARYNGEAL BREATHING DISORDERS 
NOMENCLATURE 
COLOR KEY 
Glottic  
Supraglottic 
Either/Both 
Unknown 
 
1 Acquired upper airway obstruction (Hammer, 2004) 
2 
Adductor (laryngeal) breathing dystonia (Grillone, Annino, Blitzer, Brin, & Saint-Hilaire, 
1994; Lew et al., 1994) 
3 
(Adult) spasmodic croup (Collett, Brancatisano, & Engel, 1983b; Kattan & Ben-Zvi, 
1985; Orenstein, 2001) 
4 
Arytenoid variant VCD (seen on SIG3 Listserve on 11/3/15 by Andrea Storie. Email 
communication) 
5 
Asthma-like disorder (Bisgaard & Szefler, 2007, 2007; Bucca, Rolla, Brussino, De Rose, 
& Bugiani, 1995a, 1995b; Helenius et al., 2004; Löwhagen, 1999; Löwhagen, Arvidsson, 
& Pettersson, 2002; Millqvist, 2000; Millqvist, Bende, & Löwhagen, 1998; Millqvist & 
Löwhagen, 1996, 1996; Ringsberg & Åkerlind, 1999, 1999; Ringsberg, Lepp, & 
Finnström, 2002; Ringsberg, Löwhagen, & Sivik, 1993a; Ringsberg et al., 1993a; 
Ringsberg, Löwhagen, & Sivik, 1993b; Ringsberg, Wetterqvist, Löwhagen, & Sivik, 
1997; Yüksel, Yilmaz, Kirmaz, Aydoğdu, & Kasirga, 2006) 
6 Asthmatic extra thoracic upper airway obstruction (Bucca et al., 1995a). 
7 Atypical asthma (King, Thompson, & Johnson, 1989) 
8 Central airway obstruction (Ernst, Feller-Kopman, Becker, & Mehta, 2004; Orkin, 1974) 
9 Chronic breathing disorders (Kunik et al., 2007) 
10 
Dysfunctional breathing (disorder) (Courtney et al., 2011; de Groot, Duiverman, & 
Brand, 2013; Jones, Harvey, Marston, & O’Connell, 2013; Jones, Harvey, Marston, & 
O’Connell, 2013; Thomas, McKinley, Freeman, & Foy, 2001) 
11 Dystonic respiratory stridor (Brin & Blitzer, 1991; Payne et al., 2014) 
12 Emotional laryngeal wheezing (Rodenstein, Francis, & Stănescu, 1983; Salkin, 1984) 
13 Emotional laryngospasm (Liistro et al., 1990) 
14 Episodic laryngeal dyskinesia (Ârez & Rivera, 1986) 
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15 
Episodic (paroxysmal) laryngospasm (Gallivan & Andrianopoulos, 2004; Gallivan et al., 
1996; Lion-Francois et al., 2010) 
16 
Exercise-induced inspiratory symptoms (EIIS) (Røksund et al., 2016; Campos et al., 
2014) 
17 Exercise-induced laryngeal dysfunction (Maat et al., 2007) 
18 
Exercise-induced laryngeal obstruction (Christensen et al., 2013; Christensen, Thomsen, 
Rasmussen, & Backer, 2011; Christensen & Rasmussen, 2013; Christensen et al., 2010; 
Johansson et al., 2015; Maat, 2011; Maat et al., 2009, 2011; Nielsen, Hull, & Backer, 
2013) 
19 
Exercise-induced laryngomalacia (Bent et al., 1996; Chemery et al., 2002; Smith et al., 
1995; Tilles, Ayars, Picciano, & Altman, 2013) 
20 Exercise-induced laryngospasm of emotional origin (Liistro et al., 1990). 
21 Exercise-induced paradoxical vocal fold motion (Mathers-Schmidt & Brilla, 2005) 
22 Exercise-induced stridor (Fahey et al., 2005; Olin et al., 2014) 
23 
Exercise-induced vocal cord dysfunction (Davis, Brugman, & Larsen, 2007; Heinle et al., 
2003; Tilles & Inglis, 2009) 
24 Expiratory vocal cord dysfunction (Echternach et al., 2008; El-Kersh et al., 2014) 
25 Factitious asthma (Downing et al., 1982a; Downing, Braman, Fox, & Corrao, 1982b) 
26 False croup (Kjellberg, 1949) 
27 Familial Munchausen stridor (McGrath, Greenberger, Zeiss, & others, 1984) 
28 
Functional breathing disorder (Balkissoon & Kenn, 2012; Niggemann, 2010; Ringsberg, 
Löwhagen, & Sivik, 1993c) 
29 
Functional laryngeal dyskinesia (Ferris, Eisele, & Tunkel, 1998; Renz, Hern, Tostevin, 
Hung, & Wyatt, 2000) 
30 Functional laryngeal obstruction (Peces et al., 1995; Pitchenik, 1991) 
31 Functional laryngeal stridor (Ferris et al., 1998; Renz et al., 2000) 
32 Functional stridor (Kuppersmith, Rosen, & Wiatrak, 1993; Tousignant & Kleiman, 1992) 
33 Functional (upper) airway obstruction (Rogers, 1980) 
34 Glottic dysfunction (McFadden, 1987) 
35 Hysteric croup (Dunglison, 1842) 
36 
Hysterical stridor (Kaufman, Mohebati, & Sotolongo, 2004; Lund, Garmel, Kaplan, & 
Tom, 1993; Nayar, Zanak, & Ahmed, 2003; Snyder & Weiss, 1989) 
37 Inspiratory obstruction (Clark, 1970; Smith & Cooper, 1981) 
38 
Inspiratory vocal cord dysfunction (Miller, Jungheim, Schwemmle, Schoof, & Ptok, 
2014; Morris & Christopher, 2013; Olin et al., 2015b) 
39 Inter-arytenoid region prolapse (Christopher & Morris, 2010) 
40 Irritant-associated vocal cord dysfunction (Perkner et al., 1998) 
41 
Irritable larynx syndrome (Andrianopoulos et al., 2000; Morrison & Rammage, 2010; 
Morrison et al., 1999) 
42 Irritant vocal cord dysfunction (Tonini et al., 2009) 
43 Laryngeal asthma (Shao et al., 1995) 
44 
Laryngeal dysfunction (Carr, Spier, Kortz, & Hoffman, 1996; Koike, 1973; O’Hollaren, 
1990; Ryan & Gibson, 2009; Ryan et al., 2009; Whited, 1979; Wood, Jafek, & 
Cherniack, 1986) 
45 Laryngeal dyskinesia (Denoyelle, Garabedian, Roger, & Tashjian, 1996) 
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46 Laryngeal hyperresponsiveness (Ayres & Gabbott, 2002) 
47 Laryngeal hypersensitivity syndrome (Vertigan et al., 2013) 
48 Laryngeal (sensitivity) dysfunction (Ryan & Gibson, 2009; Vertigan et al., 2013) 
49 
Laryngeal spasm (Afshan, Chohan, Qamar-Ul-Hoda, & Kamal, 2002; Chawla, 
Upadhyay, & MacDonnell, 1984; Cozanitis, Leijala, Pesonen, & Zaki, 1982; Fink, 1955; 
Murtagh & Campbell, 1954; Sasaki & Suzuki, 1977; Vas, Parsonage, & Lord, 1965) 
50 
Laryngeal stridor (Crooks, 1954; Morley, 1969; Yamaguchi, Arai, Asahina, & Hattori, 
2002) 
51 Laryngismus fugax (Pender, 1984) 
52 
Laryngismus stridulous (Bryan, 1891; Johnson, 1875; Klenner, 2013; Leo & Konakanchi, 
1999; Perkins, 1924; Powell, 1876) 
53 
Laryngospasm (Alalami, Ayoub, & Baraka, 2008; Chung & Rowbottom, 1993; Maceri & 
Zim, 2001; Mortero, Orahovac, Tsueda, Bumpous, & others, 2001; Orenstein, 2001; Roy 
& Lerman, 1988) 
54 Munchausen stridor (McGrath et al., 1984; Patterson et al., 1974) 
55 Non-organic stridor (LaRouere & Koopnann Jr, 1987) 
56 
Non-organic (acute) upper airway obstruction (Ayres, Rees, & Cochrane, 1981; Neel & 
Posthumus, 1983; Cormier, Camus, & Desmeules, 1980) 
57 Occupational vocal cord dysfunction (Muñoz et al., 2007) 
58 
Paradoxical arytenoid movement (PAM) (seen on SIG3 Listserve on 11/3/15 by Dale 
Gregore, Emai communication. No citations seen) 
59 Paradoxic(al) vocal cord motion (Martin et al., 1987) 
60 
Paradoxical vocal cord adduction (Hayes, Nolan, Brennan, & FitzGerald, 1993; Mullinax 
& Kuhn, 1996) 
61 
Paradoxical vocal cord dysfunction (Bhargava, Panitch, & Allen, 2000; Chiang et al., 
2008; Freedman et al., 1991; Heatley & Swift, 1996; Leo & Konakanchi, 1999b; 
Newsham, Klaben, Miller, & Saunders, 2002; Powell et al., 2000) 
62 
Paradoxical vocal cord movement (disorder) (Vertigan, Gibson, et al., 2007; Rogers & 
Stell, 1978; Omland & Brøndbo, 2008; Gallivan, 2001; Chalhoub, Harris, Sasso, & 
Bourjeily, 2011; Neustein, Taitt-Wynter, & Rosenblatt, 2010) 
63 
Paradoxical vocal fold dysfunction (Husein et al., 2008; Nacci et al., 2010; Ruddy et al., 
2004; Treole et al., 1999) 
64 
Paradoxical vocal fold motion (Altman et al., 2002; Altman, Mirza, Ruiz, & Sataloff, 
2000; Cukier-Blaj et al., 2008; Doyle et al., 2008; Forrest et al., 2012; Gurevich-Uvena et 
al., 2010; Guss & Mirza, 2006; Hatzelis & Murry, 2012; Hicks et al., 2008; Mathers-
Schmidt, 2001b; Mathers-Schmidt & Brilla, 2005; Maturo et al., 2011; Murry et al., 
2011; Murry & Sapienza, 2010; Olivier et al., 2013; Rafizadeh & Long, 2013; Sandage & 
Zelazny, 2004; Vasudev, 2012; Warnes & Allen, 2005) 
65 
Paradoxical vocal fold motion disorder (Chiang et al., 2013; Gallena & Kerins, 2013; 
Marcinow, Thompson, Chiang, Forrest, & Desilva, 2013; Murry, Tabaee, Owczarzak, & 
Aviv, 2006; Westby, 2014; Kürşat Yelken, Güven, Aladağ, & Eyibilen, 2009) 
66 Paradoxical vocal fold motion dysfunction (Kursat Yelken et al., 2010) 
67 
Paradoxical vocal fold movement (Blager, 2000; Franca, 2014; Gallivan & 
Andrianopoulos, 2004; Koufman & Block, 2008; Patel, Venediktov, Schooling, & Wang, 
2015; Pinho et al., 1997; Ryan et al., 2009; Shobha Sharma & Singh, 2007; van 
Griethuysen, Yaghchi, & Sandhu, 2012; Vertigan et al., 2006; Vertigan, Theodoros, 
68 Paroxysmal laryngospasm (Loughlin & Koufman, 1996; Wani & Woodson, 1999) 
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69 Pediatric bilateral vocal cord dysfunction (Steiner, Fink, & Berkowitz, 2013) 
70 
Pseudoasthma (Chiba, Beck, Scanlon, Staats, & Mottram, 1996; Dailey, 1976; Hammo & 
Weinberger, 1999; Imam & Halpern, 1994; Lillington, 1981; Lillington & Lin, 1994) 
71 Pseudo-steroid-resistant asthma (Ayres, 1999; Thomas, Geddes, & Barnes, 1999) 
72 
Psychogenic respiratory distress (Leo & Konakanchi, 1999a; Walker, Alessi, Digre, & 
McLean, 1989; Perera et al 2017) 
73 
Psychogenic stridor (Geist & Tallett, 1990; Lacy & McManis, 1994a, 1994b; Skinner & 
Bradley, 1989; Smith, 1983; Tomares, Flotte, Tunkel, & Loughlin, 1993) 
74 
Psychogenic upper airway obstruction (Barnes, Grob, Lachman, Marsh, & Loughlin, 
1986; Kissoon, Kronick, & Frewen, 1988) 
75 
Psychogenic vocal cord dysfunction (Brown, Merritt, & Evans, 1988; Mobeireek, 
Alhamad, Al-Subaei, & Alzeer, 1995) 
76 Psychogenic wheezing (Goldman & Muers, 1991) 
77 Psychosomatic stridor and wheezing (Brashear, 1987) 
78 
Reactive airways dysfunction syndrome (Alberts & Guillermo, 1996; Bardana, 1999; 
Brooks, Weiss, & Bernstein, 1985; Gautrin, Bernstein, Brooks, & Henneberger, 2006; 
Kipen, Blume, & Hutt, 1994; Leroyer, Malo, Girard, Dufour, & Gautrin, 1999) 
79 Reversible upper airway obstruction (Irwin, Pratter, Holland, Corwin, & Hughes, 1984) 
80 
Spasmodic croup (Collett et al., 1983b; Koren, Frand, Barzilay, & MacLeod, 1983; 
Peltola, 1983; Wolf, 1966) 
81 Sporadic Apnea (Paydarfar 1995) 
82 Stress-inducible functional laryngospasm (Schmidt, Brugger, & Richter, 1985) 
83 Suffocative laryngismus (Rhodes, 1892) 
84 Upper airway obstruction misdiagnosed as asthma (Coleman & Cooper, 1989) 
85 Variable extrathoracic airflow obstruction (Das et al., 1999) 
86 Variable vocal cord dysfunction (Kivity et al., 1986) 
87 
Vocal cord dysfunction (Ahrens, Seibt, & Kitz, 2001; Al-Alwan & Kaminsky, 2012; 
Amimoto et al., 2012; Anbar & Hehir, 2000; Ayres & Gabbott, 2002; Ayres & Mansur, 
2011; Bahrainwala & Simon, 2001; Balkissoon & Kenn, 2012; Benninger et al., 2011; 
Bernstein, 2014; S. Brugman, 2003; S.M.; Brugman & Newman, 1993; Brugman & 
Simons, 1998; Caraon & O’toole, 1991, 1991; Cheng et al., 2013; Cho et al., 2012; 
Christopher, 2006; Christopher et al., 1983; Christopher & Morris, 2010; Cline et al., 
2006; Cohen, 2010; Cohen & Bellucci, 2011; Cummings et al., 2013; Deckert & Deckert, 
2010; de la Hoz et al., 2008; Doshi & Weinberger, 2006; Earles, Kerr, & Kellar, 2003; 
Echternach, Verse, Delb, & Richter, 2009; Filaire et al., 2001; Fowler, Gore, Vyas, & 
Haines, 2010; Frank-Ito, Schulz, Vess, & Witsell, 2015; Gimenez & Zafra, 2011; 
Goldman & Muers, 1991; Greenberger & Grammer, 2010; Guglani et al., 2014; Hamberg 
& Karlsson, 2014; Heinle et al., 2003; Herin et al., 2012; Hicks et al., 2008; Holmes et 
al., 2009; Hoyte, 2013; Huggins et al., 2004; Jain et al., 2006; Jamilla et al., 2000; Kenn 
& Balkissoon, 2011; Kenn & Hess, 2008; Kenn & Schmitz, 1997; Landwehr, Wood II, 
Blager, & Milgrom, 1996; MacConnell et al., 2014; McFadden & Zawadski, 1996; 
McQuaid, Spieth, & Spirito, 1997; Meltzer et al., 1991; Mikita & Mikita, 2006; Mikita & 
Parker, 2006; Morris & Christopher, 2010; Morris et al., 1999; Morris, Oleszewski, 
Sterner, & Allan, 2013; Morris et al., 2006; Nascimento et al., 2013; Newman et al., 
1995; Newman, 2003; Newman & Dubester, 1994; Niggemann et al., 1998; Nolan, 
Chrysler, Phillips, Goodman, & Rusakow, 2007; Noyes & Kemp, 2007; Nugent, Nugent, 
Whisman, White, & Hagan, 2003; Parker & Berg, 2002; Parsons et al., 2010; Patterson & 
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O’Connell, 1994; Perkins & Morris, 2002; Peters et al., 2003; Rameau, Foltz, Wagner, & 
Zur, 2012; Rhodes, 2008; Richards-Mauzé & Banez, 2014; Kenneth W. Rundell & 
Weiss, 2013; Selner et al., 1987; Sokol, 1993; Sullivan et al., 2001; Suttithawil, 
Chakkaphak, Jaruchinda, & Fuangtong, 2006; Tajchman & Gitterman, 1996; Taramarcaz 
et al., 2004; Tilles et al., 2013; Traister, Fajt, Whitman-Purves, Anderson, & Petrov, 
2013; Vlahakis et al., 2002; Watson et al., 2009; Wilson & Wilson, 2006; Wood II & 
Milgrom, 1996; Young, Finn, Fox, Emery, & Bruetman, 2008) 
88 Vocal cord dysfunction syndrome (Nastasi, Howard, Raby, Lew, & Blaiss, 1997) 
89 Vocal cord malfunction (Kattan & Ben-Zvi, 1985) 
90 Vocal fold motion impairment (VFMI) (Ongkasuwan et al., 2016) 
91 
Work-associated irritable larynx syndrome (Anderson, 2015; Hoy, Ribeiro, Anderson, & 
Tarlo, 2010) 
92 Work-related laryngeal syndromes (Hoy, 2012) 
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APPENDIX B: EARLY ADOLESCENT TEMPERAMENT QUESTIONNAIRE – FEAR 
SUBSCALE 
On this questionnaire, you will find statements that people might use to describe themselves. The 
statements refer to a wide number of activities and attitudes. For each statement, please circle the 
answer that best describes how true each statement is for you. There are no best answers. People 
are very different in how they feel about these statements. 
 
1 - Almost always untrue 
2 - Usually untrue 
3 - Sometimes true, sometimes untrue 
4 - Usually true 
5 - Almost always true 
 
I feel scared when I enter a dark room at home 1     2     3      4     5 
I worry about my family when I’m not with them 1     2     3      4     5 
I get frightened riding with a person who likes to speed 1     2     3      4     5 
I worry about my parent(s) dying on me 1     2     3      4     5 
I worry about getting into trouble 1     2     3      4     5 
I am nervous about some of the kids at school who sometimes 
push people into lockers and through other kids’ books around 
1     2     3      4     5 
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APPENDIX C: ANTERIOR GLOTTAL CONFIGURATION INSTRUCTIONS FOR 
RATERS 
(1) Identify the following coordinates by clicking your mouse, using the following laryngeal 
landmarks:  
(2) Single click on medial tip of the right vocal process  
Follow medial edge of superior surface of right vocal fold to the vertex of the 
anterior commissure (or slightly passed) 
(
A) 
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(B) Double click at vertex of anterior commissure (or slightly anterior). 
 
(C) Single click on medial tip of the left vocal process  
 
 
(
B) 
(
C) 
(
B) 
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Follow medial edge of superior surface of left vocal fold to the vertex of the anterior 
commissure (or slightly beyond).  
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(D) Double click at vertex of anterior commissure. 
 
To accept, hit ENTER 
 To redo, hit any other key, and then ENTER 
 
 
(3) If the vocal process is obstructed (e.g., arytenoid prolapse), drop coordinates anterior to 
the vocal process and follow the marginal edges of the superior vocal fold (posterior to 
anterior) to vertex (or slightly anterior) of anterior commissure. Then indicate as 
“posterior obstruction” with image number (found at the top of the image [#.bmp]) to 
Adrianna.   
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(4) If the anterior commissure is occluded (e.g., epiglottic collapse), follow the marginal 
edges of the superior true vocal folds (posterior to anterior) until crosshairs are created 
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near the anterior commissure (see example below). Then indicate as “anterior occlusion” 
with image number (found at the top of the image [#.bmp]) to Adrianna.   
 
(5) If the entire glottal region is occluded, indicate “total occlusion” with image number 
(found at the top of the image [#.bmp]) to Adrianna.   
(6) If the image is so poor that you aren’t comfortable with your measurement, say “poor 
image” with the number. 
(7) Ignore humps, bumps, and lumps on vocal folds, when following the line from the 
posterior process to anterior commissure  
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APPENDIX D: VISUAL ANALOG SCALE PERCEPTUAL RATINGS 
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APPENDIX E: SUPRAGLOTTIC MOVEMENT INSTRUCTIONS FOR RATERS 
Indicate the number corresponding to the severity of laryngeal obstruction for each loci of 
obstruction on excel spreadsheet (see below for reference):  
Obstruction 
Type 
0 1 2 3 
Arytenoid 
prolapse1 
Expected maximal 
abduction of the 
aryepiglottic folds 
with no visible 
medial rotation (top 
of cuneiform 
tubercles pointed 
vertical or slightly 
lateral) 
Visual medial 
rotation of the 
cranial edge of the 
aryepiglottic folds 
and tops of the 
cuneiform tubercles 
Further medial 
rotation of the 
cuneiform tubercles 
with exposure of the 
mucosa on the 
lateral sides of the 
tubercles 
Medial rotation 
until near 
horizontal position 
of the cuneiform 
tubercles and tops 
of the cuneiform 
tubercles move 
towards the midline 
Epiglottic 
Collapse2 
Epiglottis hugs the 
tongue 
Epiglottis between 
0-45° 
Epiglottis between 
45-90° 
Epiglottis over 90° 
Ventricular 
(False) Fold 
compression
3 
Absent 1/3 of the true vocal 
folds covered 
2/3 of the true vocal 
folds covered 
True vocal folds 
completely hidden 
1Validated by Maat (2011); 2validated by Catalfumo et al., (1998); 3validated by Schonweile et al (1998) 
 207 
APPENDIX F: DYSPNEA INDEX 
 
Dyspnea Index – Revised 
 
 
Subject ID:  _________ 
 
    
 
Date:  ___/___/______ 
 
 
 
Below are some symptoms that you may be feeling.   
Please circle the number that indicates how often you feel these symptoms. 
  
 
(0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, 4 = always) 
 
 
 
 
1. I have trouble getting air in.       0    1    2    3    4 
 
2. I feel tightness in my throat when I am having my breathing problem.  0    1    2    3    4 
         
3. It takes more effort to breathe than it used to.     0    1    2    3    4 
 
4. Changes in weather affect my breathing problem.     0    1    2    3    4 
 
5. My breathing gets worse with stress.      0    1    2    3    4 
 
6. I make sound/noise breathing in.      0    1    2    3    4 
 
7. I have to strain to breathe.       0    1    2    3    4 
 
8. My shortness of breath gets worse with exercise or physical activity  0    1    2    3    4 
 
9. My breathing problem makes me feel stressed     0    1    2    3    4 
 
10. My breathing problem causes me to restrict my personal and social life.   0    1    2    3    4 
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APPENDIX G: RESPIRATORY RETRAINING THERAPY (CONCEPTUAL) 
Respiratory retraining therapy (RRT) – also known as laryngeal control therapy, breathing 
retraining, and speech therapy, among others – is the standard of care for individuals with ELBD 
(Doshi & Weinberger, 2006; Hatzelis & Murry, 2012; Hoyte, 2013; Matrka, 2014; Murry et al., 
2011; Nacci et al., 2010; Sandage & Zelazny, 2004). RRT is comprised of various breathing 
exercises using focused abdominal breathing and a semi-occluded vocal tract to slow down rate of 
breathing and regulate breathing patterns; RRT may also be used to reduce arousal and stress levels 
that can result from the these abnormal breathing rates and patterns (Chapell, 1994; Greenberger 
& Grammer, 2010; Husein et al., 2008; Newman, 2003; Powell et al., 2000). Although RRT is 
considered the “gold standard” for management of ELBD, the efficacy of RRT, to date, has not 
been empirically tested and is largely based on anecdotes and expert opinion.  
Principles central to RRT include: (1) understanding of the anatomy and physiology of the 
larynx and systems involved in ELBD, (2) increased self-awareness of one’s own breathing 
patterns, (3) increased self-awareness of physical stress and tension, (4) the use of restorative 
breathing patterns, (5) incorporation of new breathing patterns during movement and activity, and 
(6) application of breathing techniques during acute episodes (CliftonSmith & Rowley, 2011). To 
address these principles, RRT involves three components: (1) education, (2) training in supposedly 
optimal33 abdominal breathing and laryngeal configuration, and (3) recovery breathing. A 
summary of each of these components, as well as psychological and physiological hypotheses 
about the underlying therapeutic mechanisms are provided next.  
                                                 
33 Although was constitutes “optimal” is unclear due to the lack of empirical study of RRT and appreciation of normal 
respiratory laryngeal physiology, in general. 
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Education 
The educational component to RRT involves (a) psycho-educational counseling, (b) vocal hygiene 
education, and (c) trigger awareness. Psycho-educational counseling focuses on increasing the 
patient’s motivation to address the issues and adherence to the program,validates the patients’ 
concerns, and empowers the patient. Activities include counseling, anatomy and physiology 
education, and endoscopic visual biofeedback. The SLP also provides the patient with the rationale 
for behavioral management (Gibson & Vertigan, 2009). Vocal hygiene programs help reduce 
laryngeal irritation that can perpetuate laryngeal hypersensitivity and dysfunction. This goal is 
accomplished by reducing environmental or internal irritants (e.g., noxious fumes; 
laryngopharyngeal reflux) and incorporating hydration (systemic and surface) to reduce irritation 
caused by mucosal dryness (Andrianopoulos et al., 2000). Trigger awareness helps the patient 
recognize specific environments or behaviors that need to be managed (Andrianopoulos et al., 
2000; Sandage & Zelazny, 2004). 
“Optimal” abdominal breathing and laryngeal configuration in respiration 
Training in optimal abdominal breathing and laryngeal configuration focuses on coordination of a 
relaxed throat and breathing involving lower abdominal excursions during respiratory cycles. 
These techniques aid with the establishment of “low breath,” reduce extrinsic laryngeal tension, 
prevent clavicular breathing, increase self-awareness, prepare the patient for voluntary breath 
control, and direct attention away from the larynx (Gallivan, Hoffman, & Gallivan, 1996). Steps 
include placing one hand on the chest and the other hand on the mid-abdomen (below the rib cage), 
lowering the shoulders, breathing gently in through the nose and out through pursed lips, while 
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allowing the abdomen to move freely. Negative practice is also incorporated. This last therapeutic 
strategy involves tightening and relaxing various muscles (e.g., feet, thighs, hands, lips) in order 
to increase bodily awareness and help the patient identify localized tension, so that he/she may 
actively release said tension once identified (Mathers-Schmidt, 2001; Sandage & Zelazny, 2004). 
Recovery breathing 
Recovery breathing involves quick inspiration (~1 second) and slower expiration on pursed lips 
(~2-3 seconds), while simultaneously incorporating lower abdominal breathing. A quick 
inspiration forces abduction of the vocal folds while expiratory pursed lip breathing slows down 
breathing rate and reduces state of arousal (e.g., anxiety, panic), abducts the vocal folds via 
increased intraoral pressure, keeps focus away from the larynx, and helps to break the dyspneic 
cycle (Andrianopoulos et al., 2000; Gallivan et al., 1996; Mathers-Schmidt, 2001). To reach 
automaticity with the task, the patient repeats recovery-breathing techniques while asymptomatic 
for 5 minutes intervals, 10-20 times throughout the day. The SLP then works closely with the 
patient to apply the techniques to the patient’s individual triggers within different settings. The 
triggers are presented in a deliberate, yet gradual manner to increase desensitization to the triggers 
(Mathers-Schmidt, 2001). 
Potential mechanisms underlying RRT 
Various psychosocial and biomechanical hypotheses have been attributed to the putative success 
of RRT, but the exact mechanisms are unknown. Psychosocial hypotheses suggest RRT may 
increase relaxation, reduce anxiety, or give the individual an opportunity to be distracted from the 
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uncomfortable sensation of dyspnea by refocusing with a structured task. RRT may also promote 
self-reassurance, self-control, self-efficacy, self-awareness, sense of mastery, and empowerment 
(Garssen, de Ruiter, & Van Dyck, 1992; Han, Stegen, De Valck, Clement, & Van de Woestijne, 
1996; Lum, 1983). Biomechanical hypotheses suggest lowering the larynx, depressing the base of 
tongue, reducing tongue tension, or abducting the vocal folds through subglottal pressure changes 
“optimize” oropharyngeal or laryngeal posture (Gibson & Vertigan, 2009). Future studies are 
needed to elucidate the facilitative mechanisms that help relieve dyspneic symptoms in patients 
with ELBD. 
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APPENDIX H: RESPIRATORY RETRAINING (MASS EYE AND EAR PROTOCOL) 
Respiratory Retraining Therapy 
Laryngeal Control Postures: Preventative 
“Open the Gate” 
Think wide in throat 
 
● Yawn 
● Internal yawn/stifle smile or laugh 
● Pop your ears (start to yawn but don’t go into a full yawn) 
● Deliberate swallow 
● Thrust out tongue with exhale (“Lion’s breath”) 
● Thrust out jaw 
● Flare neck out (like saying “oops” with your neck) 
●  “Gimme a break” face 
● Sneeze face 
● Push entire tongue to roof of mouth 
● Curl tongue back in mouth 
● Push tongue tip to back of bottom teeth 
● Cleaning back teeth (upper and lower) with tongue 
● Puff cheeks up with air, briefly hold your breath, then release 
● Puff cheeks up with air while breathing through nose 
● Raspberries/tongue trills 
 
Ratios: _____ : _____ 
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Rescue Breathing: Recovery 
 
● Breathe/exhale/blow out gently through puckered lips (like you are 
blowing candles out on a cake) 
● Take a wide breath (not deep! “open the gate!”)  
o through your nose (like you’re smelling something nice) 
o through puckered lips (like you’re sucking a thick milkshake 
through a straw) 
● Repeat cycle. 
 
Counts:  
Inhale: _____  
Exhale: _____ 
 
_____________________________________________________ 
 
Remember! 
1. You can’t die from it 
2. It’s not a breathing problem 
3. We are retraining/reprogramming muscle patterns 
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